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Chapter 1  
Introduction 
 
The ageing process has a diverse impact on health and functional status which 
makes old populations heterogeneous (Lowsky et al., 2014). To capture this 
variability, researchers use several measures or indicators of the health status in 
old age. Among the most common measures are morbidity, physical 
functioning, cognitive functioning and disability (Santoni et al., 2015). This 
thesis investigates the variability of multimorbidity and functional limitations 
in the ageing population in England. Multimorbidity is the co-occurrence of two 
or more diseases within a person (Van den Akker, 1998). On average, every third 
person in the world has multimorbidity and the proportion of the population 
with multimorbidity is growing (Nguyen et al., 2019). Functional limitations are 
restrictions in performing fundamental physical and mental actions used in 
daily life (Verbrugge and Jette, 1993). The proportion of population with 
functional limitations is also growing (Guzman-Castillo et al., 2017). This thesis 
seeks to explore the extra-individual factors behind the growth in 
multimorbidity and functional limitation as well as their unequal distribution 
in the ageing population of England. Chapter 1 sets up the background for the 
topic, introduces the purpose and the aims of the thesis, its structure and the 





People are living longer lives but they have more diseases and disability. 
Societies have transitioned from an era dominated by communicable diseases 
to a world dominated by non-communicable diseases (Niessen et al., 2018). 
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They have become the leading cause of death in the world. In 2016 chronic 
diseases were responsible for 71% of the 57 million deaths globally and this 
proportion is increasing (World Health Organization, 2018). Among the major 
causes of death are cardiovascular diseases, cancers, chronic respiratory 
diseases and diabetes (World Health Organization, 2018). The role of non-
communicable diseases now features prominently in both the High Income and 
the Low Income Countries (Garin et al., 2015; Niessen et al., 2018).  
These trends have also been described as the global rise in multimorbidity which 
refers to the presence of two or more diseases within a person (Van den Akker, 
1998; Global Burden of Disease Study 2013 Collaborators, 2015). Estimates of 
multimorbidity prevalence vary depending on the definition, the classification 
and number of studied conditions, the type of sample, age group, etc. A 
systematic review by Violan et al. (2014) focused on studies of primary care 
patients and found that the estimates ranged from 13% among young patients 
to 95% in a population aged 65 years and older. The prevalence of 
multimorbidity in general populations has been assessed between 13% and 72% 
(Fortin et al., 2012). Another review found the variation in general populations 
between 20% and 30% and 55% to 98% among elderly people (Marengoni et al., 
2011). A rising prevalence has been documented in the United Kingdom (Reilly 
et al., 2015), the Netherlands (van Oostrom et al., 2016), Germany (Tetzlaff et 
al., 2018) and Canada (Canizares et al., 2018). The trend is unlikely to stop. The 
absolute number of people affected by multimorbidity in England is expected 
to double by 2035, and at least two thirds of the gain in life expectancy above 65 
years will be spent with four or more chronic conditions (Kingston et al., 2018). 
More older people with multimorbidity will mean more suffering as 
multimorbidity in the course of ageing often combines with functional 
limitation. Functional limitations refer to restrictions in performing 
fundamental physical and mental actions used in daily life (Verbrugge and Jette, 
1993). The fundamental physical actions include body mobility, discrete 
motions and strengths, difficulties with seeing, hearing and communicating. 
Akin to multimorbidity, the number of people living with functional limitations 
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between 2015 and 2025 in England will increase by about 2-3% per year. While 
the lifespan will increase, a quarter of life expectancy at age 65 years will involve 
functional limitation (Guzman-Castillo et al., 2017).  
Multimorbidity accompanied by functional limitation reduces quality of life 
(Kanesarajah et al., 2018). People living with multimorbidity combined with 
functional loss often experience pain, both physical and psychological. The 
impaired functioning and pain prevent them from conducting previous daily 
and social life. Typical for multimorbidity and loss of function is that physical 
and emotional difficulties compound. One illness gets aggravated by the effects 
or treatment of another (Sells et al., 2009). Such a series of escalating physical 
problems, often accompanied by psychological and social issues, has been 
referred to as “cascading crises” in individual lives or “probabilistic cascade” 
(Sells et al. 2009). Some symptoms may interfere in patients’ ability to manage 
their care (Liddy, Blazhko and Mill, 2014). People with multimorbidity 
combined with functional limitation often talk about living in a state of endless 
uncertainty, in particular when it comes to their future health. The situation 
prevents them from planning future life, leading to feelings of powerlessness, 
low self-esteem and withdrawal from social interaction (Coventry et al., 2015; 
O’Brien et al., 2014). In addition, people with more complex multimorbidities 
struggle with following strict treatment regimes, take many different medicines 
(polypharmacy) and may face hospitalization as well as high medical charges, 
for example as co-payments for care, technical aids or home care (Calderón-
Larrañaga et al., 2019).  
All this makes life with multimorbidity time-consuming, as much for patients 
as for the health care systems. People with multimorbidity and functional loss 
use disproportionately more specialist services than people with a single health 
problem. The number of chronic diseases significantly predicts hospital usage 
(Lehnert et al., 2011). Higher utilization of health care services also adds to 
higher treatment costs compared to managing a single morbidity (Picco et al., 
2016). Multimorbidity also predicts mortality. A study found that older adults 
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with multimorbidity were 44% more likely to die during follow-up than those 
with no or only one chronic disease (Calderón-Larrañaga et al., 2019). 
The significance of the increasing multimorbidity and functional limitation for 
public health and welfare is elevated by the evidence suggesting an unequal 
distribution of this burden in populations (Northwood et al., 2017). In Britain, a 
compound nexus of young age, socio-economic deprivation and combined 
physical-mental multimorbidity has been identified (Barnett et al., 2012; Reilly 
et al., 2015; Cassel et al., 2018). While multimorbidity has been studied as a 
problem of the elderly, there is evidence that in absolute terms the majority of 
people with multimorbidity are younger than 65 years of age (Barnett et al., 
2012; Sauver et al., 2015; Cassel et al., 2018). Younger age of the onset of 
multimorbidity is often related to living in poverty. Experiences of social 
deprivation also exacerbate the complexity of multimorbidity. In Scotland, the 
combination of physical and mental morbidities was two to threefold more 
prevalent in the deprived areas than in the affluent ones and among younger 
people it is more common than physical multimorbidity (McLean et al., 2014). 
The relationship between deprivation, young age and physical-mental 
multimorbidity was confirmed for a representative patient population in 
England (Cassel et al., 2018). The cluster is becoming common in the whole of 
the United Kingdom and increases at a faster rate in the poorer areas, as shown 
in a study for the period 2000-12 (Reilly et al. 2015). 
 
1.2 The research purpose and aims  
 
This thesis positions itself in the interdisciplinary efforts to understand the 
‘social drivers’ of the increase in prevalence and inequalities in multimorbidity 
and functional limitation of ageing people in England. The purpose of the study 
is to enrich the growing discussions about the relationship between 
multimorbidity and functional decline and their societal context with new 
evidence and perspectives. 
13 
 
In a representative sample of people aged 50 years and older in England, 
collected in the period 2002-2015, this thesis aims to: 
1. Explore the prevalence of multimorbidity and functional limitation 
and its variation by key socio-demographic characteristics. 
2. Examine the association of key social determinants of health with 
multimorbidity and functional limitation. 
3. Explain how childhood circumstances shape the risk of 
multimorbidity and functional limitation in old age. 
 
1.3 Thesis structure 
 
1.3.1 Chapter 1. Introduction 
Chapter 1 introduces the general topic of the thesis and its societal relevance. It 
further presents the purpose and the aims of the thesis, its structure and the 
final outputs of the project. 
 
1.3.2 Chapter 2. Literature review 
The literature review documents the evolution of thinking about 
multimorbidity from the early predominantly medical perspectives to an 
integration of the knowledge about biological mechanisms with social theories 
of health. The review pays particular attention to the socio-theoretical aspects 
of the body of research. The review identifies and discusses a series of 
knowledge gaps in the studies of multimorbidity and functional limitation, 




1.3.3 Chapter 3. Trends in multimorbidity and functional limitation in the 
ageing population of England 
The first analytical chapter builds on the emerging evidence of multimorbidity 
becoming more common and more socially stratified (Reilly et al., 2015; Van 
Oostrom et al., 2016; Tetzlaff et al., 2018; Canizares et al., 2018). The study 
focuses on changes in the multimorbidity and functional limitation of an ageing 
population in England over time. It explores trends in prevalence and 
distribution of prevalence by age, sex and socio-economic status at a population 
level. Two measures of multimorbidity are used comparatively. The first 
measure, referred to as basic multimorbidity in the study, is based on the count 
of single chronic diseases which the study argues is limited in its ability to 
identify the multimorbid individuals with higher care needs. The second 
measure, complex multimorbidity, defines a situation when three or more body 
systems are affected by chronic disease (Harrison et al., 2014).   
The repeated cross-sectional analysis covers the period between 2002-03 and 
2014-15, in total seven time points. At each time point, stratification analysis 
explores the differences in prevalence between age groups (5-year bands from 
age 50 to 85+), women and men and by quintiles of net household wealth. The 
potential health inequalities in multimorbidity and functional limitation and 
interaction effects between time and age and SES and age are verified in 
marginal effects logistic regression analysis. 
 
1.3.4 Chapter 4. Social determinants of multimorbidity and functional 
limitation in the ageing population of England  
After establishing robust inequalities in mutimorbid population by differences 
in the amount of household wealth, Chapter 4 builds on the theories of social 
determinants of health and health inequalities and includes more social 
determinants into the analysis. The extension addresses a lack of contextual 
data in studies of multimorbidity which typically focus on a few risk factors 
(Northwood et al., 2017). The study introduces material determinants 
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(household wealth, occupational level and subjective social status), psycho-
social determinants (sense of control over individual life, loneliness, supportive 
children, supportive friends, supportive partner and participation in 
community organisations) and behavioural determinants (level of physical 
activity, consumption of alcohol and smoking). The analysis explores the 
association of the social determinants with the likelihood of multimorbidity, 
complex multimorbidity and multiple functional limitations.  
Towards this aim, the study uses a population-averaged regression model, based 
on the Generalized Estimating Equations with autoregressive correlation 
structure. The model takes into account the within-individual correlation of 
outcomes over the period 2002-2015.  
 
1.3.5 Chapter 5. Material, psychosocial and behavioural pathways to 
multimorbidity and functional limitation of old people 
This explanatory study seeks to explain how the associations of the material, 
psychosocial and behavioural social determinants with multimorbidity and 
functional limitation develop over an individual life course. Instead of the usual 
single socio-economic proxy for childhood circumstances the chapter uses three 
latent measures: Social Class, Adverse Experiences and child’s health. The 
study’s aims are to establish if the effects of childhood circumstances on 
multimorbidity and functional limitation in old age are direct or indirect. 
Another aim is to assess the role of material, psycho-social and behavioural 
pathways in mediating effects of childhood circumstances on the individual 
differences in old age multimorbidity and functional limitation.  
The key methods are Factor Analysis in the initial stage of the analysis, 
Structural Equation Model with latent factors and a complex mediation analysis 
with both parallel and serial mediators in the same model. Statistical inference 




1.3.6 Chapter 6. Conclusion 
The final chapter recapitulates the knowledge gaps identified in the literature 
review. It summarizes the key research findings and discusses their contribution 
to the current knowledge in the field of multimorbidity. The limitations of the 
research are established, with suggestions about how the thesis could be 
improved. The chapter concludes with a series of ideas for possible extensions 




Chapter 3 Trends in multimorbidity and functional limitation in the ageing 
population of England is based upon Singer, Green, Rowe, Ben-Shlomo, Kulu 
and Morrissey (2019) Trends in multimorbidity, complex multimorbidity and 
multiple functional limitations in the ageing population of England, 2002-2015, 
Journal of Comorbidity, https://doi.org/10.1177/2235042X19872030.  
Chapter 3 differs from the published paper in Section 3.2.1. It contains a more 
detailed information about the core members included in the analyses and the 
weights used. 
Chapter 4 Social determinants of multimorbidity and functional limitation in the 
ageing population of England originates from Singer, Green, Rowe, Ben-Shlomo 
& Morrissey (2019) Social determinants of multimorbidity and multiple 
functional limitations among the ageing population of England, 2002-2015, 
Social Science & Medicine – Population Health, doi:10.1016/j.ssmph.2019.100413. 
Chapter 4 differs from the published version in Section 4.5.1. It has been 
expanded by explaining more about the number of core members, the data 
format and the principles behind the weighting. 
Chapter 5 Material, psychosocial and behavioural pathways to multimorbidity 
and functional limitation of old people will be submitted to Social Science & 
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Leo Singer developed the research aims of the thesis, designed the analytical 
chapters, performed the analyses and wrote the manuscripts. Mark Green and 
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helped interpret some of the findings. Yoav Ben-Shlomo helped to construct the 
health outcomes. All the co-authors were involved in revising the manuscript 
and gave final approval. Leo Singer has full access to all the data in the study 
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Chapter 2  
Literature review 
 
This literature review introduces the development of studies in multimorbidity 
since its beginning (Feinstein, 1970). The review presents and discusses the 
fundamental issues of how multimorbidity and functional limitation are defined 
and measured. The lack of a unified approach to its measurement is 
demonstrated by the variety of prevalence estimates in the literature. This 
chapter presents current evidence on the growing trends in the prevalence of 
multimorbidity and functional limitation. The drivers of this trend are critically 
discussed and the sole explanation - the ageing of society - is questioned. The 
roles of societal factors such as health inequalities and social determinants of 
health are reviewed and placed in a historical context. The review argues that 
in order to understand the mechanisms through which societal factors 
influence multimorbidity and functional limitation of ageing populations, life 
course theories and models are needed. Research gaps that arise from the 
literature review are summarised and discussed at the end of the chapter. 
 
2.1 Defining multimorbidity and functional limitation 
 
The idea of a co-occurrence of health problems dates back to studies of 
alcoholism and associated mental disorders in the United States in the 1940s 
(Kushner 2014). The American clinical epidemiologist Alvan Feinstein first 
coined the term comorbidity in 1970, referring to “any distinct additional clinical 
entity that has existed or that may occur during the clinical course of a patient 
who has the index disease under study” (Feinstein 1970, pp. 456-7). As an 
example, Feinstein mentioned lung cancer as an index disease with 
comorbidities such as ulcers, coronary artery disease or diabetes mellitus. The 
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purpose of the article was to explain how, in clinical trials focused on a single 
disease, an unobserved comorbidity confounded the treatment effects on 
participants which led to biased practices in subsequent care management. In 
the same article Feinstein expanded his definition to “also include such ‘non-
disease’ clinical entities as: pregnancy, deliberate dieting in an effort to lose 
weight and certain symptomatic reactions such as nausea, that may occur with 
various therapeutic manoeuvres” (Feinstein 1970, p. 457). This caveat opened 
the door to ambiguity in the understanding of comorbidity as it increasingly 
encapsulated a range of morbidities, conditions, symptoms and risk factors (Le 
Reste, 2013).  
At its first stage, comorbidity research was dominated by psychiatry, later joined 
by neurology, general and internal medicine, surgery, cardiology and oncology 
(Catalá-López et al. 2018). The number of publications has increased 
exponentially since 1970, with two thirds of the articles published after 2010 
(Catalá-López et al. 2018). The growing comorbidity research reflected the 
underlying processes of ageing and ailing societies in the West (Gruenberg, 
1977; Crimmins and Beltrán-Sánchez, 2011). It was shaped and driven by the 
health care demands and policies of the period (Crimmins and Beltrán-Sánchez, 
2011). A major topic in clinical and primary care studies of multimorbidity 
became the inadequacy of care management based on single-disease or index-
disease regimens. The core of the problem lay in the general assumption that 
comorbidities in every patient were physiologically associated with the index 
disease and hence a treatment plan focused on the index disease could address 
all other morbidities. However multi-factorial medicine and growing 
availability of multi-variate analytical software allowed insights into complex 
biological pathways, overlapping clinical symptoms and their genesis (Krieger, 
2011). Clinical studies increasingly agreed that the index-disease specific 
guidelines were appropriate only for situations when chronic diseases shared 
the same pathways (Van Weel and Schellevis, 2006).  
The trend towards a pluralistic understanding of comorbidity where no disease 
assumed a dominant role was reinforced by a growing interest in comorbidity 
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from epidemiology and public health (Almirall and Fortin, 2013). A more 
consistent classification was proposed, whereby the term multimorbidity would 
be used in situations where no index disease was considered, and the term 
comorbidity would be reserved for situations in which one of the diseases is 
considered as index (Van den Akker et al., 1998).  
A plurality of definitions refers to the situation of having simultaneously a 
multiple number of chronic and acute diseases (Johnston et al., 2019). Some 
authors define multimorbidity as the co-existence of “two or more diseases” 
(Van den Akker et al., 1998), “multiple diseases or medical conditions” (Huntley 
et al., 2016), “chronic diseases” (Diederichs et al., 2011) or “any combination of 
chronic disease with at least one other disease (acute or chronic) or 
biopsychosocial factor (associated or not) or somatic risk factor” (Le Reste, 
2013). Various additional terms, referring to the same health problem, can be 
found in the literature: polymorbidity, polypathology, pluripathology, 
multipathology, multicondition, multiple chronic conditions (Almirall and 
Fortin, 2013).  A bibliometric analysis of the two most commonly used concepts 
has shown that while the number of articles using the term comorbidity still 
exceeds those using multimorbidity, the difference is getting smaller (Ramond-
Roquin and Fortin, 2016).  
Functional limitation is another aspect of health status that is a subject of this 
thesis. Functional limitation can be approached within the framework of the 
Disablement Process (Verbrugge and Jette, 1993). This widely used framework 
describes a pathway starting from disease, through impairments and functional 
limitations, leading to disability (Martin et al., 2017). Impairments are defined 
as dysfunctions and structural abnormalities in body systems, which can have 
impacts on physical, mental or social functioning (Verbrugge and Jette, 1993). 
Functional limitations refer to restrictions in performing fundamental physical 
and mental actions used in daily life (Verbrugge and Jette, 1993). The 
fundamental physical actions include body mobility, discrete motions and 
strengths, difficulties with seeing, hearing and communicating. The 
Disablement Process can be illustrated by arthritis (disease) leading to joint 
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stiffness and pain (an impairment). Joint stiffness and pain may in turn result 
in difficulty bending (functional limitation), which may ultimately result in a 
mobility disability (Martin et al., 2017). 
The Disablement Process framework defines conceptually the relationship 
between multimorbidity and functional limitation as the first being the cause 
of the latter (Verbrugge and Jette, 1993; Santoni et al., 2015). Some conditions 
(e.g. high blood pressure) may have no effect on the physical functioning but 
other do, such as arthritis. Multimorbidity predicts increase in functional 
limitation of ageing and old people, which has implications for quality of life, 
need for health care, residential care and premature mortality (Sibritt, Byles and 
Regan, 2007; Ryan et al., 2015; Jindai et al., 2016). Combination of 
multimorbidity with functional impairments and limitations leads to situations 
where the total impact of multimorbidity on individuals’ health surpasses the 
impact we would expect from the summed effect of single conditions (Schaefer, 
2012; Calderón-Larrañaga, 2019).  
 
2.2 Measuring multimorbidity and functional limitation 
 
There is no consensus in the way researchers measure multimorbidity. The way 
it is measured in a population results from the choice of its definition and from 
deciding on other operationalizing criteria, such as the definition of disease 
entity and the number of diseases included in the analysis (Fortin et al., 2012; 
Johnston et al., 2019). The plurality in measurement complicates comparison of 
findings across populations and developing universal guidelines and 
interventions (Johnston et al., 2019). 
 
2.2.1 Disease definition 
The International Classification of Diseases (ICD) is the international standard 
for reporting diseases and related health conditions and the 11th version was 
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launched in 2018 (WHO Classifications, 2019). ICD is used primarily in 
hospitals. It allows for comparability of morbidity and mortality statistics 
between different countries, because it contains precise medical diagnoses  
given by trained professionals.  The other common classification system is the 
International Classification of Primary Care (ICPC). The system records 
diagnosed conditions and undiagnosed symptoms, which are both commonly 
managed in primary care.   
Regardless of the particular classificatory system, multimorbidity studies differ 
in how they define a disease entity. Some only treat a specific disease as an 
entity, while others use a group of conditions as an entity, for example 
myocardial infarction and chronic ischaemic heart disease (Diederichs et al., 
2011). Some studies tried to ensure counting only distinct entities by considering 
only chronic diseases which affect distinct body systems. The Cumulative Illness 
Rating Scale (CIRS) is used to classify chronic diseases by body systems, for 
example cardiac, vascular or haematological systems (Hudon, Fortin and 
Soubhi, 2007). Constructing a CIRS scale requires using either ICD or ICPC 
system and rating severity of conditions which can only be done by a doctor or 
a trained nurse (Hudon et al., 2007). An alternative to the CIRS system is using 
the chapters within the ICD or ICPC classifications which are both based on 
body systems. Australian researchers Harrison et al. (2014) compared 
prevalence estimates of multimorbidity if classified as ICD, ICPC and CIRS 
chapters. They confirmed the validity of the measures and found no difference 
in estimates between the three systems.  
The fact that ICD, ICPC and CIRS systems can be treated as commensurable 
means that researchers are no longer dependent on health records with 
measures of severity (CIRS). New opportunities open up to explore 
multimorbidity of distinct body systems as a specific case of multimorbidity 
using self-reported data and population-based surveys. This is relevant 
especially for multimorbidity of the elderly. The biology of ageing is 
characterised by a simultaneous breakdown or dysfunction of several distinct 
pathologies or body systems (Fabbri et al., 2015; Cesari et al., 2017). A study 
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found that the affected body systems of people aged 65+ were predictors of the 
total length of hospital stays and of the number of hospital admissions. Future 
research should consider measuring multimorbidity in the elderly by counting 
the body systems affected rather than the number of single diseases.  
 
2.2.2 Number of diseases defining multimorbidity 
While most studies define multimorbidity as the co-occurrence of two or more 
chronic diseases (2+), another common cut-off point is 3+ (Diederichs et al., 
2011). Previous studies found that using a higher cut-off point reduces the 
prevalence estimates (Diederichs et al., 2011; Fortin et al. 2012). This means that 
more people have two diseases than three, having three diseases is more 
common than having four, etc. When multimorbidity was defined as 2+ disease 
entities, nearly half of the patients in primary care had multimorbidity, whereas 
using the 3+ cut-off reduced the prevalence to less than one in four (Harrison 
et al., 2014). Multimorbidity defined as 2+ leads to especially high estimates 
among the elderly. A paper reviewing multimorbidity of the elderly found that 
prevalence among those aged 65 or older ranged between 55% and 98% 
(Marengoni et al., 2011). Another study using the 2+ definition identified almost 
91% as having multimorbidity and 66% when using 3+ among the 70-79 years 
old (Harrison et al., 2014).  
The high estimates were considered to be unhelpful in identifying old patients 
with higher need (Fortin et al., 2012). Measuring multimorbidity of elderly 
people by the number of affected body systems might be more appropriate than 
just summing up the number of single diseases (Harrison et al., 2014). Counting 
a sum of single disease entities does not differentiate between the co-occurrence 
of problems developing within one body system and within two or more 
systems. The difference matters as multimorbidity may have a larger impact on 
overall health if it arises out of disparate conditions rather than closely related 
comorbidities. Piette and Kerr (2006) distinguished between concordant 
conditions, which are part of the same pathophysiology, and the unrelated 
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discordant conditions which do not share joint pathophysiology or underlying 
risk factor. For example, diabetes is concordant with hypertension and several 
vascular diseases but discordant with chronic back pain, asthma or cancer 
(Piette and Kerr, 2006). Treating discordant conditions is more complicated as 
chronic conditions in different body systems are likely to compete for treatment 
(Piette and Kerr, 2006). 
Another consequence of merely summing up the diseases of elderly patients is 
that it may put them at risk of overdiagnoses and polypharmacy where some 
treatments act against the other (Cesari et al., 2017). A comparative use of both 
2+ and 3+ definitions of multimorbidity has been recommended by Fortin et al. 
(2012) and Harrison et al. (2014).  
 
2.2.3 Number of diseases studied  
Diederichs et al. (2011) reviewed the number of diseases studied and found that 
the selection scope ranged from four to 102 diseases (with a mean number 18.5). 
The most common criteria for the choice of a certain number was high 
prevalence or high impact on patients (Diederichs et al. 2011, Harrison et al. 
2014). It has been noted that the more diseases are analysed, the higher 
prevalence rates one gets (Van den Akker 2001; Diederichs et al., 2011; Fortin et 
al., 2012; Harrison et al., 2014). A review of 21 prevalence studies (both in primary 
care and among the general population) found much less variation in 
prevalence estimates between studies that analysed twelve or more diseases 
compared to studies with a smaller number (Fortin et al., 2012). The minimum 
of twelve diseases was recommended to achieve better commensurability of 
prevalence results between studies (Fortin et al.., 2012). 
 
2.2.4 Patterns 
The most frequently observed clusters of morbidity combinations are also 
referred to as patterns of multimorbidity (Agborsangaya et al., 2012; Prados-
Torres et al., 2014; Ng, 2018). The goal of analysing patterns is to identify relevant 
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multimorbidity groups from a larger set of diseases (Marengoni et al., 2011; 
Violan et al., 2014). In a systematic review Violan et al. (2014) distinguished 
between two types of patterns: the most frequent combinations of specific 
diseases (pairs and triplets) and clusters of health conditions with the highest 
degree of association.  
While the original research was limited to considering comorbid pairs and 
triplets of morbidities, methods such as cluster analysis, factor analysis and 
multiple correspondence analysis make it possible to consider how larger 
numbers of diseases tend to occur in conjunction with each other (Violan et al., 
2014; Prados-Torres et al., 2014; Ng, 2018). With the use of these techniques it is 
possible to gain an overall picture of how diseases are associated in a particular 
population. Violan et al. (2014) and Prados-Torres et al. (2014) agreed that the 
three most common patterns are: cardiovascular and metabolic diseases 
(diabetes, hypertension, heart diseases, hyperlipidemia, obesity); mental health 
disorders (depression, anxiety, neurological disorders); and musculo-skeletal 
diseases (arthritis, arthopathy, osteoporosis, back-neck pain). Constructing 
patterns or clusters of multimorbidity requires good quality medical data with 
clear diagnostic differentiation between diseases and accompanying health 
conditions and symptoms (Ng, 2018).  
 
2.2.5 Prevalence rate 
In order to be able to compare the magnitude of multimorbidity in populations 
with differing sizes, the calculation of prevalence rates is necessary. 
Measurement of prevalence was at the beginning of population research in 
multimorbidity (Van den Akker, 1998).  
Prevalence refers to the proportion of the population with multimorbidity at 
the time of measurement (Marengoni et al., 2011). The estimates of the 
prevalence vary, depending on the definition, the classification and number of 
studied diseases, whether the sample comes from a general population or 
primary care, age group, etc. In the first systematic review assessing both high-
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income and low-income countries, the prevalence of multimorbidity in general 
populations was estimated at 33.1% (Nguyen et al., 2019). The average was 37.9% 
for the high-income countries and 29.7% for the low-income countries. Disease 
count, based on self-reported data, was the most common measure of 
multimorbidity (Nguyen et al., 2019).  
A systematic review by Violan et al. (2014) focused on studies of primary care 
patients and found that the estimates ranged from 13% among young patients 
to 95% in a population aged 65 years and older. The prevalence of 
multimorbidity in general populations has been assessed between 13% and 72% 
(Fortin et al., 2012). Another review found the variation in general populations 
between 20% and 30% and for the elderly people between 55% and 98% 
(Marengoni et al., 2011).  
Prevalence rates based on patient data from primary care tend to be higher than 
self-reported rates measured in the population which is due to a selection bias 
(Valderas et al., 2009, Mokraoui et al., 2016). The selection bias reflects the fact 
that people who visit primary care often have more diagnoses compared to 
those who avoid medical consultations (Valderas et al., 2009, Mokraoui et al., 
2016). The variation in prevalence rates between studies makes it difficult to 
establish to what extent the differences between countries and between general 
and patient populations are real and to what extent they are caused by 
differences in methodological approaches (Fortin et al., 2012). 
 
2.2.6 Measuring functional limitation 
Measuring physical function and functional limitation in population research 
serves to enable comparing outcomes between population groups, for example 
levels of function between men and women, young and old, or according to 
some social characteristics (Lang, 2011). It can also help to predict outcomes or 
trajectories, for example disability, death and use of care or hospital admissions 
(Guralnik and Ferucci, 2003; Lang, 2011).  
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Functional limitation in older people can be measured either by standardized 
performance measures or by self‐report (Guralnik and Ferucci, 2003). Direct 
measurement of physical performance requires a trained assessor to ensure 
validity. Commonly measured outcomes are grip strength, walk speed, tests of 
balance or “get up and go” tests (Lang, 2011). Self-reported measurement is 
gained from questionnaires and includes three aspects: Activities of Daily Living 
(ADLs), Instrumental Activities of Daily Living (IADLs) and mobility. ADLs 
such as getting out of bed, toileting, bathing, dressing, grooming, and eating are 
frequently used. These measures can help to detect early onset of disability and 
are key factors for care management (Hopman-Rock et al., 2019). IADLs are used 
to measure skills for independent living and are more complex than ADLs. 
Ability to do housekeeping, shopping, bathing, to prepare food or use telephone 
are commonly assessed (Lang, 2011). Finally, self-reported measures of mobility 
include ability to walk quarter of a mile, walk 100 yards, climbing one or several 
flights of stairs and pulling or pushing objects (Lang, 2011). 
 
2.2.7 Measuring multimorbidity and functional limitation in the thesis 
Most reviewers recommend that decisions about the operationalizing criteria 
should be guided by the purpose of the study and available data (Johnston et 
al., 2019). This thesis explores multimorbidity and functional limitation in a 
representative population of people aged 50 years or older in England. As the 
ageing process is characteristic by the deterioration in physical and functional 
health, the cumulation of multimorbidity and functional limitations in the 
study population can be anticipated. Ageing is also marked by chronic 
dysregulation across multiple body systems, with multimorbidity and 
functional loss being the markers of the process (Fabbri et al., 2015). This thesis 
uses measures of multimorbidity and functional limitations that are appropriate 





Multimorbidity, defined as “the co-occurrence of two or more diseases within a 
person” (Van den Akker et al., 1998), will be called basic multimorbidity in the 
thesis. The summary count of single disease entities is the most common way 
of constructing a measure of multimorbidity in population-based studies which 
rely on self-reported data (Nguyen et al., 2019). This thesis constructs a binary 
measure of basic multimorbidity which identified persons in the ELSA survey 
who had two or more diseases out of the list of 25 diseases.  
 
Complex multimorbidity 
Summing up single disease entities cannot distinguish between the co-existence 
of problems developing within one body system and within two or more 
systems. Piette and Kerr (2006) distinguished between concordant conditions, 
which are part of the same pathophysiology, and the unrelated discordant 
conditions which do not share a joint pathophysiology or underlying risk factor. 
For example, diabetes is concordant with hypertension and several vascular 
diseases but discordant with chronic back pain, asthma or cancer (Piette and 
Kerr, 2006). Treating discordant conditions is more complicated as chronic 
conditions in different body systems are likely to compete for treatment (Piette 
and Kerr, 2006). Fortin et al. (2012) and Harrison et al. (2014) thought that this 
distinction had a broader relevance than just for clinicians managing 
multimorbidity. They proposed considering the difference between 
concordancy and discordancy in the process of defining multimorbidity itself. 
The concept of complex multimorbidity has been defined as “the co-occurrence 
of three or more chronic conditions affecting three or more different body 
systems within one person without an index chronic condition” (Harrison et al., 
2014, p. 8).  
The thesis will use complex multimorbidity as a comparative definition along 
with basic multimorbidity, in line with the recommendations made by Fortin et 
al. (2012) and Harrison et al. (2014). The body systems in the thesis were 
33 
 
represented by the chapters of the ICD (10th version). All 25 chronic diseases 
analysed in this thesis were classified to eight ICD-10 chapters. 
 
Multiple functional limitations 
To assess functional limitation this thesis will use a measure of multiple 
functional limitations. It is derived from the Disablement Process Framework 
(Verbrugge and Jette, 1993). The process defines a progression from disease, 
through impairments and functional limitations, to disability (Martin et al., 
2017). The measure of multiple functional limitations merges measures of 
functional limitations – ADLs, IADLs and mobility - with measures of functional 
impairment (geriatric symptoms) into a summary outcome.  The thesis also 
proposes the measure of having ten or more functional limitations as this might 
reflect the increase in limitations arising from multiple body systems as part of 
the ageing process (Jindai et al., 2016; Calderón-Larrañaga et al., 2019).  
 
2.3 The growth of multimorbidity and functional limitation 
 
The prevalence of multimorbidity and functional limitation is growing across 
populations of higher income countries. The occurrence of multiple diseases in 
the Netherlands doubled between 1985 and 2005. The proportion of patients 
with one and two chronic diseases remained stable, the proportion of those with 
three chronic diseases increased by approximately 60% and the prevalence of 
four or more chronic diseases increased by approximately 300% (Uijen and van 
de Lisdonk, 2009). An increasing trend among Dutch primary care patients 
between 2004 and 2011 was also noted by Van Oostrom et al. (2016). The trend 
was only partially explained by population aging, suggesting that other 
epidemiological and societal factors explained a substantial part of the increase. 
Trends for functional limitations are contradictory. Prevalence of ADLs grew by 
6% between 2000 and 2005 in the general population in the United States 
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(Fuller-Thomson et al., 2009). A study from Spain reported a concurrent growth 
in multimorbidity, ADLs and IADLs between 2001 and 2009 for both men and 
women (Palacios-Ceňa et al., 2013). Analysis of the same Health survey for the 
period 2009-2017 in contrast showed a slight decrease in ADLs and IADLs in 
Spain (Carmona-Torres et al., 2019). A slow decline in functional limitations was 
also reported from the Netherlands (Van Gool et al., 2011) and Sweden 
(Angleman et al., 2015).  
Due to the significant societal implications, the growth of multimorbidity in 
populations generates attempts to explain it. The expansion of morbidity theory 
postulates that higher life expectancy due to the decline in infectious diseases 
leads to people living longer but in chronic illness (Gruenberg, 1977). Better 
disease management and treatment contribute to even more people surviving 
in ill health (Gruenberg, 1977; Crimmins and Beltrán-Sánchez, 2011; Muschik et 
al., 2017). The theory often features as an explanation of the increasing 
prevalence of multimorbidity in the Western societies (Fabbri et al., 2015; 
Kingston et al., 2018). For example, a population study from Germany found 
that the number of life years spent with multimorbidity rose at a faster pace 
than total life expectancy. The researchers pointed to the expansion of 
morbidity theory as an explanation (Tetzlaff et al., 2017). 
The theory sometimes leads to interpretations that the growth is generated 
exclusively by people living longer lives. Solutions generated within this 
framework tend to focus on better clinical management and support for the 
elderly (Marengoni et al., 2011). The need to prevent or reduce the incidence of 
multimorbidity motivated researchers to start searching for the estimates of 
multimorbidity at younger age groups. The evidence began to challenge the 
assumptions of the expanded morbidity theory. A population-based study of the 
Adelaide region (Australia) revealed that over 40% of those who had 
multimorbidity were less than 60 years of age (Taylor et al., 2010). In a 
representative survey of the residents in Alberta (Canada), 70% of multimorbid 
population were younger than 65 years (Agborsangaya et al., 2012). Similar 
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results were reported from Scotland (Barnett et al., 2012) and the United States 
(Sauver et al., 2015).  
Canizares et al. (2018) posed an important question whether the increase in 
multimorbidity documented by others could be explained by some current 
contingent factors (period effects) or whether the tendency can be observed 
across cohorts and for an extended period of time. The multi-cohort study of a 
general Canadian population provided the strongest evidence yet that the 
growth in multimorbidity is a consistent long-term trend affecting all age 
cohorts (Canizares et al., 2018). People are becoming multimorbid at 
increasingly younger age and especially those living in deprived areas. The age-
cohort studies (Agborsangaya et al., 2012; Barnett et al., 2012; Sauver et al., 2015; 
Canizares et al., 2018) indicated that the growth in multiple diseases might be 
explained by more factors than the longer survival rates and medical 
advancements among the ageing population.  
 
2.4 Health inequalities in multimorbidity and functional limitation 
 
Multimorbidity is more common in poorer areas and manifests itself earlier in 
life among poorer people than more affluent people (Violan et al., 2014). The 
prevalence among young and middle-aged patients in the most deprived areas 
of Scotland was the same as the prevalence of 10-15 years older patients from the 
most affluent areas (Barnett et al., 2012). Experiences of social deprivation also 
exacerbate the complexity of multimorbidity. In Scotland, the combination of 
physical and mental morbidities was two to threefold more prevalent in the 
deprived areas than in the affluent ones. Among younger people the physical-
mental multimorbidity is more prevalent than purely physical multimorbidity 
(McLean et al., 2014). The relationship between deprivation, young age and 
physical-mental multimorbidity was confirmed for a representative patient 
population in England (Cassel et al., 2018). The relationship is becoming 
increasingly common in the whole of the United Kingdom and increasing at a 
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faster rate in the poor areas, as shown in study for the period 2000-12 (Reilly et 
al., 2015). The limitation of this body of research is that it is all based on data 
from primary care and social deprivation was only measured by the Carstairs 
index or at an area level. 
Multimorbidity is more common among women than men (Uijen and van de 
Lisdonk, 2008; Marengoni et al., 2011; Salisbury et al., 2011; Prados-Torres et al., 
2015), but some studies did not observe the difference (Fortin et al., 2005; Sauver 
et al., 2015). Women have higher levels of multimorbidity than men in all ages 
but the difference vary by age group and type of morbidities. For example, in 
Scotland the difference was the largest between middle-aged men and women 
(45-54 years old). The combination of physical and mental conditions was more 
common among women (Agur et al., 2016). Similar gender disparities were 
found in a U.S. population-based study (Bobo et al., 2016), with the 
physical/mental multimorbidity 1.7 times more prevalent among females than 
males. The gender differences were greater for  physical/mental multimorbidity 
than for the general multimorbidity.  
Differences in race have been documented in the United States (Quiñones et 
al., 2011, 2019; Sauver et al., 2015). In a nationally representative sample during 
the period 1998-2014, Black middle-aged people (51-55 years old) had a higher 
initial degree of multimorbidity than White participants and their onset was 
four years earlier. In contrast, middle-aged adults of Hispanic origin started 
disease accumulation later than Black adults but at a faster rate than both 
(Quiñones et al., 2019). The interpretation of the racial differences was framed 
in terms of different risk factors affecting population groups. Observing 
residents in a county in the U.S. state of Minnesota in 2000-13 showed that 
compared to White participants, the incidence of multimorbidity was higher in 
Blacks but lower in Asians (Sauver et al., 2015). Importantly, all of these studies 





2.4.1 The persistence of health inequalities 
The rise of modern capitalism, enabled by the industrial revolution, exacerbated 
the material gap between the rich and the poor. The concentration of this social 
divide in urban slums led to a whole array of health problems, including 
infectious epidemics and premature death. The fast trend gave birth to the first 
scientific inquiries into the scale and causation of what is today called health 
inequalities (Eyler, 1979). Edwin Chadwick’s seminal Report on Sanitary 
Condition of the Labouring Population of Great Britain, published in 1842 was an 
early-Victorian synthesis of the existing medical knowledge about the effects of 
industrialization on the health of the working classes (Chadwick, 1843). 
Chadwick argued that the dire effects of England’s urban environment on ill 
health were comparable to a war killing more people every year than any 
military conflict the country had ever fought (Chadwick, 1843).  
The rise in living standards in the 20th Century and especially under welfare 
state reforms led to an improvement in health and life expectancy of whole 
populations and the working classes in particular (Krieger, 2011; Bartley, 2017). 
These improvements in Western countries translated into a gradual shift in the 
major causes of mortality and morbidity from acute infectious diseases to 
chronic non-communicable diseases, a process called “the epidemiologic 
transition” (Omran, 1971). The leading killers such as cholera, typhus or 
tuberculosis were replaced by chronic diseases, such as cardio-vascular diseases 
and cancers (Global Burden of Disease Study 2013 Collaborators, 2015). 
However, despite these pervasive changes, the pattern of health inequalities 
remained similar to that in the infectious era: people with lower status in society 
were more likely to be chronically ill and to die early than people above them 
in the social hierarchy (Cockerham, 2007). The simultaneous improvement in 
the general population health and the perseverance of class differences in health 
indicated to the existence of some hidden, structural forces at play. Link and 
Phelan (1995) postulated that this time-invariant association between socio-
economic circumstances and health is a major reason why these circumstances 
should be understood as the “fundamental” cause of health inequalities. 
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2.4.2 Social determinants of health 
Risky health behaviours which contribute to chronic diseases and 
multimorbidity, such as smoking, alcohol use, diet and physical inactivity, are 
not randomly distributed in the population. They cluster within individuals and 
within certain population groups (Poortinga, 2006; Sheiham, 2012). The risks 
are more prevalent among men, those who are economically inactive, people 
with low socio-economic status and low educational attainment (Bartley, 2017; 
Poortinga, 2006). The existence of this social pattern in risk behaviour shifted 
the focus from the level of individual risk factors to include more distant, 
“upstream” factors: social determinants of health. The social determinants of 
health refer to any extra-individual and non-medical factors influencing health, 
including health-related knowledge, attitude or behaviours (Bartley, 2017; 
Braveman, Egerter and Williams, 2011). The social determinants can take the 
form of various social, cultural, economic, and political conditions that 
influence the health of individuals and populations (De Maio, Mazzeo & Ritchie, 
2013, Lucyk and McLaren, 2017). In contrast “downstream” factors are those 
located close to the health effects (both in space and time). They are influenced 
by the upstream social determinants (Braveman, Egerter and Williams, 2011; 
Short and Mollborn, 2015).  
The theory of the social determinants of health originated in the 1980s from 
debates about the limitations of focusing on individual risk factors in the 
prevention of disease. Critics argued that to understand why the ill health and 
risk behaviours were distributed in a non-random way, the focus needed to shift 
to the population level (Rose, 2001). These observations gave rise to the inter-
disciplinary programme of health inequality studies. The Black report was the 
first major synthesis of current knowledge in the United Kingdom (Black, 1980). 
Interpreting the nature of health inequalities as multi-causal, it put forward 
three possible explanations of the relationships between social inequality and 
health. 
First, it acknowledged the inequalities in the material living conditions as the 
central causal axis (Black, 1980). The report was based on census data for the 
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period from 1921 to 1971, which had no questions on income. That is why the 
material conditions were defined in terms of social class, car ownership and 
housing. Five categories of occupational status from the Registrar General were 
used as indicator of social class. The report observed a clear class gradient for 
most causes of death and mortality. Other factors such as work accidents, 
overcrowding or smoking were seen as closely related to the key importance of 
social class (Black, 1980). Inequalities were also found in the utilization of health 
care services, where members of the working classes were attending the primary 
care much less than those of higher occupational categories. 
The second explanation was cultural/behavioural (Black, 1980). People in lower 
status occupations and with lower education levels were hypothesized to belong 
to a particular culture that encourages behaviours such as alcohol consumption, 
smoking, physical inactivity and unhealthy diet. On the contrary, people in 
managerial and professional occupations with higher education tended to show 
more health-promoting behaviour (Black, 1980). A common interpretation of 
these differences was based on theories of individual choice, where change 
towards health seeking had to come from the change in individual values. The 
other alternative, supported by the authors of the report, was to see behaviour 
embedded within a social structure that is associated and reinforced by social 
class (Black, 1980).  
Third, the theory of social selection, according to which people with poor health 
in childhood and adolescence were more likely to end up in lower social classes 
and worse health as adults (Black, 1980). Social class is allocated the status of a 
dependent variable and health has a higher degree of causal significance. For 
example, the Registrar General’s class I might have the lowest premature death 
rate because it was composed of the healthiest people in the population, while 
the reverse was true for class V. The term selection refers to the fact that over 
their life time people with worse health drift towards the bottom rungs of the 
social structure while the healthiest are upwardly mobile (Black, 1980). 
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2.4.3 Socio-economic gradient of health 
The Black Report and subsequent studies, such as the Whitehall studies of the 
British civil servants, introduced the idea of the socio-economic gradient of 
health. It refers to the observed fact that health inequality increases in a gradual 
way with each step down the social hierarchy, regardless of the measure being 
occupational status or income (Bartley, 2017).  
The first Whitehall Study in 1967 explored differences in mortality among 17,530 
male employees of the highly stratified British Civil Service (Department of 
Medical Statistics and Epidemiology, 2008). The study demonstrated that the 
higher grade a person had in the hierarchy, the longer he might expect to live 
compared to people in lower positions. These disparities were independent of 
the possible risk factors, such as smoking. The observation of the gradient was 
even more interesting given the fact that the Civil Service did not employ the 
poorest and the richest members of society (Department of Medical Statistics 
and Epidemiology, 2008).  
Twenty years later, the Whitehall II study shifted the focus from mortality to 
disparities in morbidity among 10,308 civil servants aged between 35 and 55 
years (Marmot and Brunner, 2005). Two thirds were men and one third were 
women. Since the first wave in 1985-88, data had been collected every two to 
five years. The study revealed a similar socio-economic gradient for morbidity 
to the one identified earlier for mortality. The social gradient was observed for 
a range of different diseases: cancers, heart disease, lung disease, 
gastrointestinal disease, depression, suicide, back pain and general feelings of 
ill health (Marmot and Brunner, 2005). In addition to the material and 
behavioural factors observed by the Black Report (Black, 1980), the Whitehall II 
study postulated the existence of psychosocial factors influencing health 
inequality (Marmot and Brunner, 2005). For example, psychosocial working 
conditions such as job strain or job control influenced the risk of the coronary 




The social gradient in health has been repeatedly observed in other studies and 
in other countries (Cockerham, 2007; Krieger, 2011; Bartley, 2017). Longitudinal 
analyses demonstrated that the gradient remains persistent over time (Marmot 
and Brunner, 2005). The notion of the health gradient has gradually replaced an 
older notion of a clear health divide or health gap between the poorest and the 
richest (Bartley, 2017). The explanation of the existence of the gradient became 
the subject of debate among researchers (Krieger, 2011). What really puzzled 
them was the question why the disparities in health and mortality do reflect the 
stratification in social class in such a subtle way. Why does having a little more 
make a person a little healthier? (Bartley, 2017) To answer questions like these, 
a series of explanatory mechanisms were proposed, linking social conditions in 
early life with health outcomes in old age. 
 
2.5 Life course models of health 
 
The life course approach to chronic disease has been formalized and developed 
since the 1990s (Ben-Shlomo and Kuh, 2002). Life course epidemiology was 
defined as “the study of long-term biological, behavioural and psychosocial 
processes that link adult health and disease risk to physical or social exposures 
acting during gestation, childhood, adolescence, earlier in adult life, or across 
generations” (Ben-Shlomo and Kuh, 2002, p. 285). It arose out of polemics 
among epidemiologists about the causation of chronic diseases. The ‘biological 
programming’ hypothesis claimed that the foetal developments and early 
infancy determined the future adult health outcomes (Barker, 1998). Others 
focused on adult factors, such as lifestyles (alcohol consumption, smoking, 
diet), physiological and psychosocial measurements (blood pressure, stress, 
psychological dispositions) or adult socio-economic status (income, 
occupation, etc.) Life course epidemiology attempted to provide a synthesis, 
built around the idea that chronic disease over individual life is shaped by 
biological, psychological and socio-economic factors. These factors act 
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simultaneously, cumulatively and interactively (Davey Smith and Lynch, 2004) 
and during the entire life span. Incorporating the conditions of antenatal and 
infant development with previous emphases on solely adult risk factors, the life 
course models helped to improve our causal explanation of diabetes, 
cardiovascular and respiratory diseases (Stone, Netuveli and Blane, 2014).  
Crucially for understanding multimorbidity, life course epidemiology 
emphasizes that the role of time and timing is essential for explaining the links 
between societal structures, human agency and individual health consequences 
(Stone, Netuveli and Blane, 2014). The notion of the time lag between exposure 
and diagnosis or manifestation of a chronic disease is embedded in the 
etymology of the word chronic which refers to the Greek word chronos, ‘time’. 
Life course models explicitly require temporal ordering of exposures and their 
mutual relationships (Kuh et al., 2003, Stone et al., 2014). A sequence of linked 
exposures is called a pathway or chain of risk. It raises disease risk if one harmful 
exposure to lead to another. The two original life course models are critical 
period and accumulation of risk models.  
The critical period model (in the past called biological programming) refers to 
an exposure during a specific period which has lasting or long-term effects on 
the development of the individual (Ben-Shlomo and Kuh, 2002). For example, 
foetal growth retardation may lead to chronic problems in adult life, such as 
cardiovascular disease or diabetes (Haas and Oi, 2008). The accumulation of risk 
model postulates that factors increasing disease risk or protection from disease 
do accumulate over the life span (Ben-Shlomo and Kuh, 2002). For instance, a 
child from poor family is more likely to fail at school, leave school at an early 
age, take up unskilled work that is hazardous and badly paid and, when retired, 
spend the rest of their life in financial insecurity. This model is sometimes called 
the ‘chain of risks model’ as it suggests that early life advantage or disadvantage 
can set individuals on diverging paths (upward or downward), simply because 
one exposure leads to another. This has also been expressed in terms of a 
probabilistic cascade, referring to risks building up over time (Krieger, 2011). 
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Some authors took the pathway aspect from this model and formalized it into a 
distinct, pathway model (Niedzwiedz et al., 2012).  
A typical challenge for life course methodology is the long period of time 
between an early-life exposure and a health outcome. The period increases the 
likelihood that any association may be due to confounding by a third factor 
(Stone, Netuveli and Blane, 2014). For example, an analysis establishing that 
smoking mediates the association between childhood adversity and adult 
anxiety and depression needs to take into account potential confounding effects 
of low education, alcohol consumption or social isolation (Sheikh, 2017). 
Controlling for potential confounding factors is key in order to conclude that 
smoking “alone” is the pathway between childhood adversity and 
anxiety/depression in adulthood (Sheikh, 2017). The estimated strength of the 
association between exposure and outcome may be biased or entirely missed if 
a wrong time period is chosen for analysis (Stone, Netuveli and Blane, 2014). 
Among the social pathways (mediating mechanisms) linking lower social class 
position to ill health are economic deprivation, lack of educational 
opportunities and exposures resulting from neighbourhood environmental 
characteristics such as violence, pollution, lack of green spaces, etc. (Krieger et 
al., 2011). Social class position is strongly associated with access (or lack of) to 
social and public resources, health care, social networks, institutional resources, 
and inter-generational resources (Krieger, 2011; Bartley, 2017). Another pathway 
involves differences in the nature of the social and work environments, and 
includes the differences in stress levels from adverse labour market experiences, 
including unemployment, underemployment, and exposure to stressful work 
(Kawachi and Berkman, 2001). These specific pathways linking social class to 
health may change over time. New causal paths might emerge, others might be 
removed, yet as long as the society continues to have a social class structure, 
these health disparities will be perpetuated (Link and Phelan, 1995; Bartley, 




Figure 2. 1 Solar and Unwin’s framework (2010) adopted by the Commission on Social Determinants 
of Health of the World Health Organisation. In this model the intermediary determinants represent 
the same processes as that this thesis defines as pathways. Source:  
 
2.5.1 Life course approach to multimorbidity and functional limitation 
Whilst there is a wealth of longitudinal and life course studies of various health 
outcomes, research on multimorbidity lags behind. Health professionals are 
sometimes interested in predicting development of multimorbidity, especially 
for conditions that constitute the highest treatment burden and contribute to 
future health care costs (Marengoni et al., 2011). Specific diseases have different 
mean age of onset and order of appearance and some are associated with an 
increased risk of developing other morbidities (Ruel et al., 2014). For instance, 
a study found that having type 2 diabetes as the first disease was strongly related 
to subsequent rise in the number of diseases as well as to the rise in prevalence 
from 32% to 80% in the period of 16 years (Pouplier et al., 2018). 
People develop multimorbidity at different rates. Findings from ten General 
Practices in England documented five different trajectories: people with no 
recorded chronic diseases (40%), those who developed their first chronic 
morbidity over 3 years (10%), a developing multimorbidity group (37%), a group 
with increasing number of morbidities (12%), and 1% were a multi-chronic 
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group with many chronic morbidities (Strauss et al., 2014). A population-based 
study of middle-aged women in Australia identified five distinct trajectories 
over a nine-year period, two of which were cumulative. Rates of growth were 
related to individual and social factors. Being overweight or obese, having low 
education and low income were key risk factors for belonging to a trajectory 
where conditions accumulated over time. Smoking, alcohol consumption and 
physical inactivity were other risk factors for the development of some 
trajectories (Jackson et al., 2015). Trajectories of accumulation of 
multimorbidity conditional on race were modelled in the United States and 
found racial differences both in the time of onset and in the rate of developing 
multimorbidity (Sauver et al. 2015; Quiñones et al., 2019). 
The aforementioned studies explored multimorbidity over a limited period of 
time in adulthood and old age. This literature review identified only two studies 
that examined the influence of childhood circumstances on multimorbidity and 
functional limitation in adult or old age. Pavela and Latham (2015) used the 
Health and Retirement Study in the U.S. After controlling for adult SES and 
adult health behaviours (obesity, smoking, visiting a doctor visit in the past 2 
years, having health insurance), the study found no effect of childhood SES but 
the effect of childhood health did persist. They characterized the model as the 
accumulation of risk where the socio-economic circumstances from early life 
followed a pathway model while the childhood health effects reflected a critical 
period model. Haas and Oi (2018) analysed variation in multimorbidity and 
functional limitations across 13 European countries. They found that the 
relationship between childhood illness with multimorbidity and functional 
limitations in later life persisted in the presence of adult socioeconomic 
circumstances and health behaviours. The effects of childhood social class were 
attenuated by socio-economic circumstances in adulthood.  
 




This literature review has discussed the fundamental issues and problems of 
how multimorbidity and functional limitation are defined and measured. The 
chapter presented evidence of growing prevalence in multimorbidity and 
functional limitation and raised the question whether the trend can be 
explained solely by the ageing of populations. The review suggested that 
population studies of multimorbidity and functional limitation could benefit 
from the knowledge of health inequalities, social determinants and life course 
models of health, accumulated by researchers in other fields of inquiry. A series 
of research gaps gradually emerged from the literature review. 
 
2.6.1  Taking into account the biology of ageing  
The first limitation in the current understanding of multimorbidity of the 
elderly is the lack of consideration of the effects of the biological process of 
ageing. The process is characteristic by a simultaneous breakdown in several 
distinct body systems (Fabbri et al., 2015; Cesari et al., 2017). The number of 
affected body systems of old people can predict hospital stays and hospital 
admissions (Condelius et al., 2008). Outside the research in primary care based 
on health records (the CIRS system), there is currently a lack of studies 
measuring multimorbidity in the elderly by counting the body systems rather 
than single diseases.  
The thesis responds to this problem by measuring multimorbidity differently 
from counting single diseases. Compared to basic multimorbidity, complex 
multimorbidity, as a more discriminating definition, should lead to selecting 
population with discordant chronic conditions (Piette and Kerr, 2006) and with 
higher health care need (Harrison et al., 2014; Cesari et al., 2017). Biology of 
ageing also leads to an increase in functional limitations arising from distinct 
body systems (Jindai et al., 2016; Calderón-Larrañaga et al., 2019). The thesis 
proposes the measure of having ten or more functional limitations to reflect this 




2.6.2 Inequalities in the onset of multimorbidity and functional limitation 
This literature review has presented growing evidence of socio-economic 
inequalities in multimorbidity, both in terms of prevalence and in terms of its 
onset in life (Barnett et al., 2012; Violan et al., 2014). Life in social deprivation 
also leads to higher complexity of multimorbidity. A study found that 
discordant multimorbidity – affecting several body systems that is harder to 
treat (Piette and Kerr, 2006) - was more prevalent in the deprived areas of 
Scotland than in the affluent ones. Discordant multimorbidity is more prevalent 
among younger people than older people (McLean et al., 2014). The clustering 
of social deprivation, young age and discordant multimorbidity was also 
observed in England (Cassel et al., 2018). The prevalence of this cluster is 
increasing in the whole of the United Kingdom and the growth is faster rate in 
the poorer areas (Reilly et al., 2015).  
The body of research on inequality in multimorbidity is limited in three ways. 
The data originates from the primary care sources and estimates for the general 
population are missing. Secondly, multimorbidity has only been measured 
using the count of single diseases. Given the complex nature of the nexus 
between deprivation, young age and discordancy of multimorbidity, an 
alternative measure, taking into account the discordancy of multimorbidity 
(McLean et al., 2014), could uncover a more accurate distribution of 
multimorbidity across the socio-economic gradient. Thirdly, social deprivation 
was only measured by the Carstairs index and by the Index of Multiple 
Deprivation. Using area-based indices may lead to classifying some individuals 
as deprived when they are not and vice versa (Fischbacher, 2014).  
 
2.6.3 The role of the social determinants  
The integrative framework of the material, psychosocial and behavioural 
determinants and the related Solar and Unwin’s framework (Figure 1) are the 
theoretical drivers of this literature review. They help to illuminate the gaps in 
the body of research. Current studies pay insufficient attention to the 
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contextual factors of multimorbidity (Bayliss et al., 2014). Researchers use socio-
demographic, socio-economic, psychological or behavioural characteristics in 
isolation from each other (Northwood et al., 2017; Pathirana and Jackson, 2018). 
A review of 22 articles found that the most frequently studied determinants 
were the health care system (13 articles) and health behaviours (8). Psychosocial 
factors (6) and material circumstances (1) were examined less often (Northwood 
et al., 2017). Studies which include social determinants within the context of 
multimorbidity do so without any theoretical framework that would explain the 
choice of the contextual factors and their relevance (Bayliss et al., 2014; 
Northwood et al., 2017; Pathirana and Jackson, 2018). 
Building on the Black Report (Black, 1980) and Whitehall II study (Marmot and 
Brunner, 2005), the three most influential explanations of health inequality, the 
material, psychosocial and behavioural, were integrated into a unified 
framework (Moor, Spallek and Richter, 2017). These hypotheses are no more 
conceived as mutually exclusive but rather complimentary and their effects 
assessed in one model (Van Oort, van Lenthe and Mackenbach, 2005; Robertson 
et al., 2015). A systematic review found eleven studies which jointly examined 
the contributions of material, psycho-social and behavioural pathways to 
inequalities in self-reported health (Moor, Spallek and Richter, 2017). While 
results varied between studies, material pathways had the largest effect (11% to 
76% of explained variance), followed by the psycho-social (4% to 49%) and the 
behavioural factors (7% to 45%). These studies were cross-sectional, so the 
influence of reverse causation could not be excluded.  
This thesis builds on the theoretical legacy of the Black Report (Black, 1980) and 
the Whitehall Study II (Marmot and Brunner, 2005) and it applies the integrated 
framework of the material, psychosocial and behavioural determinants to the 




2.6.4 Taking a life course approach  
Some quantitative researchers characterized multimorbidity as a multi-causal 
phenomenon (Schäfer et al., 2012; Jackson et al. 2015). Multi-causality refers to 
the fact that chronic disease is caused by more than one causal mechanism, and 
every causal mechanism involves the joint action of several component causes 
(Krieger, 2011). Another major characteristic of multimorbidity is the time lag 
between exposure and diagnosis or manifestation of a chronic disease. It is a 
gradual accumulation of mundane experiences, wearing down the body systems 
rather than rare exceptional events that is characteristic of the period leading 
to onset of multimorbidity (Hertzman and Boyce 2010). Whilst it is commonly 
accepted that it often takes the whole lifetime for multimorbidity to 
accumulate, life course investigations are only beginning (Northwood et al., 
2017; Pathirana and Jackson, 2018).  
This review presented a few studies which examined trajectories of change in 
multimorbidity across a period of time (Quiňones et al. 2011, 2019; Strauss et al., 
2014; Jackson et al., 2015; Sauver et al., 2015). Considering the multi-causal and 
temporal character of multimorbidity, these studies are unable to explore life 
course pathways to multimorbidity due to their limited choice of social 
determinants and the narrow window of time.   
This literature review found only one study that formally tested pathways from 
childhood to old age in a mediation model of multimorbidity (Ferraro, Schafer 
and Wilkinson, 2016). Using data from the National Survey of Midlife 
Development in the U.S., childhood was conceptualized into three domains: 
SES (measured with 3 items), family composition (3 items) and abuse (measured 
as a scale). The hypothesized adult pathways were divided into three domains: 
socio-economic status (SES) (an index composed of years of education, 
household income and financial strain), lifestyle risk (based on obesity, 
smoking, drinking) and psychological resources (items for family and friend 
support, family and friend strain, a scale of social integration and the level of 
personal control). The study demonstrated that the childhood social class and 
parental abuse were associated with fewer adult social resources and more 
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lifestyle risks. These pathways, especially smoking and obesity, in turn affected 
the risk of adult multimorbidity. The study operationalized the multi-causality 
of multimorbidity and the time period from childhood to adulthood. 
Reconsidering multimorbidity as a multi-causal process with a long period of 
accumulation that interacts with external, social developments in individual 
lives can also inform the choice of timing of preventative interventions, making 
them more focused and efficient (Stone, Netuveli and Blane, 2014, Green and 




This chapter reviewed the literature on multimorbidity and functional 
limitation, starting from the early predominantly medical perspectives and 
progressing to integrate the knowledge about biological mechanisms with 
social theories of health. The literature review identified several gaps in the 
current state of knowledge that this thesis sought to address. The first limitation 
is methodological. Studies based on general populations with self-reported 
information on health tend to define multimorbidity as two or more diseases. 
This measure does not capture the multimorbidity of disparate body systems, 
which is an important marker of ageing (Fabbri et al., 2015). Second, little is 
known about socio-economic inequalities in the prevalence of multimorbidity 
and functional limitation in general populations and their effect on ageing. A 
few studies that highlighted health inequalities and earlier onset of 
multimorbidity in deprived areas used primary care records (Barnett et al., 2012; 
McLean et al., 2014). Third, while ageing on its own cannot explain the rising 
trends in multimorbidity, the theory of social determinants of health has not 
become part of multimorbidity research yet. Contextual characteristics are 
rather being chosen due to data availability and in isolation from each other 
(Northwood et al., 2017, Pathirana and Jackson, 2018). Fourth, the role of 
childhood and pathway mechanisms on multimorbidity at old age remains 
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unknown. Elucidating the preceding factors would benefit attempts to prevent 




Agborsangaya, C. B., Lau, D., Lahtinen, M., Cooke, T. and Johnson, J. (2012) 
‘Multimorbidity prevalence and patterns across socioeconomic determinants: a 
cross-sectional survey’, BMC public health, 12, 201. doi:10.1186/1471-2458-12-201 
Agur, K., McLean, G. and Mercer, S. (2016) ‘How does sex influence 
multimorbidity? Secondary analysis of a large nationally representative dataset’, 
International journal of environmental research and public health, 13(4), 391. 
doi:10.3390/ijerph13040391 
Almirall, J., and Fortin, M. (2013). The coexistence of terms to describe the 
presence of multiple concurrent diseases. Journal of comorbidity, 3, 4–9. PMID:  
Angleman, S., Santoni, G., von Strauss, E. and Fratiglioni, L. (2015) ‘Temporal 
trends of functional dependence and survival among older adults from 1991 to 
2010 in Sweden: Toward a healthier aging’, The Journals of Gerontology: Series 
A, 70(6), pp. 746–752,  
Barker, D. Mothers, Babies and Health in Later Life. Edinburgh: Churchill 
Livingstone, 1998 
Barnett, K., Mercer, S., Norbury, M., Watt, G., Wyke, S. and Guthrie, B. (2012) 
‘Epidemiology of multimorbidity and implications for health care, research, and 
medical education: a cross-sectional study’, The Lancet, 380(9836), pp. 37-43. 
DOI:10.1016/S0140- 6736(12)60240-2. 
Bartley, M., (2017). Health inequality: an introduction to theories, concepts and 
methods (2nd Edition). Cambridge: Polity Press. 
Bayliss, E., Bonds, D., Boyd, C., Davis, M., Finke, B. (2014) ‘Understanding the 
context of health for persons with multiple chronic conditions: moving from 
52 
 
what is the matter to what matters’, Annals of family medicine, 12(3), 260–269. 
doi:10.1370/afm.1643 
Ben-Shlomo, Y. and Kuh, D. (2002) ‘A life course approach to chronic disease 
epidemiology: conceptual models, empirical challenges and interdisciplinary 
perspectives’, International Journal of Epidemiology, 31(2), pp. 285–293,  
Black, D. (1980) Inequalities in Health: Report of a Research Working Group. 
DHSS, London. 
Bobo, W., Yawn, B., Sauver, J., Grossardt, B., Boyd, C. and Rocca, W. (2016) 
’Prevalence of combined somatic and mental health multimorbidity: patterns 
by age,sex, and race/ethnicity’, The journals of gerontology. Series A, Biological 
sciences and medical sciences, 71(11), 1483–1491. doi:10.1093/gerona/glw032 
Braveman, P., Egerter, S. and Williams, D. (2011) ‘Social determinants of health: 
coming of age’, Annual Revue of Public Health, 32, pp. 381-98. doi: 
10.1146/annurev-publhealth-031210-101218. 
Burden of Disease Network Project (2004) ‘Disability in old age: final report’. 
The Finnish Centre for Interdisciplinary Gerontology, University of Jyväskylä. 
https://ju.se/download/18.3783220012d8f123ca58000115/1520578695703/DISABI
LITY%20IN%20OLD%20AGE.pdf 
Calderón-Larrañaga, A., Vetrano, D., Ferrucci, L., Mercer, S., Marengoni, A., 
Onder, G., Eriksdotter, M. and Fratiglioni, L. (2019) ‘Multimorbidity and 
functional impairment-bidirectional interplay, synergistic effects and common 
pathways’, Journal of internal medicine, 285(3), pp. 255–271. doi:10.1111/joim.12843 
Canizares, M., Hogg-Johnson, S., Gignac, M., Glazier, R. and Badley, E. (2018) 
‘Increasing trajectories of multimorbidity over time: birth cohort differences 
and the role of changes in obesity and income’, The Journals of Gerontology: 




Carmona-Torres, J., Rodriguez-Borrego, M. and Cobo-Cuenca, A. (2019) 
‘Disability for basic and instrumental activities of daily living in older 
individuals’, PLoS ONE, 14(7): e0220157.  
Cassell, A., Edwards, D., Harshfield, A., Rhodes, K., Brimcombe, J., Payne, R. and 
Griffin, S. (2018) ‘The epidemiology of multimorbidity in primary care: a 
retrospective cohort study’, British Journal of General Practice; 68(669): e245-
e251. DOI: https://doi.org/10.3399/bjgp18X695465  
Catalá-López, F., Alonso-Arroyo, A., Page, M., Hutton, B., Alexandre-Benavent, 
R. (2018) ‘Mapping of global scientific research in comorbidity and 
multimorbidity: A cross-sectional analysis’, PloS one, 13(1), e0189091. 
doi:10.1371/journal.pone.0189091 
Cesari, M., Pérez-Zepeda, M. and Marzetti, E. (2017) ‘Frailty and multimorbidity: 
different ways of thinking about geriatrics’, Journal of the American Medical 
Directors Association, 18(4), pp. 361-364. 
Chadwick, E. (1843, reprinted 1965) Report on the Sanitary condition of the 
labouring population of Great Britain. Edinburgh: Edinburgh University Press. 
Chandola, T., Kuper, H., Singh-Manoux, A., Bartley, M. and Marmot, M. (2004) 
‘The effect of control at home on CHD events in the Whitehall II study: gender 
differences in psychosocial domestic pathways to social inequalities in CHD’, 
Social Science & Medicine, 58(8), pp. 1501-09.  
Cockerham, W., (2007). Social Causes of Health and Disease. Cambridge: Polity 
Press. 
Crimmins, E. and Beltrán-Sánchez, H. (2011) ‘Mortality and morbidity trends: is 
there compression of morbidity?’ The Journals of Gerontology. Series B, 
Psychological sciences and social sciences, 66(1), pp. 75–86. 
doi:10.1093/geronb/gbq088 
Condelius, A. (2008) ‘Hospital admissions among 65+ related to 
multimorbidity, municipal and outpatient care’, Archives of Gerontology and 
Geriatrics, 46(1), pp. 41-55. 
54 
 
Davey Smith, G. and Lynch, J. (2004) ‘Life course approaches to socioeconomic 
differentials in health’. In: Kuh D, Ben‐Shlomo Y, eds. A life course approach to 
chronic disease epidemiology. 2nd edn. Oxford: Oxford University Press. 
De Maio, F., Mazzeo, J., and Ritchie, D. (2013) ‘Social determinants of health: a 
view on theory and measurement’, Rhode Island Medical Journal, 96(7), pp. 15-
9.  
Department of Medical Statistics and Epidemiology, Whitehall Study I, 1939-
2008. London School of Hygiene and Tropical Medicine Archives. GB 809 
WHITEHALL' on the Archives Hub website, 
[https://archiveshub.jisc.ac.uk/data/gb809-whitehall], (Accessed 1st August 
2019) 
Diederichs, C., Berger, K. and Bartels, D. (2011) ‘The measurement of multiple 
chronic diseases – a systematic review’, Journal of Gerontology A: Medical 
Sciences, 66A, pp. 301-11. doi: 10.1093/gerona/glq208. 
Eyler, J. (1979) Victorian social medicine: The ideas and methods of William Farr. 
Baltimore and London: The Johns Hopkins University Press. 
Fabbri, E., An, Y., Zoli, M., Simonsick, E., Guralnik, J., Boyd, C. and Ferrucci, L. 
(2015) ‘Aging and multimorbidity: new tasks, priorities, and frontiers for 
integrated gerontological and clinical research’, Journal of the American Medical 
Directors Association, 16(8), pp. 640–647. doi:10.1016/j.jamda.2015.03.013 
Feinstein, A.R. (1970) ‘The pre-therapeutic classification of comorbidity in 
chronic disease’, Journal of Chronic Diseases, 23, 455-468. 
http://dx.doi.org/10.1016/0021-9681(70)90054-8 
Ferraro, K. F., Schafer, M. H., and Wilkinson, L. R. (2016) ‘Childhood 
disadvantage and health problems in middle and later life: Early imprints on 
physical health?’ American Sociological Review, 81(1), 107–133.  
Fischbacher, C. (2014) ‘Identifying “deprived individuals”: are there better 
alternatives to the Scottish Index of Multiple Deprivation (SIMD) for 
socioeconomic targeting in individually based programmes addressing health 
55 
 
inequalities in Scotland?’. The Scottish Public Health Observatory. Accessed 
from:  
Fortin, M., et al. (2005) ‘Prevalence of multimorbidity among adults seen in 
family practice’, Annals of family medicine, 3(3), pp. 223–228. doi:10.1370/afm.272 
Fortin, M., Hudon, C., Haggerty, J., Van den Akker, M., Almirall, J. (2010) 
‘Prevalence estimates of multimorbidity: a comparative study of two sources’, 
BMC Health Services Research, 10:111. doi: 10.1186/1472-6963-10-111. PubMed 
PMID: 20459621;  
Fortin, M., Stewart, M., Poitras, M., Almirall, J. and Maddocks, H. (2012) ‘A 
systematic review of prevalence studies on multimorbidity: toward a more 
uniform methodology’, Annals of family medicine, 10(2), 142–151. 
doi:10.1370/afm.1337 
Fuller-Thomson, E., Yu, B. and Minkler, M. (2009) ‘Basic ADL disability and 
functional limitation rates among older AMERICANS from 2000-2005: the end 
of the decline?’ The Journals of Gerontology. Series A, Biological sciences and 
medical sciences, 64(12), 1333–1336. doi:10.1093/gerona/glp130 
Global Burden of Disease Study 2013 Collaborators (2015) ‘Global, regional, and 
national incidence, prevalence, and years lived with disability for 301 acute and 
chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis 
for the Global Burden of Disease Study 2013’. The Lancet, 386(9995), pp. 743-
800.  . 
Green, M. J., and Popham, F. (2017) ‘Life course models: improving 
interpretation by consideration of total effects’, International journal of 
epidemiology, 46(3), 1057–1062. doi:10.1093/ije/dyw329 
Gruenberg, E.M. (1977) ‘The failure of success’, Milbank Memorial Fund 
Quarterly – Health and Society, 55(1), pp. 3-24.  
Guralnik, J. and Ferucci, L. (2003) ‘Assessing the building blocks of function: 
Utilizing measures of functional limitation’, American Journal of Preventive 
Medicine, 25(3), pp. 112-121.  
56 
 
Guzman-Castillo, M., Ahmadi-Abhari, S., Bandosz, P., Capewell, S. (2017) 
‘Forecasted trends in disability and life expectancy in England and Wales up to 
2025: a modelling study’ The Lancet. Public health, 2(7), e307–e313. 
doi:10.1016/S2468-2667(17)30091-9 
Haas, S. and Oi, K. (2018) ‘The developmental origins of health and disease in 
international perspective’, Social Science & Medicine, 213, pp. 123-133.  
Harrison, C., Britt, H., Miller, G. and Henderson, J. (2014) ‘Examining different 
measures of multimorbidity, using a large prospective cross-sectional study in 
Australian general practice’, BMJ Open 2014;4:e004694. doi: 10.1136/bmjopen-
2013-004694  
Harrison, C., Henderson, J., Miller, G. and Britt, H. (2016) ‘The prevalence of 
complex multimorbidity in Australia’, Australian and New Zealand Journal of 
Public Health, 40(3), pp. 239-244, doi: 10.1111/1753-6405.12509. 
Hertzman, C. and Boyce, T. (2010) ‘How experience gets under the skin to create 
gradients in developmental health’, Annual review of Public Health, 31, pp. 329-
347. doi: 10.1146/annurev.publhealth.012809.103538. 
Hopman-Rock, M., Van Hirtum, H., de Vreede, P. and Freiberger, E. (2019) 
‘Activities of daily living in older community-dwelling persons: a systematic 
review of psychometric properties of instruments’, Aging clinical and 
experimental research, 31(7), 917–925. doi:10.1007/s40520-018-1034-6 
Hudon, C., Fortin, M. and Soubhi, H. (2007) ‘Abbreviated guidelines for scoring 
the Cumulative Illness Rating Scale (CIRS) in family practice’, Journal of clinical 
epidemiology, 60. 212. 10.1016/j.jclinepi.2005.12.021. 
Jackson, C., Dobson, A., Tooth, L. and Mishra, G. (2015) ‘Body mass index and 
socioeconomic position are associated with 9-year trajectories of 




Jindai, K., Nielson, C., Vorderstrasse, B. and Quinones, A. (2016) 
‘Multimorbidity and functional limitations among adults 65 or older, NHANES 
2005-2012’, Preventing Chronic Disease, 13(160174) 
Johnson-Lawrence V., Zajacova A. and Sneed R. (2017) ‘Education, 
race/ethnicity and multimorbidity among adults aged 30-64 in the National 
Health Interview Survey’, 3, pp. 366-372.  
Johnston, M., Crilly, M., Black, C., Prescott, G. and Mercer, S. (2019) ‘Defining 
and measuring multimorbidity: a systematic review of systematic 
reviews’, European Journal of Public Health, 29(1), pp. 182–189,  
Kadam, U., uttley, J., Jones, P. and Iqbal, Z. (2013) ‘Chronic disease 
multimorbidity transitions across healthcare interfaces and associated costs: a 
clinical-linkage database study’, BMJ open, 3(7), e003109. doi:10.1136/bmjopen-
2013-003109 
Kingston, A., Robinson, L., Booth, H., Knapp, M. and Jagger, C. (2018) 
‘Projections of multi-morbidity in the older population in England to 2035: 
estimates from the Population Ageing and Care Simulation (PACSim) model’, 
Age and Ageing, 47(3), pp. 374–380,  
Kawachi, I., and Berkman, L. F. (2001) ‘Social ties and mental health’, Journal of 
urban health : bulletin of the New York Academy of Medicine, 78(3), 458–467. 
doi:10.1093/jurban/78.3.458 
Koster, A., Bosma, H., Kempen, G., van Lenthe, F. and Mackenbach, J.  (2004) 
‘Socioeconomic inequalities in mobility decline in chronic disease groups 
(asthma/COPD, heart disease, diabetes mellitus, low back pain)’ Journal of 
Epidemiology & Community Health 2004;58:862-869. 
Krieger, N. (2011) Epidemiology and the people’s health. Oxford: Oxford 
University Press. 
Kuh, D., Ben-Shlomo, Y., Lynch, J., Hallqvist, J. and Power, C. (2003) ‘Life course 
epidemiology’, Journal of Epidemiology & Community Health, 57, pp.778-783.  
58 
 
Kushner, M. (2014). Seventy-five years of comorbidity research. Journal of 
studies on alcohol and drugs. Supplement, 75 Suppl 17(Suppl 17), 50–58.  
Lang, I. (2011) ‘Physical functioning in older adults’. Survey Question Bank: 
Topic Overview 5.  
Link, B., and Phelan, J. (1995). Social conditions as fundamental causes of 
disease. Journal of Health and Social Behavior, 35 (Extra issue), 80-94.  
Lowsky, D. J., Olshansky, S., Bhattacharya, J. and Goldman, D. (2014) 
‘Heterogeneity in healthy aging’, The Journals of Gerontology. Series A, 
Biological sciences and medical sciences, 69(6), 640–649. 
doi:10.1093/gerona/glt162 
Lucyk, K. and McLaren, L. (2017) Taking stock of the social determinants of 
health: A scoping review. PLoS ONE 12(5), e0177306.  
Marengoni, A., Angleman, S., Melis, R., Mangilasche, F., Karp., A., Fratiglioni, 
L. (2011) ‘Aging with multimorbidity: a systematic review of the literature’, 
Ageing Resesearh Revue, 10, pp. 430-439. doi: 10.1016/j.arr.2011.03.003. 
Marmot, M. and Brunner, E., (2005) ‘Cohort Profile: The Whitehall II study’, 
International Journal of Epidemiology, 34(2), pp. 251–256,  
Martin, L. G., Zimmer, Z., and Lee, J. (2017). Foundations of Activity of Daily 
Living Trajectories of Older Americans. The journals of gerontology. Series B, 
Psychological sciences and social sciences, 72(1), 129–139. 
doi:10.1093/geronb/gbv074 
McLean, G., Gunn, J., Wyke, S., Watt, G., Blane, D. and Mercer, S.  (2014) ‘The 
influence of socioeconomic deprivation on multimorbidity at different ages: a 
cross-sectional study’, The British journal of general practice : the journal of the 
Royal College of General Practitioners, 64(624), e440–e447. 
doi:10.3399/bjgp14X680545 
Mokraoui, N., Haggerty, J., Almirall, J. and Fortin, M. (2016) ‘Prevalence of self-
reported multimorbidity in the general population and in primary care 
59 
 
practices: a cross-sectional study’, BMC Research Notes, 9(314). 
doi:10.1186/s13104-016-2121-4 
Moor, I., Spallek, J. and Richter, M. (2017) ‘Explaining socioeconomic 
inequalities in self-rated health: a systematic review of the relative contribution 
of material, psychosocial and behavioural factors’, Journal of Epidemiology and 
Community Health, 71, pp. 565-575. doi: 10.1136/jech-2016-207589. 
Muschik, D., Icks, A., Tetzlaff, J., Epping, J. and Geyer, S. (2017) ‘Morbidity 
compression, morbidity expansion, or dynamic equilibrium? The time trend of 
AOK-insured patients with type 2 diabetes in Lower Saxony, Germany’, Journal 
of Public Health, 25(1), pp. 19–28.  
Ng, S., Tawiah, R., Sawyer, M. and Scuffham, P. (2018) ‘Patterns of multimorbid 
health conditions: a systematic review of analytical methods and comparison 
analysis’, International Journal of Epidemiology, 47(5), pp. 1687–1704,  
Nguyen, H., Manolova, G. and Prina, M. (2019) ‘Prevalence of multimorbidity in 
community settings: A systematic review and meta-analysis of observational 
studies’, Journal of comorbidity, 9, 2235042X19870934. 
doi:10.1177/2235042X19870934 
Niedzwiedz, C. (2012) ‘Life course socio-economic position and quality of life: a 
systematic review of life course models’, BMC Public Health, 12(628).  
O’Brien, R., Wyke, S., Guthrie, B., Watt, G. and Mercer, S. (2011) ‘An ‘endless 
struggle’: a qualitative study of general practitioners’ and practice nurses’ 
experiences of managing multimorbidity in socio-economically deprived areas 
of Scotland’, Chronic Illness, 7(1), 45–59.  
Omran, A. (1971) ‘The Epidemiologic Transition: A Theory of the Epidemiology 
of Population Change’, The Milbank Memorial Fund Quarterly, 49(4), 509-538. 
doi:10.2307/3349375 
Pathirana, T., and Jackson, C. (2018) ‘Socioeconomic status and multimorbidity: 
a systematic review and meta-analysis’, Australian and New Zeealnd Journmal of 
Public Health, 42(2), pp. 186-194.   
60 
 
Pavela, G., and Latham, K. (2016) ‘Childhood Conditions and Multimorbidity 
Among Older Adults’, The journals of gerontology. Series B, Psychological 
sciences and social sciences, 71(5), 889–901. doi:10.1093/geronb/gbv028 
Piette, J., and Kerr, E. (2006). The impact of comorbid chronic conditions on 
diabetes care. Diabetes Care, 29 (3), 725-731. DOI: 10.2337/diacare.29.03.06.dc05-
2078  
Poortinga, W. (2006) ‘The prevalence and clustering of four major lifestyle risk 
factors in an English adult population’, Preventive Medicine, 44, pp. 124-128. 
Prados-Torres, A., Poblador, B., Calderon-Larranaga, A., Gonzalez-Rubio, L., 
Alcala-Nalvaiz, J. (2012) ‘Multimorbidity patterns in primary care: interactions 
among chronic diseases using factor analysis’, PloS one, 7(2), e32190. 
doi:10.1371/journal.pone.0032190 
Pouplier, S., Olsen, M. and Olivarius, N. (2018) ‘The development of 
multimorbidity during 16 years after diagnosis of type 2 diabetes’, Journal of 
comorbidity, 8(1), 2235042X18801658. doi:10.1177/2235042X18801658. 
Quiñones, A., Liang, J. and Ye, W. (2011) ‘How does the trajectory of 
multimorbidity vary across Black, White, and Mexican Americans in middle and 
old age?’ The Journals of gerontology. Series B, Psychological sciences and social 
sciences, 66(6), 739–749. doi:10.1093/geronb/gbr106 
Quiñones A., Botoseneanu, A. and Allore, H. (2019) ‘Racial/ethnic differences in 
multimorbidity development and chronic disease accumulation for middle-
aged adults’, PLoS ONE 14(6): e0218462.  
Ramond-Roquin, A., and Fortin, M. (2016) ‘Towards increased visibility of 
multimorbidity research’, Journal of comorbidity, 6(2), 42–45. 
doi:10.15256/joc.2016.6.80 
Reilly, S., Olier, I., Planner, C., Doran, T., Reeves, D. (2015) ‘Inequalities in 
physical comorbidity: a longitudinal comparative cohort study of people with 




Rose, G. (2001) ‘Sick individuals and sick populations’, International Journal of 
Epidemiology, 30(3), pp. 427–432,  
Robertson, T., Benzeval, M. and Popham, F.  (2015) ‘The role of material, 
psychosocial and behavioral factors in mediating the association between 
socioeconomic position and allostatic load ‘, Brain, behavior, and immunity, 45, 
41-9. DOI:  
Ruel, G., Levesque, J., Stocks, N., Kroger, E., Adams, R., Doucet, M., Taylor, A. 
(2014) ‘Understanding the evolution of multimorbidity: evidences from the 
North West Adelaide Health Longitudinal Study (NWAHS)’, PloS one, 9(5), 
e96291. doi:10.1371/journal.pone.0096291 
Ryan, A., Wallace, E., O’Hara, P. and Smith, S. (2015) ‘Multimorbidity and 
functional decline in community-dwelling adults: a systematic review’, Health 
and Quality of Life Outcomes, 13(168). DOI 10.1186/s12955-015-0355-9 
Santoni, G., Angleman, S., Welmer, A., Marengoni, A., Fratiglioni, L.  (2015) 
‘Age-related variation in health status after age 60’, PloS one, 10(3), e0120077. 
doi:10.1371/journal.pone.0120077 
Schaefer, I. (2012) ‘Does multimorbidity influence the occurrence rates of 
chronic conditions? A claims-data based comparison of expected and observed 
prevalence rates’, PLOS One, 7(9).  
Sheiham, W. (2012) ‘Integrating the common risk factor approach into a social 
determinants framework’, Community Dental & Oral Epidemiology, 40, pp. 289-
296. 
Sheikh, M. A. (2017) ‘Confounding and Statistical Significance of Indirect 
Effects: Childhood Adversity, Education, Smoking, and Anxious and Depressive 
Symptomatology’, Frontiers in psychology, 8, 1317. doi:10.3389/fpsyg.2017.01317 
Short, S. E., and Mollborn, S. (2015) ‘Social determinants and health behaviors: 




Sibbritt, D., Byles, E. and Regan, C. (2007) ‘Factors associated with decline in 
physical functional health in a cohort of older women’, Age and Ageing, 36(4), 
pp. 382–388,  
Sauver J., Boyd, C., Bobo, W., Roger, V., Rocca, W. (2015) ‘Risk of developing 
multimorbidity across all ages in an historical cohort study: differences by sex 
and ethnicity’, BMJ Open, 5: e006413-2014–006413. 
Sinnott, C., McHugh, S., Browne, J. and Bradley, C. (2013) ‘GPs’ perspectives on 
the management of patients with multimorbidity: systematic review and 
synthesis of qualitative research’, BMJ Open 2013;3:e003610. doi: 
10.1136/bmjopen-2013-003610  
Steptoe, A., Breeze, E., Banks, J. and Nazroo, J. (2013) ‘Cohort profile: the English 
longitudinal study of ageing’, International journal of epidemiology, 42(6), 1640–
1648. doi:10.1093/ije/dys168 
Solar, O. and Irwin, A. (2010) ‘A conceptual framework for action on the social 
determinants of health’. Social Determinants of Health Discussion Paper 2 
(Policy and Practice), World Health Organization.  
Stone, J., Netuveli, G., and Blane, D. (2014) ‘Life-course occupational social class 
and health in later life: the importance of frequency and timing of measures’, 
European journal of ageing, 11(3), pp.. 273–284. doi:10.1007/s10433-014-0307-y 
Strauss, V., Jones, P., Kadam, U. and Jordan, K. (2014) ‘Distinct trajectories of 
multimorbidity in primary care were identified using latent class growth 
analysis’, Journal of clinical epidemiology, 67(10), 1163–
1171.doi:10.1016/j.jclinepi.2014.06.003 
Taylor, A., Price, K., Gill, T., Adams, R., Pilkington, R., Shi, Z. and Wilson, D. 
(2010) ‘Multimorbidity – not just an older person’s issue: results from an 
Australian biomedical study’, BMC Public Health, 10(718) 
Tetzlaff, J., Muschik, D., Epping, J., Eberhard, S. and Geyer, S. (2017) ‘Expansion 
or compression of multimorbidity? 10-year development of life years spent in 
multimorbidity based on health insurance claims data of Lower Saxony, 
63 
 
Germany’, International Journal of Public Health, 62(6), pp. 679-686. 
doi.org/10.1007/s00038-017-0962-9 
Tetzlaff, J., Epping, J. and Geyer, S. (2018) ‘Widening inequalities in 
multimorbidity? Time trends among the working population between 2005 and 
2015 based on German health insurance data’, International Journal for Equity in 
Health, 17(103),  
Tran, J., Norton, R., Conrad, N., Rahimian, F., Canoy, D. and Rahimi, K. (2018) 
‘Patterns and temporal trends of comorbidity among adult patients with 
incident cardiovascular disease in the UK between 2000 and 2014: A population-
based cohort study’, PLOS Medicine, 15(3):e1002513. 
https://doi.org/10.1371/journal.pmed.1002513. 
Uijen, A. and van de Lisdonk, E. (2008) ‘Multimorbidity in primary care: 
Prevalence and trend over the last 20 years’, Eur. J. Gen. Pract. 2008;14(Suppl. 
1):28–32. doi: 10.1080/13814780802436093. 
Van den Akker, M., Buntinx, F., Metsemakers, J. and Knottnerus, J. (1998) 
‘Multimorbidity in General Practice: prevalence, incidence and determinants of 
co-occurring chronic and recurrent diseases’, Journal of  Clinical Epidemiology, 
51(5), pp. 367-370. 
Van Oostrom, S., Gijsen, R., Stirbu, J., Schellevis, F. and Hoeymans, N. (2016) 
‘Time Trends in prevalence of chronic diseases and multimorbidity not only due 
to aging: Data from General Practices and Health Surveys’, PloS one, 11(8), 
e0160264. doi:10.1371/journal.pone.0160264 
Van Oort, F., Van Lenthe, F. and Mackenbach, J. (2005) ‘Material, psychosocial, 
and behavioural factors in the explanation of educational inequalities in 
mortality in the Netherlands’, Journal of Epidemiology and Community Health, 
59(3), 214–220.  
Van Weel, C. and Schellevis, F. (2006) ‘Comorbidity and guidelines: conflicting 
interests’, The Lancet, 367(9510), pp. 550-551.  
64 
 
Violan, C., Foquet-Boreu, Q., Flores-Mateo, G., Salisbury, C., Glynn, L. and 
Valderas, J. (2014) ‘Prevalence, determinants and patterns of multimorbidity in 
primary care: a systematic review of observational studies’, PloS one, 9(7), 
e102149. doi:10.1371/journal.pone.0102149 
World Health Organization (2018) ‘Noncommunicable diseases country profile 
2018’.  
Xu, X., Mishra, G. D. and Jones, M. (2017). Mapping the global research 
landscape and knowledge gaps on multimorbidity: a bibliometric study. Journal 








Chapter 3  
Trends in multimorbidity and functional limitation in 
the ageing population of England 
 
Abstract 
This study aimed to estimate the prevalence of three measures of 
multimorbidity among people aged 50 years or older in England. Beside the 
basic measure of two or more diseases within a person, we added a measure of 
three or more affected body systems (complex multimorbidity) and a measure 
of ten or more functional limitations. We found that the three health outcomes 
became more prevalent between 2002 and 2015. They were more common 
among females than males and were becoming more common among younger 
age groups. While in 2002 the prevalence of basic multimorbidity exceeded 50% 
for the 70-74 age group upwards, in 2015 it crossed the same threshold in the 
65-69 age group. The distribution of multimorbidity and multiple functional 
limitations were stratified by the amount of household wealth. Multiple 
functional limitations reflected the largest differences between the most and 
the least affluent groups (5.9-fold in 2014/15), followed by the measure of 
complex multimorbidity (2.8-fold in 2014/15) and basic multimorbidity (1.9-
fold) in 2014/15. While age acted as a levelling factor for the wealth differences 
in basic multimorbidity, it had no such effect on the two other outcomes. Our 
study observed social polarization among the multimorbid ageing population 
in England with complex multimorbidity and multiple functional limitations 







Multimorbidity, when defined as the co-occurrence of two or more diseases 
within a person, is rising globally (Van den Akker et al., 1998; Garin et al., 2015; 
The Academy of Medical Sciences, 2018). The prevalence of multimorbidity 
among people aged 65 years or older in England is projected to rise from 54% 
in 2015 to 67.8% in 2035 (Kingston et al., 2018). People will live longer but in 
worse health. The extra years lived with multimorbidity will lead to higher 
utilisation of primary and secondary healthcare (Marengoni et al., 2011; Kingston 
et al., 2018). However, the definition of multimorbidity as two or more diseases 
has been criticized for leading to prevalence estimates in the elderly population 
which are too high (55% to 98% between studies) to be able to predict patients 
with higher need (Fortin et al., 2012; Harrison et al., 2014).  Practitioners need a 
measure of multimorbidity that can reflect the biology of ageing and identify 
elderly populations with higher healthcare needs.  
Harrison et al. (2014, p. 8) introduced the concept of complex multimorbidity, 
defined as “the co-occurrence of three or more chronic conditions affecting 
three or more different body systems within one person without an index 
chronic condition”. Compared to the basic definition of two or more conditions, 
the construct of complex multimorbidity leads to lower prevalence estimates 
and it has been proposed that it might better identify patients with higher needs 
(Fortin et al., 2012; Harrison et al., 2014). We argue that complex multimorbidity 
might also be better at reflecting the biology of ageing since it characterizes a 
simultaneous breakdown or dysfunction of several distinct pathologies or body 
systems (Fabbri et al., 2015; Cesari et al., 2017). The affected body systems of 
people aged 65 or older were found to be predictors of the total number of 
hospital stays and of the number of hospital admissions (Condelius et al., 2008). 
The process of ageing manifests itself not just in the number of morbidities an 
individual has, but also in physical functioning. A measure of multiple 
functional limitations was included as our third health outcome. Its purpose is 
67 
 
to identify the impact of multimorbidity on the combined functioning of ageing 
people. Some conditions (e.g. high blood pressure) may have no effect on 
physical functioning but others do, such as arthritis. Multimorbidity predicts a 
decline in physical functioning among ageing people (Ryan et al., 2015; Jindai et 
al., 2016), which has implications for quality of life, need for health care and 
residential care, and premature mortality (Sibritt et al., 2007; Ryan et al., 2015; 
Jindai et al., 2016). Measuring functional limitation also responds to the fact that 
the proportion of old people with impairments and limitations in several body 
systems increases with age (Jindai et al., 2015; Burden of Disease Network 
Project, 2004).  
Socio-economic status (SES) is a major determinant of health inequalities. 
Studies which explored the association between multimorbidity and SES 
focused on area deprivation (Barnett et al., 2012; McLean, 2014; Morrissey, 
Espuny and Williamson, 2015), income (Agborsangaya et al., 2012), occupational 
status (Van den Akker et al., 2000) and education (Agborsangaya et al., 2012; 
Schiøtz et al., 2017). Regardless of the type of measure, multimorbidity is more 
common among people with lower SES, even when controlling for age and sex. 
However, all of these studies focus on the simple definition of multimorbidity 
that may hide the nuances of relationships and the true underlying scale of 
inequalities.  
Our study is the first population-level analysis that differentiates the prevalence 
of multimorbidity by complexity and degree of functional limitation as well as 
their variation by key modifying factors. The study has two aims: (1) to compare 
temporal trends in the prevalence of basic multimorbidity, complex 
multimorbidity and multiple functional limitations in an ageing population in 
England; and (2) to examine the variation in their prevalence by age, sex and 






3.2.1 Data and study population 
We used data from the English Longitudinal Study of Ageing (ELSA) which is a 
panel study with a range of social, economic, psychological, cognitive and 
health data. It is based on a representative sample of people living in England 
aged 50 plus years. It commenced in 2002 and is followed up every two years. 
The data used in this analysis was collected via personal interviews and the 
study response rate at wave 7 was 61% (Clemens et al., 2017). The baseline 
sample consisted of 12,099 members. This analysis uses data from the core 
sample members who were recruited at either the first wave or at any of the 
refreshment samples at waves 3, 4, 6 and 7 (Steptoe et al., 2013). The number of 
core members in each wave varied: 12,099 in wave 1; 8,780 in wave 2; 8,811 in 
wave 3; 9,896 in wave 4; 9,090 in wave 5; 9,169 in wave 6 and 8,253 in wave 7.  
We conducted a repeated cross-sectional analysis, treating each wave 
separately. Respecting the multi-stage sampling process, the data in each wave 
were declared a complex survey data using Stata svyset command. This allowed 
to adjust each wave for the effects of clustering (household level), strata (the 
geographic region) and changing age structure (cross-sectional weights) by 
using specific variables provided by ELSA. The weights include a scaling factor 
in order to make sure that the original sample and refreshment samples are 
equally proportional with respect to age in the general population (Banks et al., 
2017).  
 
3.2.2 Measures of health 
ELSA records data on a range of physical and mental health conditions. Twenty 
five of these variables were consistently recorded at each wave and are used to 
measure multiple health conditions in this study (Table 3.1). This includes the 
most common conditions among the elderly (diabetes, hypertension, stroke, 




Participants were asked whether they still had the condition diagnosed by a 
doctor that they had reported previously and if not whether they could report a 
new condition. We have grouped health data into three categories: individual 
morbidities, groups representing body systems and functional limitations 
(Table 3.1). Adapting Verbrugge and Jette’s Disablement Process Framework 
(1994), instances of impairment (dysfunction and abnormalities in body 
systems) and disability (difficulty with daily activities) were included within the 
category of ‘functional limitations’ (restrictions in basic physical and mental 
actions).  
 
Table 3. 1 Health data used to measure basic multimorbidity, complex multimorbidity and multiple 
functional limitations 




1. Eye disorders   General mobility 




1.2. Macular degeneration 2 Sitting for 2 hrs 




2. Circulatory disorders 4 Climbing several flights of stairs 
6 Heart attack 2.1. High blood pressure 5 Climbing one flight of stairs 
7 Diabetes 2.2. Angina 6 Stooping, kneeling or crouching 
8 Stroke 2.3. Heart attack 7 Reaching arms above shoulders 
9 Lung disease 2.4. Congestive heart failure 8 Pulling or pushing a chair 
10 Asthma 2.5. Heart murmur 9 
Lifting/carrying weights over 10 
pounds 
11 Arthritis 2.6. Abnormal heart rhythm 10 Picking up a 5p coin 
12 Osteoporosis 2.7. Stroke  Activities of daily living 
13 Cancer 
3. Endocrine, nutritional and 
metabolic 
11 
Dressing, including putting on 




3.1 Diabetic eye disease 12 Walking across a room 




4. Musculoskeletal and 
connective system  
14 
Eating, such as cutting up your 
food 
17 Hallucinations 4.1. Osteoporosis 15 Getting in or out of bed 
18 Anxiety 4.2. Arthritis 16 
Using the toilet, including getting 
up or down 
19 Depression 5. Respiratory 17 
Using a map to figure out how to 




5.1. Lung disease 18 Preparing a hot meal 
21 Mood swings 5.2. Asthma 19 Shopping for groceries 








7. Nervous disorders 22 




25 Cataracts 7.1. Parkinson's disease 23 
Managing money (paying bills, 
track of expenses) 
  7.2. Alzheimer's disease  Symptoms 
  7.3. Hallucinations 24 Difficulty walking 0.25 mile 
  8. Mental and behavioural 25 Pain in general  
  8.1. Anxiety 26 Problems with eyesight 
  8.2. Depression 27 Problems with hearing 
  8.3. Emotional problems 28 Balance on level surface 
  8.4. Mood swings 29 Dizzy walking on level surface 
 
Measure 1: Basic multimorbidity  
We created a binary variable which identified people at each wave who had two 
or more morbidities as listed in Table 1. The list includes a few symptoms such 
as hallucinations which do not represent a condition but can be used as a proxy 
for schizophrenia or another condition, for example alcohol dependency 
(Chaudhury, 2010). In a similar way, emotional problems and mood swings are 
used as indicators of either mild anxiety and depression or possibly manic 
depressive tendencies (Valiengo et al., 2016) but the clinician has chosen to not 
use the more formal diagnostic label, for whatever reason. The information on 
whether an individual has or has not got a chronic disease was composed of the 
data fed forward from the previous wave of observation and from the 
information on the newly reported cases of disease.  
 
Measure 2: Complex multimorbidity  
Following the definition of complex multimorbidity by Harrison et al., (2014), 
we identified individuals with three or more body systems affected by disease 
as having complex multimorbidity. Body systems were defined and represented 
by the chapters of the International Classification of Diseases 10th Revision 
(ICD-10) system (Table 3.1).  
 
Measure 3: Multiple functional limitations  
The third health outcome was based on the combination of general mobility 
variables, Activities of Daily Living (ADL) variables, and data on symptoms of 
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chronic conditions (Table 3.1). ADL is used to measure functional capacity and 
it concerns the abilities necessary for basic functioning, as well as functions 
necessary for living in a community (Chatterji et al., 2015). Most studies have 
explored prevalence and effects of either single impairments and functional 
limitations or their combinations in ADL or IADL (Jindai et al., 2016), but we 
decided to examine their combined burden by summing all of them up 
including the symptoms. Difficulties with walking were captured with three 
distinct variables (having difficulty walking 0.25 mile, walking 100 yards and 
walking across a room) which, if combined, reflect the degree of severity. For 
example, a person who has got all three difficulties is more functionally limited 
than a person with only one of them. The total number of functional limitations 
per individual was summed up. Based on the exhaustive list of 29 limitations, 
the frequencies of multiple functional limitations were high, reflecting the older 
age of participants. In order to identify the participants with the highest level of 
disability we decided to set a cut-off point of ten or more functional limitations 





Age was categorized into 5-year bands, from 50-54 up to 80-84 years of age. The 




Sex is an important determinant of health. Previous studies have shown that 
while women in most countries have a longer life expectancy than men, they 
are more likely to be affected by a number of chronic diseases (Marengoni et al., 




Socio-economic status (SES) 
SES was measured using quintiles of net total household wealth. Household 
wealth embodies access to financial resources accumulated during life and 
therefore reflects social status at later life (Demakakos et al., 2015; Nazroo, 2017). 
The net household wealth is defined as the sum of savings, investments, 
physical wealth and housing wealth after financial debt and mortgage debt has 
been subtracted). It is based on 22 distinct components of wealth and debt 
(Banks et al., 2017). The wealth intervals in £s between 2002-15 are presented in 
Appendix B (Table B.4). While the median value of households increased in 
2002-15 from £100,000 to £190,000, most change was due to the outlier values in 
the poorest and the richest quintiles.  
 
3.3 Statistical analysis 
Descriptive analyses of the study population included summary statistics to 
explore general patterns. Data were weighted for non-response, stratification 
and clustering effects. The variation in the size of the age groups decreased over 
time for age groups of older people, but the pattern nevertheless justified the 
need for age standardization between waves (Appendix A). The prevalence was 
standardized to the age distribution of the population at wave 1 in 2002, to allow 
for more robust comparison of trends over time. Standardization also helps our 
results to remain representative of national patterns improving their 
generalisability.  
We have conducted repeated cross-sectional analyses of prevalence at 
a population level. Prevalence estimates were stratified by age group, sex and 
wealth quintiles, in order to observe the distribution of outcomes by selected 
covariates. We then checked for consistency and interaction effects of time*SES 
and age*SES by merging the waves of measurement into a panel dataset. This 
allowed us to compare the estimates from cross-sectional analyses with two 
multilevel logistic regression models, taking into account temporal correlation 
73 
 
within individuals. The results were plotted graphically using marginal effects 







3.4.1 General characteristics of the study population 
The general characteristics of the studied population are shown in Table 3.2. 
The number of participants varied between 11,391 (2002/03) and 8,249 (2014/15). 
The median age in 2002/03 was 64 (IQR 56-73) and it increased to 67 years in 
2014/15 (IQR 61-75). The proportion of the oldest old people, aged 85 or more, 
was between 5.2% in 2002/03 and 5.7% in 2014/15. The proportion of women was 
higher than the proportion of men (53.1%) on average during the period 2002-
15.  
 
Table 3. 2 Overview of the study population by age, sex and year 








































































































































Total  11,391 8,780 8,811 9,896 9,090 9,169 8,249 


































64 (56-73) 66 (58-74) 64 (57-74) 65 (58-73) 66 (60-74) 66 (60-75) 67 (61-75) 
 
3.4.2 Trends in the prevalence of our measures of multimorbidity  
Figure 3.1 summarizes trends in the prevalence of basic multimorbidity, 
complex multimorbidity and 10+ multiple functional limitations. The 
prevalence of basic multimorbidity grew from 41.6 percent in 2002/03 to 46.6 
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percent in 2014/15. The prevalence of complex multimorbidity grew from 12.2 
percent in 2002/03 to 21.1 percent in 2014/15. This is a larger change relative to 
the baseline estimate than the growth of basic multimorbidity. The prevalence 
of 10+ multiple functional limitations rose from 9.6 percent in 2002/03 to 14.3 
percent in 2014/15 which is larger than the growth of basic multimorbidity. 
Given our knowledge of the nature of functional limitation as a consequence of 
multimorbidity (Ryan et al., 2015, Jindai, 2016), we would expect a larger relative 
change in this outcome than in either of the multimorbidities. Hence we 
examined developments for each component subgroup (General mobility, ADLs 
and symptoms) separately and found a similar flat trend for each of them 
(Appendix D, Figure D.1). 
 
 
Figure 3. 1 Age-standardized prevalence of basic multimorbidity, complex multimorbidity and 10+ 
multiple functional limitations for England, 2002-15 (95% CIs). 
 
Figure 3.2 shows the distribution of the three health outcomes by sex over time. 
The comparison between sexes shows that regardless of the measure of 
multimorbidity or specific time point, on average a higher proportion of women 




between sexes over time was only marginal with the only exception being in 
complex multimorbidity. The prevalence for males more than doubled at the 
end of the followed period while the prevalence of complex multimorbidity for 
females grew only 1.6 times.  
 
 
Figure 3. 2 Age-standardized prevalence of basic multimorbidity, complex multimorbidity and 
multiple functional limitations by sex for England, 2002-15 (95% CIs). 
 
3.4.3 Prevalence of the three measures of multimorbidity by age group 
We further explored how the prevalence varied within age bands for each 
measure. The prevalence of both types of multimorbidity and of 10+ multiple 
functional limitations at each time point increased with age (Appendix B, Tables 
B.1-B.3). The difference in prevalence of multimorbidity between the youngest 
(aged 50 to 54) and the oldest group (aged 85+) ranged between threefold in 
wave 2012/13 and fourfold in wave 2004/05 (Table B.1). The majority of 
participants were multimorbid when and after reaching the 70-75 age group. 
From 2012/13, this threshold shifted to the 65-69 age band.  
The difference in the prevalence of complex multimorbidity between the 
youngest and the oldest group ranged between 4.6 times in 2010/11 and 8.8 times 
in wave 2004/05 (Table B.2). The variation in prevalence levels by age is larger 
in the complex than basic multimorbidity. The difference in the prevalence of 
10+ functional limitations between the youngest and the oldest group ranged 
between 3.9 times in wave 2010/11 and 7.2 times in 2014/15 (Table B.3). 
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Prevalence of both complex multimorbidity and 10+ multiple functional 
limitations remained under 50% within each age group. 
 
3.4.4 Stratification of prevalence by socio-economic status 
Regardless of the outcome, clear differences between the socio-economic 
groups were observed (Figure 3.3). Prevalence of basic multimorbidity, complex 
multimorbidity and 10+ multiple functional limitations was graded by each 
wealth quintile with people in the poorest quintile having the highest 
prevalence and people in the wealthiest quintile having the lowest. The measure 
of 10+ functional limitations captured the largest relative differences between 
the most and the least affluent groups (5.9-fold in 2014/15), followed by the 
measure of complex multimorbidity (2.8-fold in 2014/15). The relative difference 
was the smallest for basic multimorbidity (1.9-fold) in 2014/15. The interaction 
between time and household wealth was tested in a logistic marginal effects 
model and the results agreed with the stratified distribution of the prevalence 






Figure 3. 3 Age-standardized prevalence of basic multimorbidity, complex multimorbidity and 
multiple functional limitations by quintiles of household wealth for England, 2002-2015 (95% C.I.s). 
 
We further stratified each age band by quintiles of household wealth in order 
to observe differences in prevalence of our measures (Figure 3.4). In order to 
avoid data clutter, we report only results for the observation in 2014/15. We 
found the largest variation in the youngest age group (50-54 years of age). The 
prevalence of basic multimorbidity in the poorest quintile was 4.1-times higher 
than in the richest quintile in the youngest age group. People aged 50-54 years 
in the poorest quintile had levels of multimorbidity equivalent to people 15-20 
years older in the most affluent quintile. The prevalence of complex 
multimorbidity and 10+ multiple functional limitations in the poorest category 
was 18.7-times and 14-times higher than in the wealthiest category in the 
youngest age group. People aged 50-54 years in the poorest quintile had levels 
of complex multimorbidity equivalent to people 20 years older and levels of 10+ 






Figure 3. 4 Prevalence of basic multimorbidity, complex multimorbidity and 10+ multiple functional 
limitations by age band and wealth quintile for England, 2014/15 (95% C.I.s). 
 
The patterns in Figure 3.4 indicated that the effect of age on the prevalence 
estimates varies by socio-economic status. The interaction effect for the whole 
period 2002-15 was further explored in a logistic regression model. The marginal 
effects (Appendix C, Figure C.2) show changes in the probability of an outcome 
as the values of the household wealth variable change between quintiles. The 
additional effect of change in wealth quintile on the probability of having 
multimorbidity in 2014/15 was the strongest in the lowest wealth quintile up to 
the age 80-84. An overall pattern for all quintiles represents a socio-economic 
gradient up to the age of 75-80. For older age groups the effects overlap and no 
pattern is discernible any more. The pattern changes for people with 10+ 
functional limitations. The graded differences in effects between quintiles are 
more pronounced and they remain distinct even in the oldest age category. This 




3.5.1 Key results 
Our study found that the prevalence of basic multimorbidity, complex 
multimorbidity and 10+ multiple functional limitations in the ageing population 
of England increased between 2002/03 and 2014/15. We standardised our 
analysis to remove differences in age structure over time but in absolute terms 
this increase will be even larger due to the ageing poulation. Also the addition 
of refreshment samples (age 50–53) at waves 3, 4, 6 and 7 has potentially resulted 
in an underestimation of the prevalence. The distribution of these health 
outcomes at population level was influenced by sex as they were more common 
among women than among men. Age was another determinant of the 
distribution. Our health outcomes were becoming more common in younger 
age groups during the observed period. The age when the majority of an age 
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group became multimorbid shifted from the 70-74 age group to the 65-69 age 
group (Appendix B, Table B.1). Out of the three measures, the prevalence of 
complex multimorbidity had the steepest growth, followed by 10+ multiple 
functional limitations and basic multimorbidity. Furthermore, the prevalence 
of multimorbidity, complex multimorbidity and 10+ multiple functional 
limitations was socially stratified. People with less household wealth had higher 
levels of multiple health problems than people from the more affluent wealth 
quintiles. The disparity in wealth was larger for complex multimorbidity and 
10+ functional limitations than for basic multimorbidity.  
We also discovered that socio-economic status and age mutually interacted. 
The differences in the prevalence of basic multimorbidity between the wealth 
quintiles were the largest in the youngest age group and they narrowed down 
as people aged (Figure 3.4). The differences in the prevalence of complex 
multimorbidity and especially multiple functional limitations between the 
poorest and wealthiest quintile remained large for all age groups (Figure 3.4). 
The pattern of health inequality based on cross-sectional stratification analyses 
in Figures 3.3 and 3.4 were confirmed after data were reshaped into a panel 
design where time interacted with wealth (Appendix C, Figure C.1) and age 
interacted with wealth (Appendix C, Figure C.2). 
 
3.5.2 Interpretation 
The rising prevalence of multimorbidity consistent across three different 
conceptualisations between 2002/03 and 2014/15 supports projections of a 
growing trend (Kingston et al., 2018). Prevalence in general is shaped by both 
the rate at which new cases are occurring and the average duration of disease. 
Our analysis was a repeated cross-sectional and as such it examined neither the 
incidence nor the duration of multimorbidity and cannot quantify their relative 
contribution to the increased prevalence.  
Household wealth, an indicator of socio-economic status, was negatively 
associated with multimorbidity and 10+ functional limitations. This is 
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consistent with previous studies reporting socio-economic gradient in 
multimorbidity (Van den Akker et al., 2000; Agborsangaya et al., 2012; Barnett 
et al., 2012; Charlton et al., 2013; McLean, 2014; Morrissey et al., 2015; Schiøtz et 
al., 2017). Our study observed that the gap between the wealth quintiles was 
larger for participants with complex multimorbidity and largest for people with 
ten or more functional limitations. Lack of household wealth was related to 
higher complexity of multimorbidity and corresponding limitations and vice 
versa. This is consistent with the findings of a study examining growth in 
functional limitations and socio-economic factors (Calderón-Larrañaga et al., 
2018). It seems plausible that this gradient in complexity might be explained by 
problems with the self-management of multimorbidity. Patients whose 
everyday lives are overwhelmed by acute social problems are less able to manage 
the complex treatment burden and find adequate social support (O’Brien et al., 
2014). This would suggest that the true impact of inequalities is under-estimated 
if multimorbidity is defined as the presence of two or more conditions or, 
similarly, if the cut-off measure for number of functional limitations is set too 
low. 
Ageing with multimorbidity and functional limitation was differentiated by SES. 
We observed an excess of multiple health problems in the youngest age cohort 
with lowest SES. People aged 50-54 years in the poorest quintile had levels of 
complex multimorbidity comparable to those 20 years older in the most affluent 
quintile and level of 10+ functional limitations comparable to those 30 years 
older in the top wealth quintile. This suggests an earlier onset of 
multimorbidity, and especially of complex multimorbidity and multiple 
functional limitations, for people with lower socio-economic status. Earlier 
origins of basic multimorbidity in Scotland were observed by Barnett et al. 
(2012), McLean (2014) and Canizares et al. (2019). The differences in prevalence 
between wealth quintiles were largest in the youngest age group but they 
narrowed down as people aged. Similar levelling effects of ageing on basic 
multimorbidity prevalence have been reported previously (Barnett et al., 2012). 
The differences in the prevalence of complex multimorbidity and especially 
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multiple functional limitations between the poorest and the wealthiest quintile 
remained large for all age groups. This suggests that accumulated financial 
resources at older age can act as a protective factor against increased disease 
complexity. One pathway in which this accumulated financial resources may 
protect against increased disease complexity is via financial advantage 
translating into an actual healthy behaviour. For example, Link and Phelan 
(1995) postulate that individuals from higher social class backgrounds are 
capable to use resources such as power, money, knowledge, prestige or social 
contacts to either protect themselves from the health risks or compensate for 




Our exploratory study focused on the assessment of the burden of 
multimorbidity, complex multimorbidity and multiple functional limitations at 
the population level. Using a repeated cross-sectional design does not allow any 
explanatory inferences to be drawn regarding individual trends or causal 
relationships between covariates and outcome variables.  
The estimates of prevalence might be under-estimated as they are based on self-
reported information on health problems. A previous study found that 
prevalence based on self-reports was lower than if data were obtained from 
medical examinations (Schramm et al., 2008). A combination of data sources 
was suggested as the best way of providing the most reliable results (Fortin et 
al., 2012).  
This study could be expanded if we had shown an association between the two 
multimorbidity measures and the measure of ten or more functional 
limitations. Such an analysis might be interesting especially as both complex 
multimorbidity and multiple functional limitations represent problems 









To our knowledge, this paper is the first study to examine trends in the 
prevalence of multimorbidity as measured through three types of 
conceptualisations of multimorbidity. We uncovered processes of clear 
polarization within the ageing population of England. Alongside a stable 
proportion of people who were free of any chronic disease and a declining 
proportion of those with one disease, we observed that the increase in 
complexity overtakes the rise in basic multimorbidity and multiple functional 
limitations. Another axis of differentiation is by socio-economic status where 
the higher household wealth is related to lower prevalence. At the same time 
this process introduces health inequality within age groups. Complex 
multimorbidity and multiple functional limitations are increasing faster and 
capture stronger inequality than the measure of basic multimorbidity. Using 
different measures of multimorbidity can contribute to identifing population 
groups with higher health care needs and to a better allocation of health care 
resources. Reporting the patterns of body systems affected by chronic 
conditions may help health care planners identify services which should be co‐
located, for an optimal care of these patients (Harrison et al., 2016). The complex 
multimorbidity measure would also allow identification of patients who may 
need help in coordinating care between multiple health care providers. 
Policies aiming to prevent and reduce the growth in multimorbidity should be 
approaching the older population as diverse and take into account the multiple 
polarizations we have described. It would be meaningful to focus the preventive 
efforts on younger age groups where social inequality appears to be more 
intertwined with chronic complexity and functional limitation than in older 
age. The contribution of these younger cohorts as they age into the older 
population, along with growing numbers of the very old, could significantly 
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Table B.1 Prevalence of basic multimorbidity by age 
         2002/03          2004/05           2006/07          2008/09          2010/11          2012/13           2014/15 
Age (years) n* Prevalence (95 % CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) 
50-54 481 21.8 (19.9-23.8) 158 18.8 (16.1-21.7) 279 22.5 (20.3-24.9) 303 23.3 (20.7-26) 69 24.7 (19.4-30.9) 422 26.3 (22.8-30.1) 375 23.6 (20.1-27.5) 
55-59 616 30.3 (28.3-32.4) 485 25.8 (23.7-28) 523 28.9 (26.7-31.2) 652 29.3 (27.1-31.5) 645 30.3 (28.1-32.7) 563 35 (32.1-37.9) 521 38.3 (34.8-41.8) 
60-64 619 36.8 (34.3-39.3) 501 35.5 (33-38) 528 36.5 (33.9-39.2) 668 38.5 (36.3-40.8) 743 40.7 (38.4-43) 611 40.3 (37.9-42.8) 568 45.6 (43-48.3) 
65-69 678 43.8 (41.5-46.2) 530 40.3 (37.7-42.9) 538 45.4 (42.5-48.4) 640 49.2 (46.6-51.8) 689 49.3 (46.6-51.9) 713 51.8 (49.3-54.3) 729 57.3 (54.9-59.8) 
70-74 755 54 (51.4-56.7) 570 50.9 (48.1-53.8) 534 52.9 (49.8-55.9) 652 57.8 (55.1-60.4) 671 57.3 (54.5-60) 617 61.3 (58.5-64) 616 66.2 (63.4-68.9) 
75-79 696 59.8 (56.8-62.7) 574 58.3 (55.2-61.4) 548 64.6 (61.3-67.8) 623 67.4 (64.1-70.5) 634 67.7 (64.7-70.6) 600 72.4 (69.6-75) 570 75.8 (73.1-78.4) 
80-84 496 64.3 (60.8-67.6) 471 65 (61.3-68.5) 433 69.6 (65.7-73.3) 445 70.7 (66.6-74.5) 493 77.3 (73.6-80.5) 474 78 (74.5-81.1) 426 79.2 (75.6-82.3) 
85-100 396 68.9 (64.2-73.1) 376 74.7 (70-78.9) 375 75.3 (70.5-79.6) 412 74.1 (69.6-78.1) 501 82.8 (79-86.1) 397 77.7 (73.6-81.3) 372 80.2 (76.1-83.7) 
Total  4,739 41.6 (40.6-42.6) 3,664 
   41.7 (40.6- 
42.9) 3,759 43.4 (42.3-44.5) 4,396 44.8 (43.8-45.9) 4,446 49.5 (48.4-50.6) 4,398 48.5 (47.3-49.8) 4,178 51.2 (49.9-52.6) 
Mean age (SD) 68.9 (10.5)  70.7 (10.3)  70.1 (11.1)  69.8 (10.3)  70.8 (9.5)  70.8 (9.6)  71.4 (9.2) 
Median age (IQR) 69 (60-77)   71 (62-78)   70 (61-78)   69 (62-77)   70 (63-78)   71 (64-78)   71 (65-78) 
* Number of persons with BMM 
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Table B.2 Prevalence of complex multimorbidity by age 
         2002/03       2004/05           2006/07           2008/09         2010/11         2012/13             2014/15 
Age (years) n * Prevalence (95 % CI) n * 
Prevalence (95 
% CI) n * 
Prevalence (95 
% CI) n * 
Prevalence (95 
% CI) n * 
Prevalence (95 
% CI) n * 
Prevalence (95 
% CI) n * 
Prevalence (95 
% CI) 
50-54 90 4.1 (3.3-5.1) 32 3.8 (2.6-5.5) 77 6.2 (5-7.6) 77 5.9 (4.6-7.5) 25 8.9 (5.8-13.3) 131 8.2 (6.2-10.8) 113 7.1 (5.2-9.6) 
55-59 122 6 (5.1-7) 109 5.7 (4.8-6.9) 144 8 (6.7-9.5) 196 8.8 (7.5-10.2) 180 8.5 (7.2-9.9) 230 14.3 (12.3-16.5) 163 12 (9.7-14.6) 
60-64 142 8.4 (7.2-9.9) 140 9.9 (8.4-11.6) 164 11.4 (9.8-13.2) 240 13.8 (12.3-15.5) 261 14.3 (12.7-16) 260 17.2 (15.4-19.2) 200 16.1 (14.2-18.1) 
65-69 168 10.8 (9.4-12.4) 182 13.9 (12.1-15.8) 158 13.4 (11.5-15.5) 240 18.4 (16.4-20.6) 287 20.6 (18.5-22.8) 325 23.6 (21.6-25.8) 293 24 (20.9-25.4) 
70-74 233 16.7 (14.8-18.7) 208 18.5 (16.4-20.9) 184 18.2 (15.9-20.8) 265 23.5 (21.3-25.9) 298 25.4 (23-28) 302 30 (27.4-32.7) 282 30.3 (27.7-33.1) 
75-79 245 21 (18.7-23.6) 224 22.8 (20.2-25.6) 195 23 (20.3-25.9) 288 31.1 (27.9-35.7) 309 33 (30-36.1) 325 39.2 (36.3-42.2) 266 35.5 (32.6-38.5) 
80-84 223 28.9 (25.9-32) 210 29 (25.7-32.6) 176 28.3 (24.7-32.1) 199 31.6 (28.1-34.3) 255 40 (36-44) 275 45.2 (41.2-49.2) 236 43.8 (39.8-47.9) 
85-100 178 31 (26.6-35.7) 168 33.4 (28.8-38.4) 151 30.4 (26.3-34.9) 194 34.9 (30.5-39.5) 250 41.3 (36.9-45.7) 214 41.9 (37.4-46.5) 203 43.6 (39.1-48.3) 
Total  1400 12.3 (11.7-12.9) 1,272 14.5 (13.7-15.3) 1,250 14.4 (13.7-15.2) 1,698 17.3 (16.5-18.1) 1,865 20.8 (19.9-21.7) 2,062 22.8 (21.8-23.7) 1,756 21.5 (20.5-22.6) 
Mean age (SD) 71.9 (10.6)  73 (9.9)  71.6 (11.2)  71.5 (10.2)  72.5 (9.4)  72 (9.5)  73 (9.1) 
Median age (IQR) 72 (64-80)   74 (66-81)   72 (63-80)   71 (63-80)   73 (65-80)   72 (65-79)   73 (66-80) 
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Table B.3 Prevalence of 10+functional limitations by age    
         2002/03     2004/05          2006/07        2008/09           2010/11          2012/13           2014/15 
Age (years) n* Prevalence (95 % CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) n* 
Prevalence (95 
% CI) 
50-54 104 4.7 (3.9-5.7) 55 6.6 (4.9-8.7) 83 6.7 (5.5-8.2) 128 9.8 (8.1-11.9) 30 10.8 (7.3-15.6) 157 9.8 (7.5-12.6) 110 6.9 (5.1-9.3) 
55-59 149 7.3 (6.3-8.5) 150 7.9 (6.8-9.3) 157 9.2 (7.8-10.8) 200 10.2 (8.8-11.7) 189 8.9 (7.5-10.5) 213 13.2 (11.3-15.4) 138 10.1 (8.1-12.5) 
60-64 136 8.1 (6.8-9.5) 153 10.9 (9.4-12.6) 165 11.4 (9.8-13.3) 228 11.5 (10.1-13.2) 160 8.8 (7.5-10.2) 174 11.5 (10-13.2) 129 10.4 (8.8-12.2) 
65-69 138 8.8 (7.6-10.3) 124 9.4 (8-11.1) 157 12.1 (10.3-14.1) 179 13.8 (12.1-15.7) 174 12.5 (10.7-14.4) 184 13.4 (11.7-15.2) 141 11.1 (9.5-12.9) 
70-74 145 10.3 (8.8-12.1) 149 13.4 (11.5-15.5) 147 14.5 (12.5-16.8) 175 15.5 (13.6-17.6) 176 15 (13.1-17.2) 160 15.9 (13.8-18.2) 139 15 (12.9-17.3) 
75-79 160 13.7 (11.7-16) 162 16.4 (14.1-19) 157 18.6 (16-21.4) 175 20.9 (18.3-23.9) 183 19.6 (17.2-22.3) 153 18.5 (16.2-21) 158 21 (18.5-23.8) 
80-84 147 19 (16.4-21.9) 192 26.6 (23.3-30.1) 162 26 (22.4-29.8) 193 27.9 (24.2-31.9) 178 28 (24.4-31.8) 158 26 (22.5-29.9) 163 30.3 (26.7-34.2) 
85-100 191 33.2 (28.7-37.9) 221 43.9 (38.8-49) 216 43.4 (38.6-48.3) 218 39.1 (34.5-44) 254 42 (37.6-46.7) 206 40.2 (35.8-44.8) 231 49.8 (45-54.6) 
Total  1169 10.3 (9.6-10.9) 1,207 13.7 (12.9-14.6) 1,240 14.3 (13.5-15.1) 1496 15.3 (14.5-16.1) 1,346 15 (14.2-15.8) 1,405 15.5 (14.7-16.4) 1,210 14.8 (14-15.7) 
Mean age (SD) 70.7 (12)  72.6 (11.8)  72.3 (12.6)  71.2 (12.1)  73.2 (10.6)  72 (11)  74.3 (10.6) 
Median age (IQR) 70 (61-80)   73 (62-81)   72 (62-82)   70 (61-80)   73 (64-82)   72 (63-81)   75 (66-83) 













 Household wealth (£s  in 1,000s)2002/ 3 2004/05 2006/07 2008/09 2010/11 2012/13 2014/15
Lower bound Upper bound Lower bound Upper bound Lower bound Upper bound Lower bound Upper bound Lower bound Upper bound Lower bound Upper bound Lower bound Upper bound
Quinti le 1 -108,000 0 -130 27,5 -160 37,5 -450 56 -80 65 -20 65 -220 70
Quinti le 2 3,000 75 29,5 129 37,5 150 56,5 150 66 150 66 150 71,1 160
Quinti le 3 75,250 125 129,3 185 151 200 150,5 200 150,5 208 151 210 161 240
Quinti le 4 126,000 200 185,4 265 201 300 200,2 300 208,7 300 211 320 241 350
Quinti le 5 200,500 2,486 266,7 2,000 301 4,440 301 3,500 304 4,000 321 4,500 351 4,000
Median (IQR*) 100 (33-180) 155 (75-245) 175 (89-261) 175 (91-265) 180 (100-285) 180 (95-290) 190 (100-310)





                
Figure C.1 Marginal interaction effects of time and wealth on the probability of basic multimorbidity, complex multimorbidity and 10+ 






























































































Figure C.2 Marginal interaction effects of age and wealth on the probability of basic multimorbidity, complex multimorbidity and 10+ 
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Chapter 4  
Social determinants of multimorbidity and functional 
limitation in the ageing population of England 
 
Abstract 
This study explores longitudinal relationships between material, psycho-social 
and behavioural social determinants of health and multimorbidity of people 
aged 50 years or older in England. We used data from the English Longitudinal 
Study of Ageing collected biannually between 2002 and 2015. Apart from the 
basic measure of multimorbidity (two or more diseases within a person) we 
constructed two distinct measures in order to take into account the biology of 
ageing (complex multimorbidity and multiple functional limitations).  
We found that the likelihood of multimorbidity and multiple functional 
limitations was consistently associated with the levels of household wealth, 
sense of control over one’s life, physical activity and loneliness. Larger health 
inequalities were observed when health was measured as complex 
multimorbidity and multiple functional limitations than basic multimorbidity. 
We did not find a dose-response relationship between alcohol consumption, 
smoking and multimorbidity but rather evidence of people in ill health actively 
moderating their health behaviour. 
We suggest that materialist models of multimorbidity at older age can not, on 
their own, explain the health inequalities as  behavioural and psycho-social 
factors play an important role. Policies aiming to reduce the risk of 
multimorbidity and functional limitation should address the issue at these three 







Multimorbidity, the co-occurrence of two or more diseases within a person, 
affects over a quarter of primary care patients older than 18 years of age in 
England (Cassell et al., 2018). Individuals with multimorbidity have higher rates 
of GP consultations, prescriptions, and hospitalisations compared to people 
without multimorbidity (Salisbury et al., 2011; Cassell et al., 2018). 
Multimorbidity also leads to lower health-related quality of life (Bayliss et al., 
2012; Peters et al., 2018) and decline in physical functioning (Jindai et al., 2018). 
Multimorbidity among people older than 65 years in England is set to rise with 
prevalence projected to increase from 54% in 2015 to 67.8% in 2035 (Kingston et 
al., 2018). People will live longer lives in worse health and this will increase the 
utilization of health services and the costs of health care (Cassell et al., 2018, 
Kingston et al., 2018).  
While current studies of multimorbidity focus on the impact of biomedical and 
socio-demographic characteristics on patients’ individual risk (Northwood et 
al., 2017), we also need to understand the extra-individual factors contributing 
to the increase of multiple health problems in the ageing population. Only a few 
studies examined simultaneously longitudinal trends in multimorbidity and 
their relationship with extra-individual factors such as society and environment 
(Schäfer et al., 2012, Jackson et al., 2015, Dhalwani et al., 2017 and Mounce et al., 
2018). None of them referred to any theoretical framework that would justify 
the choice of the contextual characteristics. This leads to the risk of omitting 
relevant factors which might explain more of the outcome variance and to 
exaggerating effects of the observed characteristics (Frohlich, Corin and Potvin, 
2001). Choosing an appropriate measure should be backed by theory too. For 
instance, education and income reflect different mechanisms through which 
socio-economic status operates (Demakakos et al., 2008). We argue that 
multimorbidity should be studied with the help of the theories of social 
determinants of health (SDoH). These refer to the social, cultural, economic, 
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and political conditions that influence the health of individuals and populations 
(De Maio, Mazzeo & Ritchie, 2013, Lucyk and McLaren, 2017).  
Further, we suggest that measuring multiple health problems of older people 
should be consistent with our knowledge of biological ageing. The concept of 
multimorbidity should reflect the build-up of damage within cells (Kirkwood, 
2008, Austad, 2009, Barnes, 2015) that accumulates during the life course and 
leads to a chronic dysregulation of multiple body systems (Fabbri et al., 2015, Li 
et al., 2015). Accumulation of diseases is a milestone for this system 
dysregulation, loss of resilience and accelerated ageing (Fabbri et al., 2015). The 
role of body systems in development of multimorbidity is beginning to receive 
some attention (Sturmberg et al., 2017, Yarnall et al., 2017).  
Our study seeks to address these gaps in the understanding of multimorbidity 
among ageing people. Alongside the basic definition of multimorbidity (Van 
den Akker et al., 1998) we propose two measures which in our view better reflect 
the biological process of ageing: complex multimorbidity (Harrison, Britt & 
Henderson, 2014) and multiple functional limitations. These outcomes should 
not be omitted when studying multimorbidity as they have implications for 
quality of life, need for health care and residential care, and premature mortality 
of old people (Zulman, Pal & Wagner, 2015, Jindai et al., 2016). Our approach is 
also novel in that it brings together new measures of multimorbidity with social 
theory of SDoH in a longitudinal design. The aim of our study is to explore the 
association of material, psycho-social and behavioural determinants to the 
probability of developing basic multimorbidity, complex multimorbidity and 
multiple functional limitations in the ageing population of England over a 14 
year period. 
 
4.2 Theoretical framework 
 
Our starting point is the centrality of dysfunction in several body systems that 
is conducive to multiple impairment, limitation and disease. We postulate that 
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if we can identify diverse social determinants that simultaneously affect an 
individual, changes could be observed across a number of body systems that 
will be involved in generating compound health outcomes. Here we follow the 
Generalized Health Impact model of White et al. (2013) that showed how a 
combination of social determinants (stress, poverty or quality of housing) 
generated a range of host responses encompassing more than one health 
condition. This model informed our approach to the choice of social 
determinants and for measuring multimorbidity.  
 
4.3 Measuring multimorbidity 
 
Multimorbidity has been measured by a range of methods. In primary care 
settings, indices based on diagnostic or pharmaceutical data have been used 
such as the Charlson Index, Adjusted Clinical Groups System or Cumulative 
Illness Index Rating Scale (Diederichs, Berger & Bartels, 2011, Huntley at al., 
2012). Multimorbidity estimates in general populations are based on a simple 
unweighted enumeration of the number of diseases. The most common 
definition is “the co-occurrence of two or more diseases within a person” (Van 
den Akker et al., 1998) but different cut-off points have been used too 
(Marengoni et al., 2011). In our study this measure will be called basic 
multimorbidity in order to distinguish it from two other measures. The 
limitation of the concept of basic multimorbidity is that it leads to very high 
estimates among old people (55% to 98% between studies) which may be less 
informative than other definitions (Marengoni et al., 2011). Neither does it 
differentiate between co-occurrence developing within one body system and 
two or more systems. Multimorbidity may have a larger impact on overall health 
if it arises out of disparate conditions (such as physical and mental health) 
rather than closely related comorbidities (Piette and Kerr, 2006). 
The construct of complex multimorbidity addresses these issues. It has been 
defined as “the co-occurrence of three or more chronic conditions affecting 
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three or more different body systems within one person without an index 
chronic condition” (Harrison et al., 2014, p. 8). Individuals with chronic 
conditions in 3+ body systems may require more complex care, as chronic 
conditions in different body systems are likely to compete for treatment, while 
conditions within the same system are more likely to be complementary (Piette 
and Kerr, 2006). With regard to the theories of ageing based on dysregulation of 
body systems described earlier, we argue that complex multimorbidity might be a 
more appropriate measure for ageing people than basic multimorbidity. 
The third measure of multiple functional limitations reflects the knowledge that 
the proportion of old people with physical impairments and limitations in 
multiple body systems increases with age (Burden of Disease Network Project, 
2004, Jindai et al., 2016). Functional limitations are defined as restrictions in 
performing vital situation-free physical actions needed in everyday life 
(Verbrugge and Jette, 1994). Most studies have explored prevalence and effects 
of single impairments or functional limitations but we know less about the 
relationships between combined burden of impairments and functional 
limitations and social determinants (Burden of Disease Network Project, 2004).  
 
4.4 Social determinants  
 
The theoretical approach to health inequalities and the role of SDoH in the UK 
was shaped by the publication of the Black Report in 1980 that concluded that 
material conditions were the major determinant of health and premature 
mortality (Black, 1992). This led to discussions between proponents of the 
materialist explanations and those who claimed that health inequalities are 
result of culturally mediated choices and behaviours (Bartley, 2004, Cockerham, 
2007). The debate has been enriched by a third perspective, the role of psycho-
social factors highlighted in the Whitehall II Study (Marmot et al., 1991). The 
current approach is to understand these hypotheses as complimentary rather 
than mutually exclusive and to assess their effects in one model with three 
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groups of determinants (Van Oort, van Lenthe and Mackenbach, 2005, 
Robertson et al., 2015).  
Material determinants refer to the distribution of income and wealth in society 
and to resources that allow people to secure goods and services needed for a 
healthy life, e.g. housing, healthcare (Bartley, 2004, Cockerham, 2007). Studies 
of ageing population in England and the UK found disparities by socio-
economic status (SES) for a range of health outcomes (Nazroo et al., 2017). The 
few longitudinal studies of multimorbidity showed associations with low 
education, low household income, difficulties managing on income and total 
household wealth (Schäfer et al., 2012, Jackson et al., 2015, Mounce et al., 2018). 
A lower level of education, manual occupation and poor social network 
predicted a higher number of functional limitations in the Swedish population 
older than 60 years of age (et al., 2018). Subjective social status (SSS) has been 
referred to as a subjective measure of SES as it reflects individual’s perceived 
standing in a social hierarchy and hence can be included in the group of material 
determinants (Singh-Manoux, Marmot and Adler, 2005). SSS also captures 
feelings and perceptions of anxiety, stress and the sense of inequality (Charonis 
et al., 2017). To our knowledge there are no studies of how SSS is related to 
multimorbidity and only one study has examined its association with functional 
decline (Chen et al., 2012). 
Psycho-social determinants, such as leisure and social activities and social 
networks and contacts, are increasingly more relevant to older people’s idea of 
healthy ageing (Bowling, 2008, Cosco et al., 2013). Social networks affect health 
via pathways such as provision of social support, social influence, social 
engagement and attachment, and access to resources and goods (Berkman, 
2000). Living as a couple, in a family, having a large social network and having 
a sense of control over one’s life were all protective factors reducing the risk of 
multimorbidity (Marengoni et al., 2011, Melis et al., 2014). Older multimorbid 
people with a supportive social network have longer survival time compared to 
those without social support (Olaya et al., 2017). Loneliness has been found 
positively associated with multimorbidity in England, although the relationship 
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was stronger for people younger than 44 than for people older than 65 (Stickley 
and Koyanagi, 2018). The stress-buffering hypothesis suggests that social 
relationships can provide resources that buffer the effect of stress on health 
(Uchino, 2009, Gellert et al., 2018). The direct effects’ model says that social 
networks can facilitate positive health behaviours and access to health care by 
providing resources such as material assistance or transportation (Olaya et al., 
2017).  
Behavioural determinants describe different types of consumption and leisure 
activities that directly affect health and are, to some extent, subject to individual 
choice and decision-making (Bartley, 2004). While sociology of health 
described an interplay between human agency and social structure 
(Cockerham, 2007), health behaviours are still treated in isolation from other 
social determinants (Moor, Spallek and Richter, 2016). Dhalwani et al. (2017) 
reported a social gradient between multimorbidity and physical activity, fruit 
and alcohol consumption, smoking tobacco and Body Mass Index. 
Each type of social determinant can work through any or several of the body 
systems (Blane et al., 2013). For instance, occupation can affect respiratory, 
endocrine or cardiovascular system through toxins at work (Agency for Toxic 
Substances & Disease Registry, 2018) or nervous system and immune system 
through stress (Marmot et al., 1991). Smoking tobacco can affect nervous, 
respiratory, cardiovascular or digestive systems through both inhaled 
carcinogens and lower self-esteem (Bartley, 2004). These examples illustrate our 
assumption that the combined long-term impact of material, psycho-social and 
behavioural determinants should be sufficiently wide to be observable across a 
range of body systems through our measures of complex multimorbidity and 





4.5 Material and methods 
 
4.5.1 Data 
The English Longitudinal Study of Ageing (ELSA) is a multidisciplinary panel 
study of a representative sample of men and women aged 50 years and over 
living in England. ELSA explores the dynamics between ageing and 
demographic, socio-economic, psychological and health factors. The study 
began in 2002 with 12,099 participants and the sample is re-examined every two 
years. It was replenished at waves 3, 4, 6 and 7 with new participants to maintain 
the size and representativeness of the study (Steptoe et al., 2013). We used data 
from the core sample members who are individuals aged 50 or older who were 
recruited at the first wave or at any of the refreshment samples. The numbers 
of core members were: 12,099 in wave 1; 8,780 in wave 2; 8,811 in wave 3; 9,896 
in wave 4; 9,090 in wave 5; 9,169 in wave 6 and 8,253 in wave 7.  
Data on core members from waves 1 to 7 were merged into a panel dataset. In 
order to give additional effect to those who dropped out of the analysis, we used 
longitudinal weights. In each wave, every individual who took part in all 
preceding waves was assigned a longitudinal weight by ELSA. Those who 
missed on one or more waves had been given a weight with a missing value by 
ELSA. In order to include a maximum number of core members in the analysis, 
we gave these individuals a weight that was equal to their longitudinal weight 
in the last wave they had participated.  
 
 
4.5.2 Dependent variables: measures of health 
We used data on 25 physical and mental health conditions that were 
consistently recorded at each wave (Table 4.1). The data were grouped into three 
categories: individual morbidities, groups representing body systems and 
functional limitations, a decision based on Verbrugge and Jette’s Disablement 
Process Framework (1994). We decided to enlarge their category ‘functional 
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limitations’ by including instances of impairment (dysfunction and 
abnormalities in body systems) and disability (difficulty with daily activities) 
(Table 4. 1).  
 
Table 4. 1 Health data used to measure basic multimorbidity, complex multimorbidity and multiple 
functional limitations 




1. Eye disorders   General mobility 




1.2. Macular degeneration 2 Sitting for 2 hrs 




2. Circulatory disorders 4 Climbing several flights of stairs 
6 Heart attack 2.1. High blood pressure 5 Climbing one flight of stairs 
7 Diabetes 2.2. Angina 6 Stooping, kneeling or crouching 
8 Stroke 2.3. Heart attack 7 Reaching arms above shoulders 
9 Lung disease 2.4. Congestive heart failure 8 Pulling or pushing a chair 
10 Asthma 2.5. Heart murmur 9 
Lifting/carrying weights over 10 
pounds 
11 Arthritis 2.6. Abnormal heart rhythm 10 Picking up a 5p coin 
12 Osteoporosis 2.7. Stroke  Activities of daily living 
13 Cancer 
3. Endocrine, nutritional and 
metabolic 
11 
Dressing, including putting on 




3.1 Diabetic eye disease 12 Walking across a room 




4. Musculoskeletal and 
connective system  
14 
Eating, such as cutting up your 
food 
17 Hallucinations 4.1. Osteoporosis 15 Getting in or out of bed 
18 Anxiety 4.2. Arthritis 16 
Using the toilet, including getting 
up or down 
19 Depression 5. Respiratory 17 
Using a map to figure out how to 




5.1. Lung disease 18 Preparing a hot meal 
21 Mood swings 5.2. Asthma 19 Shopping for groceries 








7. Nervous disorders 22 
Doing work around the house or 
garden 
25 Cataracts 7.1. Parkinson's disease 23 
Managing money (paying bills, 
track of expenses) 
  7.2. Alzheimer's disease  Symptoms 
  7.3. Hallucinations 24 Difficulty walking 0.25 mile 
  8. Mental and behavioural 25 Pain in general  
  8.1. Anxiety 26 Problems with eyesight 
  8.2. Depression 27 Problems with hearing 
  8.3. Emotional problems 28 Balance on level surface 




Measure 1: Multimorbidity (MM) 
A binary variable was created in order to identify participants at each wave who 
had two or more morbidities. At each wave this variable was composed of the 
data fed forward from the previous wave and the data on newly reported 
morbidities.  
 
Measure 2: Complex multimorbidity (CMM) 
Individuals with three or more body systems affected by disease were 
considered as having CMM. Body systems were represented by the Chapters of 
the International Classification of Diseases 10th Revision (ICD-10) (Table 1). A 
patient with CMM had one or more chronic conditions within each of three or 
more different ICD-10 Chapters. 
 
Measure 3: Multiple functional limitations (MFLs) 
We derived the measure of MFLs from the combination of general mobility 
variables, Activities of Daily Living (ADL) variables, and data on symptoms of 
chronic conditions (Table 1). ADL is a common measure of the abilities 
necessary for basic functioning and for living in a community (Chatterji, Byles & 
Cutler et al., 2015). We counted the number of functional limitations per 
individual. The frequencies of MFLs per individual were high, reflecting the 
older age of participants and the large list of 30 limitations. Therefore we 
decided to specify the measure of MFLs as the presence of 10 or more functional 
limitations within the same person. This cut-off point allowed us to identify a 
group of participants with a total high functional limitation, compared to a cut-




4.5.3 Explanatory variables 
Material SDoH were represented by four variables: net household wealth (high, 
medium, low), subjective social status (high, medium, low), the last occupation 
(managerial/professional, intermediate, semi/routine) and education (A-level 
or higher, O-level or equivalent and less than O-level). Psycho-social SDoH 
reflected aspects of social engagement, social support and individual sense of 
control. Social engagement was measured through individual participation in 
community organizations. A person was defined as very active if they took part 
in 3 or more community organizations and active if they participated in 1 or 2.  
Perception of loneliness was a binary variable (yes/no). Social support was 
represented by the variables supportive children (very/some, a little/not at all, 
no children), supportive friends (very/some, a little/not at all, no friends) and 
supportive partner (very/some, a little/not at all, no partner). Behavioural SDoH 
were represented by the variables physical activity (vigorous, moderate, mild, 
none), alcohol consumption (never, monthly or less, weekly, daily) and tobacco 
smoking (never, ex-smoker, current smoker). Confounding variables were: wave 
(with values 1 to 7), age (categorized in 5-year bands and 90+ years age band) 




All explanatory and outcome variables were time-varying. We chose to use the 
population-averaged regression method rather than subject-specific regression. 
This is more appropriate as our focus is on the differences in the risk of 
multimorbidity between population groups and not between individuals 
(Muller and MacLehose, 2014). We used the Generalized Estimating Equations 
(GEE) model which extends standard regression analysis by taking into account 
correlation between repeated measurements. The GEE models estimate the 
average occurrence of an outcome for a group over time. The advantage of GEE 
is that they use robust estimation of standard errors to allow for clustering 
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(correlation) between individuals. The standard errors are derived from the 
observed variability in the data rather than variability predicted by the model 
(Twisk, 2013). The GEE method adjusts for within-subject correlation by 
assuming an a priori correlation structure for the repeated measurements of the 
outcome variables. Correlation matrices for each of the three outcomes showed 
a decrease in correlation coefficients with increasing time between the 
measurements, which justified the choice of an autoregressive correlation 
structure (Twisk, 2013). Confounding factors of time (wave of measurement), 
age (varying between waves) and sex were taken into account in our regression 
models where both the explanatory factors and confounders were included as 
covariates. The associations were measured in odds ratios as our outcome 
variables were all binary and it is a common measure of health inequalities in 
large population-based studies (Di Lorenzo et al., 2014). In order to give 
additional effect to those who dropped out of the analysis, we used longitudinal 
weights. They calculated the inverse predicted probability of response among 
respondents who responded to all previous waves and multiplied that weight 
by the previous wave’s longitudinal weight (Banks et al., 2018). Analyses were 




The general characteristics of the studied population are presented in Table 4.2. 
The number of participants decreased from 10,331 (wave 1) to 7,130 (wave 7). The 
retained population are those who remained in the study and took part in the 
self-completion interviews. The mean age was 66 years (SD 10.9). The 
proportion of women was 55.3%. All longitudinal studies are subject to 
problems with non-response and attrition and these problems are starker in 
studies of ageing where rates of attrition tend to be higher (Banks et al. 2016). 
In our study respondents who took part in all waves of measurements were 
different to those who dropped out or refused to fill in the self-completion 
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interview. The retained cohort was slightly older (mean age 67 years compared 
to 66.2 years), more female (56.2% versus 54.9%) and more affluent (23.3% in 
the top wealth tertile compared to 21.6%). The core cohort was also more active, 
with a third conducting vigorous PA compared to 27% of those who dropped 
out at one or more occasions. A quarter of them was very active in their 
community compared to 17%. The problem of the differences between the two 
populations was less relevant for our analysis because we focused on all core 





Table 4. 2 Descriptive sample characteristics 




  Sense of control  
Basic MM 26,179 46.6  High 15,513 27.6 
Complex MM 9,663 17.19  Some 35,708 63.54 
MFL10+ 6,345 11.29  Low 3,608 6.42 




 A lot/some 
37,399 66.54 
50-54 5,576 9.92  A little/not at all 1,549 2.76 
55-59 10,074 17.92  No partner 16,953 30.16 
60-64 10,434 18.57     
65-69 9,569 17.03  Children support  
70-74 8,166 14.53  A lot/some 43,693 77.74 
75-79 6,233 11.09  A little/not at all 4,230 7.53 
80-84 3,791 6.75  No children 7,895 14.05 
85-89 1,789 3.18     
90 plus 570 3.18  Friends' support  
    A lot/some 42,705 75.98 
Females 31,106 55.3  A little/not at all 9,076 16.15 




    
Vigorous 16,327 29.05  Loneliness  
Moderate 27,124 48.26  Yes 6,720 11.96 
Mild 8,319 14.8     
No 4,416 7.86  Household wealth  






Never 6,635 11.81  Low 10,490 18.66 
Monthly or less 15,661 27.87     
Weekly 14,111 25.11  SSS   
Daily 18,661 33.2  Top 9,080 16.16 
    Medium 38,025 67.66 
Smoking    Low 6,756 12.02 
Never 21,041 37.44     
Ex-smoker 27,526 48.98  Occupational level  
Smoker 7,564 13.46  Managers/professionals 18,555 33.01 
    Intermediate 13,895 24.72 
Participation    Semi/routine 22,334 39.74 
Very active 11,162 19.86     
Active 26,940 47.93  Educational level  
Not active 15,142 26.94  High 18,418 32.77 
    Medium 14,436 25.69 




The probability of people aged 50 or older in England to develop 
multimorbidity, complex multimorbidity and 10 or more functional limitations 
has increased between 2002 and 2014-15 (Table 4.3). Compared to 2002/03, the 
odds of having multimorbidity in 2014/15 were 2.33 times larger (95% CI 2.14–
2.54), the odds of having complex multimorbidity 2.57 times larger (95% CI 2.29-
2.88) and the odds of having MFLs 2.28 times larger (95% CI 1.97-2.65). The 
probability of having multimorbidity increases with age across the three 
measures. The increase peaked in multimorbidity at the age 85-89 years and in 
complex multimorbidity at the age 80-84 years. Females were more likely to 
have basic MM (OR 1.31, 95% CI 1.21 – 1.41), complex MM (OR 1.26, 95% CI 1.14 – 
1.38) and MFLs (OR 1.24, 95% CI 1.1 – 1.4). 
 
Table 4. 3 Basic multimorbidity, complex multimorbidity and functional limitation by year of 















Year       
2002/03 1  1  1  
2004/05 0.87 0.82-0.92 1.06 0.96-1.17 1.38 1.22-1.57 
2006/07 1.07 1.01-1.13 1.17 1.05-1.29 1.70 1.50-1.93 
2008/09 1.42 1.33-1.52 1.79 1.62-1.99 1.43 1.24-1.63 












       Age group (years)      
50-54 1  1  1  
55-59 1.23 1.11-1.37 1.36 1.09-1.68 1.17 0.94-1.44 
















80-84 4.98 4.24-5.86 5.41 4.19-7.01 2.11 1.61-2.79 
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       Females 1.31 1.21-1.41 1.26 1.14-1.38 1.24 1.11-1.41 
 
4.7.1 Material determinants 
We observed a health gradient across the three levels of household wealth in 
basic multimorbidity, complex multimorbidity and multiple functional 
limitations (Table 4.4). Compared to the population group with the highest 
wealth, those with the lowest wealth had 47% higher odds of basic MM, 73% 
higher odds of complex MM and 91% higher odds of 10+ functional limitations  
(Table 4). Low subjective social status was associated with higher odds of having 
all three outcomes compared to reporting high SSS, with odds ratios at 1.14 (95% 
CI 1.04-1.24), 1.2 (95% CI 1.07-1.35) and 1.35 (95% CI 1.15-1.59) respectively. People 
in routine or semi-routine occupations had higher odds of having basic 
multimorbidity and MFLs than people in the managerial and professional 
group, with odds ratios at 1.07 (95% CI 1.04-1.24) and 1.2 (95% CI 1.04-1.38) 
respectively. People with basic education had higher odds of having MFLs than 
people with at least A-levels (OR 1.1, 95% CI 1-1.21).  
 



















      
High 1  1  1  
Medium 1.13 1.10-1.19 1.20 1.09-1.31 1.28 1.12-1.47 




       Subjective 
social status 
      
High 1  1  1  
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Low 1.14 1.04-1.24 1.21 1.07-1.35 1.35 1.15-1.59 
       Occupation       
Manager/prof. 1  1  1  








       Education       




















4.7.2 Psycho-social determinants 
Relationships between the predictors of social support and our outcomes were 
limited (Table 4.5). We observed that on average people without friends had 
14% higher odds of basic multimorbidity than people whose friends were very 
supportive or supportive to some degree. Similarly people with no partner had 
odds of having basic multimorbidity and multiple functional limitations higher 
than those who reported having supportive partner, with OR 1.15 (95% CI 1.06-
1.26) and 1.13 (95% CI 1.02-1.26) respectively. The perception of loneliness was 
positively associated with all three outcomes: for basic MM OR 1.18 (95% CI 1.10-
1.26), for complex multimorbidity OR 1.21 (95% CI 1.11-1.32) and for MFLs OR 1.31 
(95% CI 1.18-1.46). The relationship between the sense of control and the 
probability of having each of our health outcomes was graded by the degree of 
the perceived control. The odds ratios were higher for MFLs than for the other 
two outcomes. Participation in community was not associated with 
multimorbidity and complex multimorbidity (Table 4.5). The odds of having 
MFLs increased the less people participated, with those not active in 
























      








Not active 1.04 
0.96-
1.12 
1.01 0.91-1.12 1.27 1.11-1.46 
       Sense of control      
High 1  1  1  






Low 1.57 1.41-1.74 1.70 1.51-1.91 3.31 
2.84-
3.84 
       Supportive children      
Very/some 1  1  1  




















       Supportive friends      
Very/some 1  1  1  











No friends 1.14 
1.02-
1.26 
1.07 0.95-1.2 1.09 
0.95-
1.25 
       Supportive partner      
Very/some 1  1  1  




















       Loneliness       
Yes 1.19 1.11-1.28 1.22 1.12-1.33 1.31 1.18-1.46 
 
4.7.3 Behavioural determinants 
The relationship between physical activity and the probability of having each of 
our health measures was graded by the level of intensity of physical activity 
(Table 4.6). Compared to those who exercised vigorously, people who were 
physically inactive had 1.6 times larger odds of having basic MM (95% CI 1.21 – 
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1.41), twice larger odds of having complex MM (95% CI 1.78-2.27) and 8 times 
larger odds of having MFLs (95% CI 7.01-9.69). The frequency of alcohol 
consumption was associated with our health outcomes but not in the expected 
way. The probability of developing each of our health outcomes increased with 
decreasing frequency of drinking (Table 6). The history of smoking was related 
to the health outcomes. Ex-smokers had higher odds ratios compared to people 
who never smoked: 1.27 (95% CI 1.17 – 1.37) for basic MM, OR 1.29 (95% CI 1.17 – 
1.42) for complex MM and OR 1.3 (95% CI 1.15 – 1.48) for multiple functional 
limitations.  
 


















     
Vigorous 1  1  1  





















       Alcohol consumption      






























       Smoking       
Never 1  1  1  
Ex-smoker 1.27 1.17-1.37 1.29 1.17-1.42 1.30 1.15-1.48 












4.8.1 Main results 
We have explored the longitudinal association between material, psycho-social 
and behavioural determinants and three multimorbidity outcomes in an 
English population of people aged 50 years or older. We found a consistent 
association between the outcome measures and the levels of household wealth, 
the sense of control over one’s life, physical activity and loneliness. The 
relationship with smoking and alcohol consumption was not linear but 
complex, showing signs of reverse causation. Multiple functional limitation and 
complex multimorbidity captured larger inequalities than basic multimorbidity. 
 
4.8.2 Interpretation 
We have presented evidence that a variety of material, psycho-social and 
behavioural determinants are to varying extents related to basic 
multimorbidity, complex multimorbidity and multiple functional limitations. 
We found consistent inequalities in multimorbidity and functional limitation 
across the levels of household wealth, the sense of control over one’s life, 
physical activity and loneliness. These inequalities appeared larger when 
measured as multiple functional limitation and complex multimorbidity than 
basic multimorbidity. Our results suggest that solely materialist models of 
multimorbidity at older age are insufficient, as behavioural and psycho-social 
factors play an important role. Behavioural patterns in smoking and alcohol 
consumption suggest that while health inequality accumulates during the life 
course, psycho-social resources and active human agency also contribute to 
shaping the individual health trajectories.  
Among material determinants the strongest health disparities were captured by 
household wealth. Compared to the population group with the highest wealth, 
those with the lowest wealth had 47% higher odds of basic MM, 73% higher 
odds of complex MM and 91% higher odds of multiple functional limitations. 
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The stark disparities support the evidence that the amount of available 
household wealth or assets constrains individuals’ consumption choices on 
quality of housing, usable outdoor space, type of residential area or quality of 
health care (Joseph Rowntree Foundation, 2014). Savings also act as a buffer 
against unexpected loss of income due to ill health in later life thus reducing 
the exposure to stress. We observed that individuals with the lowest subjective 
social status had 14% larger odds of having basic MM, 20% larger odds of having 
complex MM and 35% larger odds of having multiple functional limitations than 
those with the top SSS. These differences might reflect two-way effects: a very 
low subjective perception of one’s status contributes to worse health but having 
more complex issues (with simultaneously affected body systems and limited in 
everyday lives) additionally reinforces the negative rating of individual status 
(O’Brien, Wyke and Watt, 2014).  
Occupational status was weakly associated with basic MM and MFLs and 
educational qualifications were weakly related to MFLs. In comparison to the 
measure of household wealth which reflects a process of life-long accumulation, 
the indicators of education and occupation reflect periods of time from a more 
distant past. This might explain stronger and more consistent effect of 
household wealth and suggest that it is a better indicator of an older person’s 
status (Adena and Myck, 2014, McGovern and Nazroo, 2015).  
Psycho-social determinants produced mixed results. We found a clear gradient 
between individuals with the strongest and the weakest sense of control over 
their lives. The more people felt in charge of their lives the less likely they were 
to develop ill health. Low control beliefs can affect health in several ways. They 
may lead to anxiety and aggression which facilitates chronic stress response, 
smoking and drinking. Feeling low control over destiny can also lead to passive 
responses such as low self-esteem which induce depression (Whitehead et al., 
2016). Loneliness was the other factor consistently related to all of our measures. 
The feeling of being socially isolated is relatively common among the elderly 
because some relationships are lost as people get older (Singh and Misra, 2009).  
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Participation in community groups was a protective factor against the 
probability of developing 10 or more functional limitations but not protective 
from multimorbidity. Participating in at least three community groups 
presupposes certain level of health and physical functioning which acts as a 
clear barrier for those with at least 10 functional limitations. This health 
selection process might explain why we can see a social gradient for functional 
limitations but not for multimorbidities. Other measures of social support 
showed either no significant relationship or a limited relationship. We found an 
association with friendship among people with basic MM and MFLs. The effects 
of support on health of older people depend on the source of support and the 
quality of relationship. For example relationships with friends can be beneficial 
to one’s health while relationship with family members not (Huxhold, Miche & 
Schüz, 2014). 
In the group of behavioural determinants we found a dose-response 
relationship between all levels of physical activity and the probability of all three 
health outcomes. This confirms that the lack of physical activity is an important 
factor increasing the probability of chronic and complex health problems and 
limitations in the ageing population (Cimarras-Otal et al., 2014, Dhalwani et al., 
2017). Increasing frequency of alcohol consumption seems to have protective 
effect on the odds of multimorbidity and functional limitation. We suggest that 
our findings can be explained by reverse causality. Holdsworth, Mendonça, 
Pikhart et al., (2016) found that older people with good or improving self-
reported health were increasing their drinking over time while people with bad 
or worsening health were moderating their drinking.  
The relationship between smoking and both types of multimorbidity is 
ambiguous. Compared to people who never smoked, ex-smokers were more 
likely to develop any of the three outcomes but there was no relationship 
between current smokers and those who never smoked for basic or complex 
MM. Cross-tabulating smoking, age and prevalence of multimorbidity, we 
found that ex-smokers were more prevalent among older age groups with 
higher morbidities and current smokers were younger and healthier. The 
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explanation of similar findings by Nazroo, Zaninotto and Gjonca (2008) is that 
when people become ill they might stop smoking. The results for alcohol 
consumption and smoking exemplify how people in later life continue making 
active choices within their social context (Elder, 1994).  
Multiple functional limitation and complex multimorbidity captured larger 
inequalities than basic multimorbidity. Working with the basic measure of 
multimorbidity might limit our ability to see the social heterogeneity of an 
ageing population. But apart from improving the measure we also need to try 
to explain why different measures lead to different inequalities. Functional 
limitation and decline in the elderly is a consequence of chronic disease, with 
greater effect among people with a higher number of morbidities (Ryan et al., 
2015, Jindai et al., 2016). Complex multimorbidity results from dysfunction in 
three or more body systems. Both outcomes demand complex and long-term 
care but we know that patients’ responses are socially differentiated (Bartley, 
2004, Cockerham, 2007). People from higher social backgrounds are capable of 
using resources such as power, money, knowledge, prestige or social support to 
protect themselves from health risks or mitigate the consequences of 
multimorbidity (Link and Phelan, 1995). Taking into account this socially 
patterned human agency might help to explain why inequalities in complex 





There are several limitations to our study related to methodology and the scope 
of analyses. Our study was exploratory and based on using the GEE method with 
population-averaged data. It allowed us to observe the averaged distribution of 
certain characteristics between individuals. However this study design does not 
enable building explanatory analyses or drawing conclusions on both within-
individual and between-individual variance or change in outcomes.  
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Recent studies reported that social determinants do not only influence health 
simultaneously but also influence each other (Short and Mollborn, 2015, Moor, 
Spallek and Richter, 2016). For instance, social support can mitigate the effect 
of stress on people with low social status (Gellert et al., 2018). We have not 
examined these interaction effects but they could lead to modification of some 
effects. 
We constrained our classification to a generic count of single diseases, ICD-10 
chapters and functional limitations without identifying the most frequent 
combinations. These have been studied either as pairs and triplets or as clusters 
with the highest degree of association and due to their synergistic effects are of 
special interest to clinicians (Ng et al., 2018). Unpacking the associational 
heterogeneity might shed some light on the relationships between these 





Our study was the first study to comprehensively explore materialist, psycho-
social and behavioural determinants of health in relation to multimorbidity and 
multiple functional limitations. Policies aiming to reduce the risk of 
multimorbidity and functional limitation should address the issue at several 
levels, as a socio-economic and behavioural intervention. Pension reform policy 
introducing changes to retirement age which are uniform for all population 
groups should take into account the evidence of the social gradient in the risk 
of multimorbidity and functional decline. Behavioural and therapeutic 
approaches in the community can help to compensate for social isolation, 
reduced self-esteem or to regain more sense of control over people’s lives 
(Public Health England and UCL Institute of Health Equity, 2015). This strategy 
should be based around local primary care centres. They could be provided with 
additional resources to spend more time as the frontline assessors of 
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multimorbidity and consistent coordinators acting as a link between patients 
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Different definitions of multimorbidity and social determinants 
 








ratio 95% CI 
  Odds  
ratio 95% CI 
    Odds 
ratio 95% CI 
 
Household 
wealth       
High 1  1  1  
Medium 1.13 1.10-1.19 1.20 
1.09-
1.31 1.18 1.1-1.28 
Low 1.47 1.34-1.61 1.73 
1.52-
1.96 1.66 1.49-1.86 
       Subjective 
social status       
High 1  1  1  
Medium 1.04 0.98-1.10 1.11 
1.00-
1.20 1.06 0.98-1.14 
Low 1.14 1.04-1.24 1.21 
1.07-
1.35 1.16 1.04-1.28 
       Occupation       
Manager/prof. 1  1  1  
Intermediate 0.93 0.85-1.01 0.92 
0.81-
1.03 0.93 0.84-1.04 
Semi/routine 1.07 1.04-1.24 1.03 
0.92-
1.15 1.05 0.95-1.16 
       Education       
A-level+ 1  1  1  
0-Level or 
equiv. 0.93 0.86-1.00 0.92 
0.81-
1.03 0.94 0.86-1.05 
Less than 0-
Level 1.02 0.97-1.07 1.04 
0.92-

























ratio 95% CI 
  Odds  
ratio 95% CI 
 Odds 
 ratio 95% CI 
 
Participation       
Very active 1  1  1  
Active 0.97 0.92-1.03 1.03 
0.95-
1.12 1.03 0.96-1.11 
Not active 1.04 0.96-1.12 1.01 
0.91-
1.12 1.04 0.99-1.24 
       Sense of control      
High 1  1  1  
Some 1.21 1.16-1.27 1.28 
1.20-
1.37 1.28 1.21-1.35 
Low 1.57 1.41-1.74 1.70 
1.51-
1.91 1.62 1.44-1.92 
       Supportive children      
Very/some 1  1  1  
A little/not 
at all 1.02 0.94-1.11 1.02 
0.90-
1.15 1.05 0.95-1.16 
No children 0.96 0.86-1.07 0.98 
0.86-
1.11 0.98 0.87-1.09 
       Supportive friends      
Very/some 1  1  1  
A little/not 
at all 0.99 0.94-1.06 0.96 
0.89-
1.04 0.99 0.93-1.06 
No friends 1.14 1.02-1.26 1.07 0.95-1.2 1.06 0.95-1.18 
       Supportive partner      
Very/some 1  1  1  
A little/not 
at all 0.93 0.81-1.07 0.98 
0.81-
1.18 0.91 0.78-1.07 
No partner 1.15 1.06-1.26 1.03 
0.94-
1.14 1.11 1.02-1.21 
       Loneliness       
Yes 1.19 1.11-1.28 1.22 
1.12-
























ratio 95% CI 
   Odds 
 ratio 95% CI 
   Odds 
ratio 95% CI 
 
Physical activity      
Vigorous 1  1  1  
Moderate 1.22 1.16-1.28 1.32 
1.22-
1.42 1.29 1.21-1.37 
Mild 1.57 1.46-1.68 1.92 
1.75-
2.12 1.79 1.65-1.94 
None 1.60 1.45-1.76 2.01 
1.78-
2.27 1.78 1.60-1.99 
       Alcohol consumption      
Don't drink 1  1  1  
Monthly or 
less 0.90 0.83-0.99 0.79 
0.71-
0.87 0.80 0.73-0.87 
Weekly 0.82 0.75-0.91 0.68 
0.61-
0.77 0.73 0.65-0.81 
Daily 0.81 0.73-0.88 0.65 
0.58-
0.74 0.69 0.62-0.77 
       Smoking       
Never 1  1  1  
Ex-smoker 1.27 1.17-1.37 1.29 
1.17-
1.42 1.31 1.20-1.44 
Current 1.03 0.91-1.14 1.04 
0.90-
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Chapter 5  
Material, psychosocial and behavioural pathways to 




Rates of multimorbidity - the co-occurrence of multiple diseases within a person 
– are increasing in the United Kingdom (Kingston et al. 2018) and globally 
(Garin et al., 2015). More than a quarter of primary care patients older than 18 
years in England have multimorbidity (Cassell et al., 2018). As a result of ageing, 
multimorbidity tends to combine with a decline in physical functioning (Ryan 
et al. 2015, Jindai et al. 2016). This reduces quality of life (Bayliss et al., 2012) and 
leads to more primary care consultations, prescriptions and hospitalisations 
than in people who have no or a single chronic disease (Cassell et al., 2018).  
The prevalence of multimorbidity in people older than 65 years in England is 
projected to increase from 54% in 2015 to 68% in 2035 (Kingston et al., 2018). An 
additional problem is a persisting inequality in the prevalence of 
multimorbidity in advanced countries (Tetzlaff et al. 2018; Mondor et al. 2018). 
People with poorer socio-economic background (Taylor, 2010; Agborsangaya 
2012, Schaefer et al. 2012), low education (Johnson-Lawrence, Zajacova & Sneed 
2017; Pathirana & Jackson 2018), women (Prados-Torres et al. 2015, Agur et al. 
2016), people who smoke, drink alcohol and the physically inactive (Dhalwani 
et al., 2017) are at higher risk of having multimorbidity in older age.  
In order to prevent the growth of prevalence and reduce health inequalities in 
multimorbidity, we need to better understand what triggers these risks for some 
and not for others and how they develop over individual lives. We also need to 
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consider multimorbidity in conjunction with functional limitations and 
examine if and to what extent their development differs over the life span. 
Researchers need to consider the role of childhood circumstances and extra-
individual social determinants of multimorbidity to assess its causality and 
temporal trends (Vetrano et al., 2018). The number of studies that have explored 
longitudinal trends in multimorbidity and their relationship with extra-
individual factors is small (Schäfer et al., 2012; Jackson et al., 2015; Pavela and 
Latham 2015; Dhalwani et al., 2017). Furthermore, the studies that do exist did 
not develop explicit models of the relationships between the proximate and 
distal factors affecting multimorbidity. This makes the risk of omitted variables 
more likely. Some relevant factors may have remained “under the radar”, while 
the role of those observed could have been inflated or attenuated depending on 
the failure to control for confounders and the inclusion of mediating factors 
(Frohlich, Corin and Potvin 2001).  
Our study builds on a series of contextual analyses of multimorbidity and 
multiple functional limitations of the ageing population in England. We started 
with an investigation into the changes in prevalence between 2002 and 2015 as 
well as modification by age, sex and household wealth (Singer et al., 2019a). We 
found that multimorbidity and functional limitations were becoming more 
common in general, more common among women than men and among 
individuals with less wealth than more wealth. In the next step, we expanded 
the analysis by exploring the role of material, psychosocial and behavioural 
determinants. We found that household wealth, sense of control over individual 
life, physical activity and loneliness were associated with the risk of having 
multimorbidity and functional limitation (Singer et al, 2019b). However, the 
analysis did not attempt to establish the causal direction of these associations. 
Our paper builds on the existing knowledge and on our own findings by setting 
out the following research questions: 
What are the effects of childhood circumstances (social class, self-rated health 
and adverse childhood experiences) on individual differences in old age 
multimorbidity and functional limitation? 
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What is the role of material, psycho-social and behavioural pathways in 
mediating effects of childhood circumstances on individual differences in old 
age multimorbidity and functional limitation? 
In order to achieve these goals, this paper develops a theoretical framework for 
life course pathways to multimorbidity and functional limitation. We have 
empirically tested this using data from the English Longitudinal Study of Ageing 






5.2 Lifecourse models of health 
 
Chronic disease and multimorbidity are characterized by a time lag between 
exposure to negative experiences and diagnosis or manifestation of a chronic 
disease and later development of other diseases. More specifically, it is the 
gradual accumulation of mundane experiences, wearing down the body systems 
rather than rare exceptional events that is characteristic for the period leading 
to the onset of multimorbidity (Hertzman and Boyce 2010). The onset is socially 
patterned. For example, people living in socially deprived areas of Scotland 
acquired multimorbidity 10-15 years earlier than people from affluent areas 
(Barnett et al. 2012). These features make inequalities in multimorbidity an 
appropriate subject for life course studies. 
Life course analyses explore simultaneously the biological and social contexts 
and development of individual health and disease (Bartley, Blane, and Davey 
Smith, 2005). The common premise behind all life course approaches is that the 
antecedent circumstances in an individual’s life influence the health states and 
their rate of change across an individual’s life course. Therefore they explicitly 
require temporal ordering of exposures and their mutual relationships (Kuh et 
al., 2003). A variety of theoretical life course models have been formalized (Ben-
Shlomo and Kuh 2002). The critical period model assumes that an exposure only 
has an effect within a circumscribed time window, an observation elaborated 
earlier by Kuh and Wadsworth (1993). For example, growth retardation in utero 
can change several physiological processes for the rest of life, such as cardio-
metabolic, immune or inflammatory systems (Haas and Oi 2018). The concept 
of a sensitive period assumes exposures can act across multiple time windows 
but some are more sensitive to a specific exposure (Ben-Shlomo and Kuh, 2002). 
For example, smoking during puberty may have a stronger risk on future breast 
cancer than post-pubertal cigarette consumption (Clarke and Joshu, 2017). 
Barker and colleagues put forward the developmental origins of health and 
disease model arguing that chronic diseases resulted from short term 
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developmental perturbations that had long term maladaptive effects (Barker, 
1998). 
The accumulation of risk model postulates that factors increasing disease risk or 
protection from disease accumulate over a life time (Ben-Shlomo and Kuh 
2002). For instance, a child from a poor family is more likely to fail at school, 
leave school at an early age, take up unskilled work that is hazardous and badly 
paid and, when retired, spend the rest of their life in financial insecurity. Early 
life advantage or disadvantage sets individuals on diverging pathways or chains 
of risk, as one exposure leads to another. The process is not deterministic but 
has been expressed as a probabilistic cascade, capturing how risks build up over 
time (Ferraro, Schafer and Wilkinson 2016).  
Rather than being mutually exclusive, both models are combined in research 
practice (Ben-Shlomo, Cooper and Kuh 2016). Critical (sensitive) period, 
accumulation and pathways are increasingly treated as mutually entangled 
trends. For instance, Hallqvist et al. (2004) compared three hypotheses: critical 
period, accumulation and the role of social mobility in their study of trajectories 
leading to myocardial infarction. The study found strong interdependence 
between the critical period, accumulation and social mobility patterns. Power 
and Hertzman (1997) suggested that it might be useful to start thinking in terms 
of the relationship between latency (early-life) and pathway (or path-
dependency) effects.  
Despite their interdependencies, it is important to distinguish between 
critical/sensitive period models and accumulation of risk models because they 
can inform the timing of possible preventive interventions to reduce health 
inequalities (Green and Popham, 2017). Life course models can guide the 
choices about whether action must take early in life or whether it could be more 
effective when risk factors may be present but before disease onset. This is the 




5.2.1 Socio-economic inequalities 
The Black Report (Black, 1980) put forward four possible explanations for socio-
economic inequalities in health: artefact (no relationship between social class 
and health), selection (health determines social class position), materialist 
(multi-faceted social class affects health) and cultural/behavioural (socially 
patterned risky behaviours affect health). These explanations later turned into 
competing perspectives guiding subsequent research, especially divided 
between proponents of health selection versus social causation (Warren, 2009) 
and materialist versus psychosocial (Marmot & Wilkinson, 2001) or materialist 
versus behavioural approaches (Davey Smith, Blane & Bartley 1994). The arrival 
of life course theory allowed researchers to redefine these hypotheses into 
temporal pathways and to integrate them into a coherent framework 
(Macintyre, 1997; Moor, Spallek and Richter, 2016).  
Material pathways link lower social class position to health and mortality 
through the role of occupational status, income and financial wealth across the 
life course. Material inequality can affect health in two ways, either through the 
lack of resources of individuals and/or through the under-investment in 
services and community infrastructure (Kaplan et al., 1996; Lynch 2000) which 
may interact. Within this pathway, studies identified a range of determinants, 
such as working conditions (Benach, Muntaner, Solar et al. 2013), housing 
conditions (Krieger & Higgins 2002), neighbourhood deprivation (Pickett & 
Pearl, 2001; Barnett et al., 2012) and environmental pollution (Briggs, 2003).  
Lack of education is a major determinant through which inequality is passed 
between generations (Bartley 2017; Cockerham 2007) as it reflects parental 
social class. Research has found that socially patterned literacy levels (i.e. 
number of books at home) translate to school achievement in childhood and 
adolescence which has implications for the risk of school drop-out and the total 
time spent in education (Due et al., 2011). A child from a family with multiple 
disadvantages is more likely to fail at school, leave it at an early age and take up 
unskilled work. There is a higher probability that when retired, the person 
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spends the rest of their life in financial insecurity and with disease accumulation 
(Bartley, 2017; Due et al., 2011).  
The psychosocial pathway comprises a variety of psychosocial resources, such 
as leisure, social activities and networks, from the level of the family or 
household out to the wider community and society (Bartley, 2004). These 
pathways benefit health by providing social support, social influence and 
attachment, and access to resources and goods (Berkman and Glass, 2000). The 
perception of control over life is another determinant with effects on later 
health (Whitehead et al., 2016). One pathway associated with the lack of 
subjective control acts through passive response and induced depression. An 
alternative route is through chronic stress leading to higher risk of 
cardiovascular disease and lower endocrine and immune function (Bosma, 
2006). Research has also reported a relationship between multimorbidity and 
social support. The risk of multimorbidity was reduced for people living as a 
couple, in a family, who had a large social network and a sense of control over 
their lives (Marengoni et al., 2011).  
Behavioural pathways (or health behaviours) define how consumption and 
leisure activities affect health and are, to some extent, modifiable by individual 
decision-making (Bartley, Blane, and Smith Davey, 2005). Examples of health 
behaviours include physical activity, smoking, substance use, diet, risky sexual 
activities, health care seeking and adherence to prescribed medication (Short 
and Mollborn, 2015). Individuals with a higher number of risk factors are more 
likely to develop multiple health issues than those who engage in only one type 
of risky behaviour (Fortin et al. 2014, Dhalwani et al. 2017; Katikireddi, 2017). 
Several theories exist to explain behavioural inequalities. Bourdieu (1984) notes 
that members of the same class do not consciously choose to act in a risky way. 
Instead, they reproduce practices, formed within their social locations, which 
instil them with a corresponding world view and values. Factor, Kawachi and 
Williams (2011) proposed that engaging in risky behaviours forms part of 
practices of resistance by minority groups as long as healthy lifestyles are 
associated with the dominant groups and ideas.  
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Material, psycho-social and behavioural pathways are commonly described as 
the key life course mechanisms explaining socio-economic inequalities in 
health (Bartley, Blane, and Smith Davey, 2005; Van Lenthe et al., 2014). A review 
of studies using this classification of pathways (Moor, Spallek and Richter, 2016) 
found that most studies have focused on single pathways, which led to an over-
estimation of their effects. In contrast, only four studies examined all three 
pathways simultaneously (Moor, Spallek and Richter, 2016). The review found 
that material conditions were the strongest mediator of the relationship 
between socio-economic status and self-reported health, which supports the 
materialist hypothesis from the Black Report. However, all studies were based 
on cross-sectional data which makes causal interpretation problematic. 
 
5.2.2 Adverse experiences 
Childhoods differ by more than just their socio-economic positions. Adverse 
childhood experiences (ACEs) include direct harm to children (physical, sexual, 
verbal abuse) and indirect experiences such as domestic violence, parental 
separation, substance absuse, mental illness and crime (Hughes et al. 2017). 
ACEs have been recognized as important determinants of adult health (Felitti, 
et al., 1998) for adult mental health, respiratory disease, cardio-vascular 
diseases, cancer, diabetes and risky health behaviours including self-harm 
(Felitti et al., 1998; Taylor et al. 2015).  
The ways in which early adversity contributes to the risk of multimorbidity and 
functional limitation remains unclear. There is some evidence for the 
behavioural pathway where individuals with  a history of ACEs adopt hazardous 
lifestyles (Sinnott et al., 2015). Other studies proposed that adversity in 
childhood creates a vulnerability to increased chronic stress later in life (Raposa 
et al., 2014) which translates into higher risks of mental and physical health 
problems (Font and Maguire-Jack, 2016). Therefore early adversity should be 
considered simultaneously with childhood social class in any life course model 
of multimorbidity. Distinguishing between the causal chains of social class and 
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those of adverse experiences will help better understand the explanatory 
mechanisms behind the development of adult multimorbidity. 
 
5.2.3 Childhood health 
Experiences of poverty, parental abuse, neglect or domestic violence can be 
intertwined with concurrent child health problems. Childhood health is 
another determinant that can influence later health development of individuals 
(Haas 2006; Haas and Oi, 2018; Pavela and Latham 2015). Early studies of this 
relationship used birthweight, child’s height and weight as proxies for health or 
nutrition and showed an inverse relationship between the scores in childhood 
and later health outcomes (Bartley, Blane, and Smith Davey, 2005). The 
collection of more specific medical information in the British Birth cohorts 
facilitated a direct examination of health development from early years to young 
and middle age. For example, participants with chronic illnesses in childhood 
were at a higher risk of chronic disease, psycho-social problems and social 
isolation at age 23 years (Power, 1992). In the U.S., self-reported conditions in 
childhood were directly associated with cancer, lung disease, cardiovascular 
conditions, and arthritis/rheumatism in a nationally representative sample of 
Americans aged 55 to 65 years (Blackwell, Hayward and Crimmins, 2001). The 
associations were explained by direct biological effects (the critical period) but 
social pathways were also found to be relevant. Using a U.S. longitudinal study 
covering the period 1968-1996, Haas (2006) developed a mediation model 
showing that socio-economic deprivation increased risk of poor birth outcomes 
and childhood illness. Children with worse health later completed education at 
an earlier age, progressed to lower status occupation, leading to lower income 
and household wealth. The social pathway was associated with worse adult 




5.2.4 Multimorbidity and functional limitation 
Life course models of multimorbidity and functional limitation are rare. Those 
that exist (Pavela & Latham, 2015; Ferraro, Schafer and Wilkinson, 2016; Haas & 
Oi, 2018) conceptualized multimorbidity as a multi-causal phenomenon and 
used multiple domains of circumstances in childhood and adult life. Pavela and 
Latham (2015) used recalled information about childhood SES and health and 
adult multimorbidity observed over 18 years in the Health and Retirement Study 
in the U.S. After controlling for adult SES and adult health behaviours (obesity, 
smoking, visiting a doctor in the past 2 years, having  health insurance), the 
study found no effect of childhood SES, but the effect of childhood health did 
persist. They characterized the model as the accumulation of risk where the 
socio-economic circumstances from early life followed a pathway model while 
the childhood health effects reflected a critical period model. The authors 
concluded that childhood health seemed to be an indicator for an increased risk 
of multimorbidity.  
Haas and Oi (2018) used multimorbidity and functional limitations as 
alternative outcomes. They found that, despite variation across 13 European 
countries, the relationship between childhood illness with multimorbidity and 
functional limitations in later life persisted in the presence of adult 
socioeconomic circumstances and health behaviours. The effects of childhood 
social class were attenuated by socio-economic circumstances in adulthood. 
Unlike the two previous studies, which built models in a series of stepwise 
logistic regressions, Ferraro, Schafer and Wilkinson (2016) explicitly tested 
hypothesized pathways via a mediation model of multimorbidity. Using data 
from the National Survey of Midlife Development in the United States, 
childhood disadvantage was measured across three domains – SES, family 
composition and abuse with three types of pathways considered: SES (index 
composed of years of education, household income and financial strain), 
lifestyle risk (obesity, smoking, drinking) and psychological resources (family 
and friend support, family and friend strain, a scale of social integration and the 
level of personal control). Childhood social deprivation was indirectly related to 
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multiple health problems via smoking and lack of personal control. The physical 
and emotional abuse in childhood affected later health through smoking, lack 
of family support and personal control. The limited evidence indicates that 
social and psychological factors in childhood influence the risk of 
multimorbidity and functional limitation in late life but the effects are mediated 
via material, psychosocial and behavioural pathways. However, it is important 
to note that the impact of childhood health was not tested by Ferraro, Schafer 
and Wilkinson (2016). 
 
5.3 Life course model of multimorbidity and functional limitation for ageing 
people in England 
 
In order to answer our research questions, Figure 5.1 represents a framework  
that identifies pathways to multimorbidity and multiple functional limitation 
from childhood to adult and old age. Both direct and indirect effects of 
childhood circumstances on health in old age are included. We expect that the 
paths will follow the accumulation of risk model with mediation through 
independent material, psychosocial and behavioural indirect effects (pathways) 
which may or may not explain the total effect leaving little or no direct effect. 
We adopt a theoretically informed “life stage” approach (Stone, Netuveli and 
Blane, 2014). We assume that a series of social exposures during life will 
contribute to the total effect on multimorbidity in a cumulative rather than a 
simple additive effect, i.e. some periods in life have greater importance than 
others. For this reason, we chose four life stages where literature has 
documented specific effects on individual health process. Some of them 
(childhood, adolescence) can be related to the concept of sensitive period from 
lifecourse epidemiology (Ben-Shlomo and Kuh, 2002; Stone, Netuveli and Blane, 
2014). We extend the idea of sensitivity from the biological to the social terrain 
by including the cohort aged between 50 and 64 years. In Britain, this is the 
period in life when individual and household wealth is at its peak and surpasses 
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the role of income (Crawford, Innes and O’Dea, 2016). A detailed analysis of the 
pathways of accumulation for this age cohort revealed that the accumulation is 
wider than economic, involving psychological and cultural mechanisms 
(McGovern and Nazroo, 2015). Individual differences in smoking, alcohol 
consumption, physical activity and BMI at age 59 years predicted greater 
differences in the probability of developing multimorbidity than at younger or 
older ages (Katikireddi et al., 2017). This adds to the relevance of the pre-
retirement life stage for our model, as the focus is on pathways to inter-
individual differences in old age health. 
In order to capture a diversity of experiences that might differ between children, 
we use three domains of childhood circumstances: social class, adverse 
childhood experiences and self-rated health. We acknowledge their mutual 
inter-relationships by allowing them to correlate in the model (Hoffman, Kröger 
and Geyer, 2019). In line with the accumulation of risk theory and the findings 
summarized in Sections 5.2.1 to 5.2.4, we expect that the differences in the social 
class of children will set them on diverging material, psychosocial and 
behavioural pathways. Children in higher socio-economic positions will 
increase their likelihood of improving their material and psychosocial 
circumstances as well as health-related behaviours in pre-retirement. These 
differences will in turn increase their likelihood of lower multimorbidity and 
functional limitation. Similarly, we expect that those who avoided adverse 
experiences in childhood will be more likely to score better in the measures of 
adult social class, psychosocial support and health behaviours, which will 
translate to a lower degree of multimorbidity and functional limitation.  
It is unlikely that the indirect effects of childhood circumstances on 
multimorbidity and functional limitation can exist without some mediation 
through the health status. Our model tests for this possibility by predicting 
direct effects of childhood exposures on the risk of multimorbidity in pre-
retirement which then affects the risk of multimorbidity and functional 
limitation in the old age. These paths are illustrated as red arrows in Figure 5.1 
to distinguish them from the other pathways. At the same time we assume 
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that multimorbidity at pre-retirement can act as confounder of the 
relationships between the pre-retirement mediating factors and the outcomes 
(illustrated by the red arrows leading from multimorbidity in pre-retirement 
to the mediators and to the outcome variables). 
 
 
Figure 5. 1 Theoretical framework for lifecourse pathways to multimorbidity and functional 
limitation. The circles indicate latent variables whilst squares indicate measured variables. 
 
Several more assumptions in our model of lifecourse multimorbidity include: 
(a) Moving from left to right assumes passage of time, (b) vertically aligned 
variables are contemporaneous and (c) relations among contemporaneous 
variables are correlational. The correlation reflects that the causal order is 
unknown. (d) directional relations express the passage of time. (e) there are no 
additional unmeasured confounders in the model (f) measurement error is 
minimal. These conditions, although unrealistic, determine the hypothetical 
path that can exist between two variables in our model (MacKinnon, Fairchild 






The English Longitudinal Study of Ageing (ELSA) is a representative study 
using a panel of individuals aged 50 years and older in England. ELSA is focused 
on understanding the physical, psychological, social and economic aspects of 
ageing. The first wave of ELSA was carried out in 2002 and over 12,000 core 
sample members and their partners were interviewed during this wave. 
Participants are interviewed every two years, with a total of eight waves of 
observations. Retrospective data on the participants’ childhood were collected 
in the Life History interviews recorded at wave 3.  
Following from our conceptual framework (Fig. 5.1) we merged the recalled data 
from the Life History interviews with data from wave 1 and wave 8 in order to 
achieve the maximum time lag between the measurement of the hypothesized 
mediators and their effects on the outcome. Only individuals who took part in 
Life History interviews, wave 1 and wave 8 were selected for analyses. The final 
selection included only those who were aged 50-64 years (n) at wave 1 and 157 
cases were excluded from analysis due to missing values on all variables. The 
resulting sample size was 3,088 individuals. We took into account the 
longitudinal complex structure of the data by using three types of variables 
provided by ELSA. A stratification variable took into account the geographic 
stratification, a cluster variable addressed the non-independence of 
observations due to cluster sampling and the longitudinal weight at wave 8 to 
deal with the unequal probability of selection.  
 
Table 5. 1 Variables selected for the analysis  
Variable Category Number Frequency 
 
Wave 1 
   
Sex    
Male 1 1391 45.0 
Female 2 1697 55.0 
Occupation    
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High 1 1178 39 
Intermediate 2 709 23.5 
Low 3 1130 37.5 
Household wealth   
Top 1 835 27.6 
Medium 2 1858 61.4 
Low 3 333 11 
Subj. social status   
Top 1 591 19.4 
Medium  2 2215 72.8 
Low 3 235 7.7 
Sense of control   
Maximum 1 1245 40.8 
Some 2 1691 55.4 
Low 3 118 3.9 
Loneliness    
No 1 2804 91.1 
Yes 2 275 8.9 
Physical activity   
Vigorous 1 1108 35.9 
Moderate 2 1515 49.1 
Mild 3 305 9.9 
No 4 158 5.1 
Alcohol consumption   
Don't drink 1 212 6.9 
Monthly or less 2 806 26.1 
Weekly 3 1145 37.1 
Daily 4 925 30 
Smoking    
Never 1 1171 37.9 
Ex-smoker 2 1317 42.6 
Current smoker 3 600 19.4 
    
Recall at wave 3   
Main carers job   
Higher  1 819 26.7 
Intermediate 2 1187 38.7 
Lower or poor 3 986 32.1 
Other 4 79 2.6 
Number of books   
Many 1 548 18.5 
Some 
 
2 1710 57.6 
Few or none 3 710 23.9 
In-door toilet   
Yes 1 2046 68.5 
151 
 
No 2 941 31.5 
Physical abuse   
No 1 2575 96.2 
Yes 2 103 3.8 
Parents' neglect   
No 1 2482 92.9 
Yes 2 190 7.1 
Arguments & Fights   
No 1 2071 78.4 
Yes 2 571 21.6 
Child's health   
Excellent 1 1133 36.9 
Very good 2 1009 32.9 
Good 3 578 18.8 
Fair 4 258 8.4 
Poor 5 89 2.9 
Educational completion   
Age 17 years or 
older 
1 1074 34.8 
Age 14-16 years 
 
2 2013 65.2 
Wave 8    
Basic multimorbidity   
0 conditions 1 359 16.4 
1 2 591 27 
2 3 531 24.3 
3 4 379 17.3 
4 5 165 7.6 
>5 conditions 6 160 7.3 
Complex multimorbidity   
0 ICD chapters 1 360 16.5 
1 2 654 29.9 
2 3 611 28 
3 4 377 17.3 
>4 ICD chapters 5 183 8.4 
MFL    
0 FLs 1 605 27.7 
1 2 424 19.4 
2 3 278 12.7 
3 4 170 7.8 
4 5 125 5.7 
5 to 9 6 341 15.6 






Data on childhood and the age of educational completion originate from self-
reported interviews collected in ELSA at wave 3 (2006-07). The variables 
Adversity, Social Class (in childhood and pre-retirement), Psychosocial Factor 
and the Behavioural Factor were measured as latent factors. Latent constructs 
represent processes which are not directly measurable and are only identifiable 
through chosen indicators.  
 
Social Class in childhood 
Social class is a key determinant of health (Bartley, 2017; Krieger, 2011). It is a 
marker of social stratification, leading to socio-economic inequality between 
individuals that transmits from generation to generation (Link and Phelan, 
1995; Bartley 2017; Cockerham, 2007). The concept of social class is more 
appropriate for our aims than the concept of socio-economic status, which 
typically reflects direct indicators such as income, educational attainment and 
occupational classification. This reduces class position to single economic issues 
and complicates the explanation of the underlying mechanisms between social 
positions and health (Galobardes et al., 2006; Nazroo, 2017). Social class reflects 
both objective aspects of social stratification as well as its subjective dimension, 
i.e. cultural differences between people and their self-identification in the social 
hierarchy (Kraus, Piff and Keltner 2011). Wealth, education, and occupational 
status combined form the objective substance of social class (Kraus, Piff and 
Keltner, 2011; Oakes and Rossi, 2003). These objective domains of social class 
give rise to patterned distinctions in the material lives of individuals: living in 
different areas, belonging to different social clubs, attending different schools, 
enjoying different forms of leisure, wearing different clothes (Kraus, Piff and 
Keltner, 2011). To the extent that these stratified behaviours are observable and 
associated with individual wealth, occupation and education, they become 
signals to others of a person’s social class.  
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In the absence of data on parental income and education in ELSA Life History 
interviews, Social Class was measured by three indicators. The number of books 
at home exemplifies inter-generational reproduction of social stratification and 
class identity (Krieger, 2011). The measure was found to independently affect 
quality of life at later life in Australia (Kendig et al., 2016) suggesting it is a useful 
measure within our framework. The presence of an indoor toilet at home 
articulated the aspect of material circumstances of households for children born 
between 1938 and 1952 in England. The third dimension of social class is 
represented by the father’s or main carer’s occupational status, a useful measure 
of health inequality with origins in the UK (Bartley, 2017).  
 
Adversity 
There is a limited evidence base about the relationship of ACEs with  lower 
income (Font and Maguire-Jack, 2016; Nurius, Fleming and Brindle, 2019), 
educational attainment (Raposa et al., 2014), divorce or separation (Font and 
Maguire-Jack, 2016), risky health behaviours, lack of social support (Nurius, 
Fleming and Brindle, 2019) and multimorbidity (Sinnott et al., 2015). Physical, 
emotional or sexual abuse had both direct and indirect effects on negative 
health outcomes in adulthood while experiences of neglect were related only 
indirectly (Font and Maguire-Jack, 2016). The risk of subsequent chronic 
problems and negative health behaviours increases with the number of different 
types of ACEs reported per individual (Felitti 2002; Bellis et al., 2014).  
The latent variable Adversity was constructed from three binary indicators. The 
variable Arguments & Fights was based on the survey question asking whether 
parents argued or fought very often when the respondent was younger than 16 
years of age. The variable Physical Abuse reflects the question whether the 
respondent was physically abused by their parents when under the age of 16. 
The third indicator Parents’ Neglect measured whether parents drunk 
excessively, took drugs or had mental health problems when the respondent 
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was younger than 16 years of age. The three variables were chosen to reflect 
aspects of both direct and indirect harm (Hughes et al. 2017). 
 
Health 
Self-rated health in childhood, inquired by the question whether the 
respondent thought their health in childhood was excellent, is coded in five 
categories: excellent, very good, good, fair or poor.  
 
End of Education  
The effect of education on adult health increases with increasing years of 
education. Additional time spent in education contributes to lower mortality 
and lower risks of chronic conditions (Cutler and Lleras-Muney, 2006). We 
categorized the variable into two categories, those who left education before the 
age of 16 and those who stayed in education after 17 years of age. 
 
Social Class in pre-retirement 
An individual’s social class before and after retirement in England may have the 
largest effect through the material resources accumulated since childhood 
(Nazroo, 2017). These resources are related to previous income, employment 
and occupational status and combined they affect how individuals perceive 
their life achievements and social status (Bolam, Murphy and Gleeson, 2004; 
Nazroo, 2017). In our study social class in the pre-retirement period will be 
constructed from three indicators. The net household wealth is the sum of 
savings, investments, physical wealth and housing wealth (after financial debt 
and mortgage debt were subtracted). It is based on 22 distinct components of 
wealth and debt (Marmot et al., 2016) and divided into three categories (top, 
medium, low). The second measure is last occupation, re-categorized from the 
standard NS-SEC classification into three categories (managerial/professional, 
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intermediate, semi/routine). The subjective aspect of the social class is reflected 
in the measure of subjective social status (high, medium, low). 
 
Psychosocial Factor 
Psychosocial factors were found to be associated with childhood socio-
economic status, health and adversity as well as with later multimorbidity 
(Pavela & Latham 2015, Sinnott et al. 2015, Ferraro, Schafer & Wilkinson 2016). 
The latent variable Psychosocial Factor was constructed from three indicators, 
sense of control, loneliness and reliable friends. The variable Sense of control 
was measured by the question whether the respondent felt that what happened 
to them was out of their control. Four options were coded to three categories 
(never, not often/sometimes, often). Having sense of control over life was found 
to be a protective factor for the risk of multimorbidity (Marengoni et al. 2011, 
Melis et al. 2014). The second variable Loneliness (whether respondent felt 
lonely last week) was binary. Loneliness was associated with multimorbidity in 
England but the direction of influence remained unclear (Stickley and 
Koyanagi, 2018). The third variable Reliable Friends had three categories 
(very/some, a little/not at all, no friends). Supportive friendships as part of 
social support networks belong to protective factors for multimorbidity 
(Marengoni et al. 2011).  
 
Behavioural Factor 
Physical activity, tobacco smoking, alcohol consumption, diet and BMI were 
found to independently predict the risk of multimorbidity in Quebec (Fortin et 
al. 2014), England (Dhalwani et al. 2016, 2017) and Scotland (Katikireddi 2017). 
Our latent Behavioural Factor was constructed from three indicators: Physical 
Activity (vigorous, moderate, mild, none), Alcohol (never, monthly or less, 




Basic multimorbidity  
We follow the most common definition of multimorbidity as “the co-occurrence 
of two or more diseases within a person” (Van den Akker et al., 1998). This 
variable was created by summing up the number of morbidities reported by the 
ELSA participant, separately for each wave of measurement. The minimum 






Complex multimorbidity was defined as “the co-occurrence of three or more 
chronic conditions affecting three or more different body systems within one 
person without an index chronic condition” (Harrison et al., 2014, p. 8). We 
chose it as an alternative measure of multimorbidity as it reflects disease 
accumulation across disparate body systems. Compared to basic 
multimorbidity, complex multimorbidity leads to more complex care (Piette 
and Kerr, 2006) with higher health care utilization. We constructed this 
measure by selecting only individuals with three or more body systems affected 
by at least one disease per system. Body systems were classified according to the 
Chapters of the International Classification of Diseases 10th Revision (ICD-10) 
(Table 5.2). We grouped the variable to range between zero chapters and 
maximum of four or more. 
 
Multiple functional limitations  
The measure of multiple functional limitations was constructed by combining 
the variables for mobility, Activities of Daily Living (ADL) and on health 
symptoms (Table 5.2). ADL refers to the abilities necessary for basic functioning 
and for living in a community (Chatterji, Byles & Cutler et al., 2015). The total 
number of functional limitations per individual was summed up. 
 
Table 5. 2 Health data used to measure basic multimorbidity, complex multimorbidity and multiple 
functional limitations 




1. Eye disorders   General mobility 




1.2. Macular degeneration 2 Sitting for 2 hrs 




2. Circulatory disorders 4 Climbing several flights of stairs 
6 Heart attack 2.1. High blood pressure 5 Climbing one flight of stairs 
7 Diabetes 2.2. Angina 6 Stooping, kneeling or crouching 
8 Stroke 2.3. Heart attack 7 Reaching arms above shoulders 
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9 Lung disease 2.4. Congestive heart failure 8 Pulling or pushing a chair 
10 Asthma 2.5. Heart murmur 9 
Lifting/carrying weights over 10 
pounds 
11 Arthritis 2.6. Abnormal heart rhythm 10 Picking up a 5p coin 
12 Osteoporosis 2.7. Stroke  Activities of daily living 
13 Cancer 
3. Endocrine, nutritional and 
metabolic 
11 
Dressing, including putting on 




3.1 Diabetic eye disease 12 Walking across a room 




4. Musculoskeletal and 
connective system  
14 
Eating, such as cutting up your 
food 
17 Hallucinations 4.1. Osteoporosis 15 Getting in or out of bed 
18 Anxiety 4.2. Arthritis 16 
Using the toilet, including getting 
up or down 
19 Depression 5. Respiratory 17 
Using a map to figure out how to 




5.1. Lung disease 18 Preparing a hot meal 
21 Mood swings 5.2. Asthma 19 Shopping for groceries 








7. Nervous disorders 22 
Doing work around the house or 
garden 
25 Cataracts 7.1. Parkinson's disease 23 
Managing money (paying bills, 
track of expenses) 
  7.2. Alzheimer's disease  Symptoms 
  7.3. Hallucinations 24 Difficulty walking 0.25 mile 
  8. Mental and behavioural 25 Pain in general  
  8.1. Anxiety 26 Problems with eyesight 
  8.2. Depression 27 Problems with hearing 
  8.3. Emotional problems 28 Balance on level surface 
  8.4. Mood swings 29 Dizzy walking on level surface 
 
 
5.6 Methods and analyses 
 
Using Structural Equation Modelling (SEM) we integrated our conceptual 
framework of lifecourse multimorbidity and functional limitation with the 
latent factors and other variables (Figure 5.1) outlined in Section 3. SEM is an 
extension and combination of multivariate regression analysis, path analysis 
and factor analysis. SEM is commonly used to test hypotheses about 
simultaneous relationships among variables as well as path effects across time, 
which makes it appropriate for the needs of our study (Geiser 2013; Schumacker 
& Lomax 2016). Another advantage of SEM is its use of latent factors (constructs) 
that allows us to take measurement error into account for both independent 
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and dependent variables. Parameter estimation, especially the regression 
coefficients for dependent variables, and the association between variables are 
less biased (Warren 2009; Schumacker & Lomax 2016).  
We conducted bivariate analysis of the associations between the variables 
chosen from our literature review. Weakly correlated variables were eliminated 
and those making theoretical sense were further tested in a confirmatory factor 
analysis (Appendix, Table A2). We assessed which of the potential explanatory 
variables shared sufficient variance so that they could be explained by a shared, 
directly unobservable commonality, a latent factor (Appendix, Table A2). We 
then specified the paths between measures of childhood circumstances, 
mediating latent factors (adult Social Class, the Psychosocial Factor and the 
Behavioural Factor), the confounder (adult multimorbidity) and the outcomes 
(basic/complex multimorbidity and functional limitation).  
We used Stata version 13 for data cleaning and to prepare the data in panel 
format. For model estimation we used the Weighted Least Square Means and 
Variance adjusted estimator (WLSMV) in Mplus 7.4.  WLSMV has been shown 
superior to the alternative Maximum Likelihood estimator, as its standard 
errors are more accurate when data are non-normally distributed and the 
sample size is large (Li 2015). As we could not assume a normal distribution of 
the path effects, their statistical significance was inferred by the bootrapping 
method rather than the t-test (Taylor, MacKinnon & Tein 2008). The bias-
corrected bootstrap confidence intervals were calculated for standard errors of 




Table A4 in the Appendix presents the results from three SEMs for our 
theoretical framework (Figures 5.2.- 5.3), including an assessment of overall 
model fit. We proceed by presenting the results in relationship to our two 
research questions.  
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We did not find evidence of direct effects of childhood circumstances - social 
class, adverse experiences and health – on basic multimorbidity, complex 
multimorbidity and functional limitation for people aged 65 to 74 years. We 
found evidence of indirect effects of the three domains of childhood 
circumstances on the three health outcomes. The indirect effects were mediated 
via material, psychosocial and behavioural pathways and via multimorbidity in 
pre-retirement.  
The total indirect (pathway) effect of social class was 0.255 (CIs: 0.080-0.408) 
for basic multimorbidity, 0.265 (CIs: 0.125-0.265) for complex multimorbidity 
and 0.320 ( CIs: 0.229 to 0.708) for multiple functional limitations. This means 
that 26% of the variation in basic multimorbidity, 27% of the variation in 
complex multimorbidity and over 32% in functional limitation can be explained 
by changes in the pathways. The pathways of childhood social class varied 
depending on the outcome. Basic and complex multimorbidity were influenced 
via all three pathways – material, psychosocial and behavioural – but multiple 
functional limitations only via the material and behavioural pathways. The 
paths in Figures 5.2-5.3 can be interpreted in the following way. Individuals with 
lower social class in childhood are more likely to have lower social class as adults 
which predicts a higher risk of having one of the three health outcomes in old 
age. For instance, two participants who differed by one unit in their reported 
childhood social class are estimated to differ, due to their difference on adult 
social class, by 9 % in the risk of basic multimorbidity, by 8 % in the risk of 
complex multimorbidity and by 6.8% in the risk of multiple functional 
limitation at old age. The effect was significant with 95% BC bootstrap 
confidence intervals 0.034 to 0.169 in the first model, 0.031 to 0.161 in the second 
model and 0.005 to 0.312 for functional limitations (Appendix, Table A4). Some 
of the effect of social class was mediated via the role of education. A shorter 
school attendance predicted worse material circumstances and more unhealthy 
behaviours later in life, increasing the risk of multimorbidities and functional 





Figure 5. 2 Lifecourse pathways of basic and complex multimorbidity (correlation values for 
mediators shown in the Appendix, Table A3).  
Note: BMM refers to OLS regression coefficients for basic multimorbidity, CMM 
is for complex multimorbidity. The paths to and from adult multimorbidity is 
highlighted in red. 
Adversity in childhood influenced three health outcomes through the 
psychosocial pathway. The pathway effect of the adverse experiences was 0.239 
(CIs: 0.084 to 0.461) for basic multimorbidity, 0.169 (CIs: 0.045 to 0.331) for 
complex multimorbidity and 0.245 (CIs: 0.016 to 0.363) for multiple functional 
limitations. This means that 24% of the variation in basic multimorbidity, 17% 
of the variation in complex multimorbidity and almost a quarter of the variation 
in functional limitation can be explained by changes in the psychosocial 
pathway from childhood adversity. Due to the Psychosocial Factor, two 
participants who differed by one unit in their reported ACEs are estimated to 
differ by 6.6 % in the risk of basic multimorbidity, by 5.7% in the risk of complex 
multimorbidity and by 11.3% in functional limitations. The 95% BC bootstrap 
confidence intervals 0.020 to 0.158, 0.020 to 0.115 and 0.029 to 0.742 indicate 
that we can be 95% confident that the effects exclude the null effect (Appendix, 
Table A4). Outside the psychosocial pathway, early adversity exerted some 




Childhood health influenced multimorbidities in old age via all three pathways, 
irrespective of the outcome. The sum of the pathway effects of childhood health 
was 0.161 (CIs: 0.117 to 0.225) for basic multimorbidity, 0.132 (CIs: 0.096 to 0.187) 
for complex multimorbidity and 0.146 (CIs: 0.078 to 0.667) for multiple 
functional limitations. This means that the variation in the pathways from 
childhood health can explain 16% of the variation in basic multimorbidity, 13% 
of variation in complex multimorbidity and almost 15% of variation in 
functional limitation. Childhood health directly influenced adult social class 
and childhood social class influenced multimorbidity at pre-retirement age 
(Figure 5.2). This indicates a cross-lagged type of effect (Warren 2009, Hoffman, 
Kröger and Geyer 2019). 
 
 
Figure 5. 3 Lifecourse pathways of multiple functional limitations.  
 
Our framework enables us to compare and assess the difference in the 
magnitude of the effects measured at two life stages. Following the approach by 
Green and Popham (2017) we found that the effects of the adult SES, 
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Psychosocial Factor and Behavioural Factor at pre-retirement age on old age 
multimorbidity and functional limitation were larger than the total effects of 
childhood social class, adverse experiences and child’s health. The only 
exception is complex multimorbidity where childhood adversity had a stronger 
effect than adult Psychosocial factor (0.239 versus 0.150), suggesting a possible 




5.8.1 Key results 
Assessed simultaneously, childhood social class, adverse childhood experiences 
and childhood health did influence basic/complex multimorbidity and multiple 
functional limitations in old age. Childhood social class and childhood health 
affected basic and complex multimorbidity through material, psychosocial and 
behavioural pathways. Childhood social class influenced functional limitations 
only via the material pathway. Adversity affected both types of multimorbidity 
and functional limitation through the psychosocial pathway. The three domains 
of the childhood circumstances had no direct effect on basic/complex 
multimorbidity and functional limitation. The years of completed education 
were an intervening mechanism influencing material and behavioural pathways 
from childhood social class to all three outcomes. The effects of adult social 
class, Psychosocial Factor and Behavioural Factor on old age multimorbidity 
and functional limitation were larger than the effects of childhood social class, 
adverse experiences and child’s health. Interestingly, childhood adversity had a 




Our study presents a life course model exploring pathways for understanding 
the risk of multimorbidity and functional limitation from childhood to old age. 
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People in England, who grew up in worse circumstances in childhood than their 
better-off peers, had a greater risk of multimorbidity and functional limitation 
when aged 64-78. Childhood circumstances influenced multimorbidity and 
functional limitation at old age indirectly via the completed years of education 
in combination with material, psychosocial and behavioural pathways. These 
pathways acted as magnifiers of early inequalities, in the way that they 
expanded the unequal impacts of the pre-existing differences between 
individuals in socio-economic position, psychological connections and health. 
The pathway effects measured at age 50-64 years were larger than the total 
effects of childhood social class, adverse experiences and child’s health. Pre-
retirement appears to be an important period for adults in England. However, 
in people suffering from complex multimorbidity the total effect of the adverse 
experiences of abuse and family dysfunction in childhood surpassed the effect 
of adult psychosocial circumstances, which suggests an early-life sensitive 
period for this outcome.  
The combined effect of childhood social class was pervasive. Those who were 
born between 1938 and 1952 and grew up in homes with fewer financial, material 
and cultural resources were estimated to be set on a probabilistic trajectory 
leading through lower accumulated wealth, lower occupational and subjective 
status (either directly or through the contributing effect of education) to worse 
health at the age 64-78. Independently from home adversity (presence of abuse, 
violence or chaos from parents), their family social class predicted also the 
access to psychosocial resources in adulthood such as social networks, reliable 
friendship or the sense of control over their lives. The cascade of disadvantage 
in childhood continued to shape their multimorbidity status in old age. 
Children from these families were more likely to engage in risky health 
behaviours – less physically active, more smoking and alcohol consumption 
which in turn translated into higher degrees of multimorbidity. Children born 
to more affluent conditions were likely to progress in the opposite direction, 
along all three pathways. Compared to Ferraro, Schaffer and Wilkinson’s (2016) 
mediation model of multimorbidity, which found evidence of smoking and lack 
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of personal control as pathways to multimorbidity, we identified a broader 
range of mediating mechanisms. 
As with social class, negative experiences such as physical abuse, domestic 
violence and substance abuse  in a child’s home had the potential to set 
individuals on diverging paths in later life. Adversity predicted a higher burden 
of multimorbidity via psychosocial attributes such as lack of control in life, 
social isolation and lack of support from reliable friendships. The results are 
consistent with Ferraro, Schaffer and Wilkinson (2016) who found mediating 
effects through smoking, lack of family support and lack of personal control. 
These associations can be explained with the help of the stress proliferation 
theory, which states that early adversity increases the likelihood of subsequent 
stress exposures, which undermines self-esteem and makes problematic the 
building and maintainance of supportive relationships (Pearlin, 2010). The 
cascade further increases the chances of disease accumulation (O’Rand and 
Hamil-Luker, 2005).  
Chains of risks between adversity and harmful health behaviours have been well 
documented (Felitti 2002; Hughes et al. 2017), but in our sample physical 
activity, alcohol consumption and smoking were influenced by ACEs only 
indirectly, via adult multimorbidity (Figures 5.2 and 5.3). A significant pathway 
between ACEs and adult social class was also mediated via adult 
multimorbidity. Strong clustering of adversity and further diseases might be 
underestimated in the literature as it is less visible than material pathways 
(Nurius et al., 2017). A recent study reported that the risk of developing chronic 
diseases for people who experienced multiple ACEs was higher at a young age 
(18-34 years) than at old age. (Sonu, Post and Feinglass, 2019). Our path model 
shows that the chain of risks does not stop with adult multimorbidity but affects 
other determinants of health.  
Childhood health directly influenced adult social class and childhood social 
class influenced health measured as multimorbidity at pre-retirement for both 
basic and complex multimorbidity (Figure 5.2). This suggests a simultaneous 
presence of both social causation and health selection in our sample. A similar 
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co-occurrence of both types of effects was reported by Hoffman, Kröger and 
Geyer (2019) but only for the period between childhood and the age 30-50 years. 
The relationship between both pathways at later age reflected only social 
causation. Bi-directional relationships highlight the need to assess both 
variables jointly rather than choose a single hypothetical direction (causation 
or selection) a priori.  
Life course models of health implicitly rest on the theory that social factors 
interact with human biology (Diez Roux 2007; Blane et al. 2013). This interaction 
is part of our lives from the foetal period until death. Therefore an explanation 
seeking to explain causal mechanisms must consider the role of biology. 
Material, psychosocial and behavioural pathways would never be able to 
influence risks of multimorbidity and functional limitation in a patterned stable 
way, if there were no socio-biological interacting mechanisms. One such 
mechanism is stress (Pearlin, 2010). In general, poor people experience higher 
doses of stress due to their living conditions and daily problems with just getting 
by (Krieger 2011; Bartley, 2017). According to the stress proliferation theory, 
exposure to one stressor (an event or a process) leads to exposure to other 
secondary, stressors (Pearlin, 2010). These stresses interact with psychosocial 
risks such as lack of social support, insecure employment and job strain, all of 
which are associated with health difficulties. Stress during the life course 
becomes embodied by changing the body’s immune and neuroendocrine 
responses which leads to higher cumulative physiological burden and the onset 
of disease accumulation (Krieger, 2011).  Another biological pathway associated 
with multimorbidity and functional limitation is chronic inflammation 
(Friedman et al., 2019). Levels of inflammatory proteins rise in a linear fashion 
with the number of chronic conditions in individuals with multimorbidity 
(Fabbri et al., 2015). A life course study of six European populations identified a 
robust inverse relationship between SES and level of inflammation (Berger et 
al., 2019). The pathway may be explained by a pro-inflammatory environment 
in childhood, such as infections, risky health behaviours, and continued pro-




5.9 Strengths and limitations 
 
This paper developed and tested a life course model of pathways leading to old 
age multimorbidity and functional limitation. We approached childhood 
circumstances from a broader angle than the usual focus on either the material 
conditions or extreme experiences of children. Our framework integrated 
multi-causality with accumulation, the two key features essential for explaining 
development of multimorbidity over time. It was based on a complex mediation 
analysis with both parallel and serial mediators where the SEM framework with 
latent factors is an excellent tool to handle multiple regression relationships and 
measurement error. Bias-corrected bootstrapping is a more powerful approach 
to statistical inference than the normal theory testing (Hayes, 2013). Our 
bootstrap confidence intervals follow the irregularity of the sampling 
distribution and the inferences are more accurate than when using the normal 
theory based approach.  
Compared with the three other life course studies of multimorbidty and 
functional limitation (Pavela and Latham, 2015; Ferraro, Schaffer and 
Wilkinson, 2016; Haas and Oi, 2018) that were identified, our study improved 
the methodology and study design in several aspects. We developed a model 
with clear temporal lags between observations. We intervened against the 
possibility of a spurious effect by adding a variable for multimorbidity measured 
simultaneously with potential mediators. SEM with latent factors enabled us to 
make stronger statistical inference about the standard errors in our model while 
the other studies relied on observed variables only. From a conceptual 
perspective, our study considered a range of material, behavioural and 
psychosocial resources and risks, an approach also taken by Pavela and Latham 
(2015) and Ferraro, Schafer and Wilkinson (2016). 
As a retrospective study, our information on the circumstances in early life was 
dependent on participants’ subjective recall. This introduces a potential bias but 
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studies have shown that the difference relates to the magnitude of associations, 
not changes to direction of effects (Niedzwiedz et al., 2012). Reliability of recall 
in ELSA was tested in comparison with prospective data from the 1958 Birth 
Cohort by selecting participants of similar age and the same time point (Jivraj 
et al., 2017). The results were the most similar for parental occupation, but in 
general, statistical significance and direction of effects were similar but not the 
magnitude of regression coefficients. A general limitation common to all life 
course studies is the potential bias from selective survival (Liu, Jones and 
Glymour, 2010; Niedzwiedz et al., 2012). Childhood experience of poverty and 
illnesses may lead to premature mortality, thus the cohort aged 64-78 might 
have been pre-selected into those who had a more advantageous early life. This 





In conclusion, we have shown that the conceptualization of lifecourse pathways 
into the material, psychosocial and behavioural, dating back to the Black Report 
(Black, 1980), is useful and can explain how social exposures shape the risks of 
health problems into old age. Unlike the usual focus on pathways of socio-
economic status, we identified three types of pathways across three domains of 
early life disadvantage simultaneously. Depending on the domain and the 
health outcome, these pathways explained between 13 percent (the pathways 
from health to complex multimorbidity) and 32% (the pathways from social 
class to functional limitation) of the variation in outcomes. The remaining 
variance can be attributed to the effect of multimorbidity in pre-retirement 
which we took into account plus other unexplained factors. 
Rather than the individual strength of any particular relationship, it is the range 
of childhood factors and their relationships with a number of social 
determinants of health that is the most striking. Our findings show that a 
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variety of pathways is operating between early life and adult health and a 
lifecourse approach to multimorbidity is vital (Kuh and Wadsworth, 1993).  
Our study provides a convincing argument for life course models to integrate 
dimensions of social class, psychosocial adversity and health. We tested 
empirically our hypothesis that multi-dimensional childhood circumstances 
shape later-life multimorbidity through a diversity of social, psycho-social and 
socio-biological pathways. The approach to childhood circumstances developed 
in this paper will be beneficial for those researchers who are interested in 
exploring early life effects on other multi-factorial and cumulative outcomes 
(processes) than multimorbidity and functional decline, such as disability, 
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Table A.1 Polychoric correlation with variables selected for the analysis 
 





















Arguments & Fights            
Parents’ neglect 0.606           
Physical abuse 0.571 0.480          
No. of books -0.085 -0.149 0.008         
Father's/Carer's occupation -0.020 -0.040 -0.049 0.355        
In-door toilet -0.053 0.024 -0.046 -0.329 -0.241       
Occupational level -0.010 -0.033 0.034 0.326 0.269 -0.213      
Household wealth -0.026 -0.051 -0.093 0.294 0.274 -0.214 0.464     
Subjective social status -0.042 -0.043 -0.061 0.259 0.208 -0.126 0.390 0.478    
Sense of control -0.125 -0.085 -0.151 -0.008 -0.031 0.038 0.052 0.133 0.216   
Loneliness -0.130 -0.112 -0.089 0.152 0.114 -0.115 0.205 0.300 0.282 0.286  
End of education 0.075 0.040 0.031 0.496 0.376 0.256 0.546 0.410 0.400 0.173 0.140 
Baseline Model fit index            










B SE R-Square 
Father's/Carer's occupation Childhood SC 0.560*** 0.025 0.313*** 
In-door toilet Childhood SC 0.319*** 0.037 0.102*** 
Number of books Childhood SC 0.629*** 0.027 0.395*** 
Arguments & Fights Adversity 0.752*** 0.043 0.566*** 
Parents' neglect 
Adversity 
0.766*** 0.048 0.586*** 
Physical abuse 
Adversity 
0.721*** 0.044 0.520*** 
Occupational level 
Social Class 
0.610*** 0.022 0.372*** 
Household wealth 
Social Class 
0.731*** 0.019 0.535*** 
Subjective social status 
Social Class 
0.683*** 0.020 0.466*** 
Loneliness Psycho-social factor 0.677*** 0.050 0.458*** 
Sense of control Psycho-social factor 0.360*** 0.034 0.194*** 
Reliable friends Psycho-social factor 0.377*** 0.040 0.142*** 
Physical activity Behavioural factor 0.426*** 0.038 0.181*** 
Smoking Behavioural factor 0.328*** 0.032 0.107*** 
Fit indices     
Model Chi-square (df) 394.913*** (91)    
RMSEA (90% CI) 0.033 (0.030 - 0.036)   
CFI 0.959    




Table A.3 Correlation between the latent factors 
 Childhood SC Adversity Adult SC PS Factor BH Factor 
Childhood SC 1     
Adversity 0.165*** 1    
Adult SC 0.660*** 0.108*** 1   
P-S Factor 0.280*** 0.345*** 0.631*** 1  













Table A.4 Pathway effects from childhood circumstances to basic/complex multimorbidity and functional limitation 
Childhood 
circumstances 
Basic multimorbidity Complex multimorbidity  Multiple functional limitations 
Social Class 
   









   
Coefficient        SE 
 Lower 
2.5%  C.I. 
 Upper 
2.5%   C.I. 
Total indirect effect 0.255 0.111 0.08 0.408 0.265 0.097 0.125 0.265 0.320 0.101 0.229 0.708 
Material pathways            
via adult SC  0.090 0.038 0.034 0.169 0.079 0.034 0.031 0.161 0.068 0.680 0.005 0.312 
via Edu and adult SC  0.080 0.030 0.035 0.137 0.069 0.025 0.032 0.130 0.058 0.463 0.007 0.322 
Psychosocial pathways            
via PS Factor 0.049 0.036 0.006 0.131 0.046 0.033 0.011 0.137 0.097 0.371 -0.165 0.276 
via Edu and PS Factor 0.021 0.021 -0.007 0.084 0.019 0.019 -0.007 0.065 -0.048 0.320 -0.578 0.043 
Behavioural pathways            
via BH Factor 0.077 0.052 0.012 0.199 0.064 0.044 0.010 0.168 0.116 0.584 -0.066 0.379 
via Edu and BH Factor 
 0.103 0.046 0.041 0.198 0.079 0.036 0.032 0.169 0.194 0.407 0.065 0.381 
Adjusting for MM at 
wave 1             
via MM 0.038 0.020 0.004 0.085 0.027 0.014 0.007 0.061 -0.059 0.065 -0.836 0.004 
Adversity             
Total indirect effect 0.239 0.093 0.084 0.461 0.169 0.071 0.045 0.331 0.245 0.603 0.016 0.363 
Material pathways            
via adult SC  -0.004 0.016 -0.023 0.046 -0.005 0.003 -0.037 0.018 -0.005 0.073 -0.036 0.007 
via Edu 0.019 0.020 -0.001 0.036 0.009 0.012 -0.006 0.044     
via Edu and adult SC  -0.011 0.009 -0.016 0.000 -0.010 0.008 -0.032 0.000 -0.005 0.054 -0.049 0.000 
Psychosocial pathways            
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via PS Factor 0.066 0.033 0.020 0.158 0.057 0.026 0.020 0.115 0.113 0.603 0.029 0.742 
via Edu and PS factor 0.003 0.004 0.000 0.021 0.003 0.004 0.000 0.002 0.004 0.039 -0.003 0.112 
Behavioural pathways            
via BH Factor 0.017 0.045 -0.062 0.101 0.006 0.034 -0.043 0.065 0.007 0.058 -0.063 0.137 
via Edu and BH Factor -0.014 0.014 -0.054 0.002     -0.017 0.038 -0.066 -0.001 
Adjusting for MM at 
wave 1             
via MM 0.113 0.038 0.046 0.203 0.078 0.029 0.028 0.130 0.072 0.041 0.020 0.323 
via MM and SC 0.010 0.004 0.003 0.021 0.008 0.004 0.002 0.017 0.028 0.033 0.012 0.225 
via MM and PS Factor 0.015 0.009 0.004 0.038 0.014 0.007 0.004 0.033 0.036 0.118 0.011 0.145 
via MM and BH Factor 0.033 0.015 0.012 0.068 0.025 0.012 0.008 0.053 0.041 0.041 0.012 0.090 
Health             
Total indirect effect 0.161 0.028 0.117 0.225 0.132 0.023 0.096 0.187 0.146 0.194 0.078 0.667 
Material pathways            
via adult SC  0.014 0.007 0.004 0.032 0.013 0.006 0.004 0.029 0.012 0.017 0.001 0.048 
via Edu 0.007 0.006 0.000 0.025 0.003 0.004 -0.001 0.018     
via Edu and adult SC  0.004 0.003 0.000 0.012 0.003 0.002 0.000 0.010 0.002 0.006 -0.001 0.020 
Psychosocial pathways            
via PS Factor 0.016 0.009 0.003 0.036 0.015 0.008 0.004 0.029 0.052 0.174 0.015 0.353 
via Edu and PS Factor -0.001 0.001 -0.005 0.000 -0.001 0.001 -0.005 0.000 -0.002 0.007 -0.049 0.001 
Behavioural pathways            
via BH Factor 0.035 0.017 0.012 0.076 0.028 0.014 0.009 0.072 0.075 0.037 0.023 0.135 
via Edu and BH Factor 0.005 0.004 0.000 0.002 0.004 0.003 0.000 0.011 0.007 0.010 -0.003 0.025 
Adjusting for MM at 
wave 1             
via MM 0.061 0.012 0.040 0.086 0.044 0.009 0.028 0.064 0.050 0.077 0.006 0.082 
Fit indices             
188 
 
Model Chi-square (df) 376.823*** (96)    374.205*** (96)    784.456*** (101)  
RMSEA (90% CI) 
0.031 (0.028 - 
0.034)    
0.031 (0.027 - 
0.034)    0.046 (0.043-0.049)  
CFI/TLI   0.961/0.930       0.961/0.930       0.898/0.831   
Mediation effects were tested for statistical significance. This involved testing the significance of the paths between each childhood 
exposure and each adult latent factor and the paths from the mediating factors to the outcomes (MacKinnon, Fairchild and Fritz 2007).  
We could not assume a normal distribution of the path effects and their statistical significance was inferred by the bootrapping method 
rather than the t-test (Taylor, MacKinnon & Tein, 2008). The bias-corrected bootstrap confidence intervals were calculated for standard 
errors of the path effects.   
 
The chi-square fit index tests whether the sample variance-covariance matrix and the model generated variance-covariance matrix are 
similar. Statistical significance implies that this difference might be due to the sampling variation while a statistically non-significant 
chi-square value indicates that the theoretical model significantly reproduces the actual data structure. However, the usefulness of this 
test has been discussed due to its sensitivity to sample size. With increasing sample size (above 200), the chi-square test tends to show 
a significant probability value which may lead to an exclusion of a well-specified model (Schumacker and Lomax 2016). The chi-square 
value generated by our analysis was statistically significant. Given the mentioned sample size sensitivity and our aims being to assess 
the role of pathways and not to search for the best fitting parsimonious model, we do not see this as a reason for rejecting our model. 
In addition, the complementary fit indices the Root Mean Square Error of Approximation (RMSEA), the Comparative Fit Index (CFI) 
and the Tucker-Lewis Index (TLI) showed acceptable levels of fit.
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This final chapter seeks to summarise the major results and the contribution of 
the thesis to the current state of research in multimorbidity. The chapter 
presents key research gaps identified in the literature review. It recapitulates 
the research aims and the research strategy chosen to achieve them. The 
chapter summarizes the key research findings and discusses their contribution 
to the current knowledge, methodology and policy. Next, the limitations of the 
research are established, with suggestions about how the thesis could be 
improved. The chapter concludes with a series of ideas for possible extensions 
of the research that could build upon the achievements of this thesis. 
 
6.2 Research purpose and strategy 
 
This thesis positions itself among the interdisciplinary efforts to understand the 
‘social drivers’ of the increase in prevalence and inequalities in multimorbidity 
and functional limitation of ageing people. The purpose of this study is to 
intervene in the emerging discussions of the relationship between ageing, 
multimorbidity and functional decline, the role of the social determinants and 
the influence of early life circumstances  on old age multimorbidity and 
functional limitation. With this purpose in mind, the literature review identified 
several gaps in the current state of knowledge. The first limitation is 
methodological. Studies based on general populations with self-reported 
information on health tend to define multimorbidity as two or more diseases. 
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This measure does not capture the multimorbidity of disparate body systems 
which is an important marker of ageing (Fabbri et al., 2015). Second, little is 
known about socio-economic inequalities in the prevalence of multimorbidity 
and functional limitation in general populations and their effect on ageing. A 
few studies that highlighted health inequalities and earlier onset of 
multimorbidity in deprived areas used primary care records (Barnett et al., 2012; 
McLean et al., 2014). Third, while ageing on its own cannot explain the rising 
trends in multimorbidity, the theory of social determinants of health has not 
become part of multimorbidity research yet. Contextual characteristics are 
instead being used due to data availability and in isolation from each other 
(Northwood et al., 2017, Pathirana and Jackson, 2018). Fourth, the role of 
childhood and pathway mechanisms in shaping multimorbidity at old age 
remains unknown. Elucidating the preceding factors would benefit attempts to 
prevent and reduce the burden of multimorbidity in society.  
In order to address these gaps, the thesis formulated the following aims: 
1. Explore the prevalence of multimorbidity and functional limitation and its 
variation by key socio-demographic characteristics. 
2. Examine the association of key social determinants of health with the risk of 
developing multimorbidity and functional limitation. 
3. Explain how childhood circumstances shape  the risk of multimorbidity and 
functional limitation in old age. 
The research strategy to approach these aims set out with an exploratory study 
of the trends in the prevalence of multimorbidity and functional limitation. 
Stratification analyses and marginal logistic regression were employed to 
examine the distribution of multimorbidity and functional limitation between 
age groups, men and women and according to household wealth. The 
investigation further applied the theory of the social determinants of health in 
order to consider a broader range of contextual characteristics. It used a 
population-averaged regression method that took into account temporal 
correlation between individual health states during the period 2002-2015. The 
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thesis concluded with an explanatory study of the chains of risks in 
multimorbidity and functional limitation from childhood to the old age. A 
complex Structural Equation Model was employed to test theoretical 
hypotheses. Latent factors were modelled to operationalize multiple 
dimensions of the key explanatory constructs. 
 
6.3 Research aims and findings 
 
Research aim no.1 
To explore the prevalence of multimorbidity and functional limitation and its 
variation by key socio-demographic characteristics. 
This aim was motivated by the emerging evidence of multimorbidity becoming 
more common and more socially stratified (Reilly et al., 2015; van Oostrom et 
al., 2016; Tetzlaff et al., 2018; Canizares et al., 2018). The study explored trends 
in prevalence and distribution of prevalence by age, sex and socio-economic 
status at a population level. The study argued that the measure of basic 
multimorbidity had limited ability to identify multimorbid individuals with 
higher care needs. It used a comparative measure of complex multimorbidity 
that defines a situation when three or more body systems are affected by chronic 
diseases (Harrison et al., 2014). The repeated cross-sectional analysis covered 
the period between 2002-03 and 2014-15, using a total of seven time points. 
Health inequalities in multimorbidity and functional limitation and interaction 
effects between age and wealth were verified in marginal effects logistic 
regression analysis. 
 
Finding 1:  
Multimorbidity and functional limitation are becoming more common in 
England. The prevalence of basic multimorbidity grew from 41.6% in 2002/2003 
to 46.6% in 2014/2015. The prevalence of complex multimorbidity increased 
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from 12.2% in 2002/2003 to 21.1% in 2014/2015. The prevalence of 10+ functional 
limitations rose from 9.6% in 2002/2003 to 14.3% in 2014/2015. 
 
Finding 2:  
Multimorbidity and functional limitation were more common among females 
than males and among people with less wealth than more wealth. Complex 
multimorbidity and 10+ functional limitations reflected larger inequalities than 
basic multimorbidity. The disparities between the most and the least affluent 
groups were the largest for multiple functional limitations (5.9-fold in 2014/15), 
followed by complex multimorbidity (2.8-fold in 2014/15) and basic 
multimorbidity (1.9-fold) in 2014/15. 
 
Finding 3: 
The levels of complex multimorbidity among people from poorer social 
backgrounds in their early 50s were comparable to the levels among people 20 
years older in the most affluent strata. For multiple functional limitations the 
difference was even greater, at 30 years. The study observed social polarization 
among multimorbid ageing population in England, with complex 
multimorbidity and multiple functional limitations increasing faster and 
reflecting stronger inequality than basic multimorbidity. 
 
Research aim no. 2: 
To examine the association of key social determinants of health with 
multimorbidity and functional limitation. 
Building on the theories of social determinants of health and health 
inequalities, the analysis included a range of social determinants. The extension 
addressed the lack of contextual data in studies of multimorbidity which 
typically focus on a few risk factors (Northwood et al. 2017). The study 
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introduced material determinants (household wealth, occupational level and 
subjective social status), psycho-social determinants (sense of control over 
individual life, loneliness, supportive children, supportive friends, supportive 
partner and participation in community organisations) and behavioural 
determinants (level of physical activity, consumption of alcohol and smoking). 
The analysis explored the association of the social determinants with the 
likelihood of multimorbidity, complex multimorbidity and having ten or more 
functional limitations. The study used a population-averaged regression model, 
based on the Generalized Estimating Equations with autoregressive correlation 
structure. The model took into the account the within-individual correlation of 
outcomes over the period 2002-2015.  
 
Finding 1: 
Increasing odds of  multimorbidity, complex multimorbidity and having ten or 
more functional limitations is associated with less household wealth, sense of 
control over one’s life, physical activity and more loneliness. 
 
Finding 2: 
Larger health inequalities were observed when health was measured as complex 
multimorbidity and multiple functional limitations than basic multimorbidity. 
Compared to the population group with the highest wealth, those with the 
lowest wealth had 47% higher odds of basic multimorbidity (95% C.I. 1.34-1.61), 
73% higher odds of complex multimorbidity (95% C.I. 1.52-1.96) and 90% higher 






A dose-response relationship between alcohol consumption, smoking and 
multimorbidity could not be found, but rather  evidence of people in ill health 
actively moderating their health behaviour.  
The study concluded that neither the common behavioural nor  materialist 
models of multimorbidity and functional limitation at older age can, on their 
own, explain the observed health inequalities. Material, psychosocial and 
behavioural determinants simultaneously influence the risk of multimorbidity 
and functional limitation.  
 
Research aim no. 3: 
To explain how childhood circumstances shape  the risk of multimorbidity and 
functional limitation in old age. 
To achieve this aim, the strategy pursued two objectives. First, to establish if the 
effects of childhood circumstances on multimorbidity and functional limitation 
in old age were direct or indirect. Second, the study assessed the role of material, 
psycho-social and behavioural pathways in mediating the effects of childhood 
circumstances on old age multimorbidity and functional limitation. The 
methodology involved Factor Analysis in the initial stage of the analysis, which 
enabled to accurately measure the latent constructs. Next, a Structural Equation 
Model was used to formally test the hypothesized path effects between 
variables. A complex mediation analysis enabled simultaneously assessment of  
childhood’s social class, psycho-social and health circumstances and their 
relative contributions to the late life inequalities in multimorbidity and 






Assessed simultaneously, childhood social class, adversity and health 
influenced basic multimorbidity, complex multimorbidity and functional 
limitation in old age through material, psychosocial and behavioural pathways.  
Childhood social class influenced functional limitations only via the material 
pathway and behavioural pathways. Adversity affected both types of 
multimorbidity and functional limitation only through the psychosocial 
pathway. Childhood health influenced multimorbidities and function in old age 
via all three pathways, irrespective of the outcome.  
 
Finding 2. 
The material, psychosocial and behavioural pathways acted as magnifiers of 
inequalities from the early life period. The diverging pathways expanded the 
unequal impacts of the pre-existing differences between individuals in socio-
economic position, psychological adversity and general health. Education was 
an intervening mechanism influencing material and behavioural pathways from 
childhood social class to all three outcomes.  
 
Finding 3. 
The effects of adult social class, the Psychosocial Factor and the Behavioural 
Factor on old age multimorbidity and functional limitation were larger than the 
effects of childhood social class, adverse experiences and child’s health. Pre-
retirement appears to be an important period for adults in England. 
 
6.4 Contribution to the current knowledge and methodology 
 
This thesis responds to the trend of increasing prevalence and health inequality 
in multimorbidity. The thesis addresses the gaps in the current state of research 
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in multimorbidity and functional limitation and makes a nnumber of novel 
contributions to the state of knowledge in this research field. These are 
expanded on below. 
 
6.4.1 Higher inequality in complex multimorbidity and 10+ functional 
limitations 
The first limitation in the current understanding of multimorbidity of the 
elderly is the lack of consideration for the effects of the biological process of 
ageing. These effects are manifested in chronic problems appearing across 
several body systems (Fabbri et al., 2015). Population-based studies at present 
prefer to measure multimorbidity as the count of single diseases and disregard 
the role of the body systems. The solution suggested by this study is to add two 
distinct measures to the common measure of multimorbidity based on the 
count of single diseases. Complex multimorbidity, proposed by Harrison et al. 
(2014), defines a situation when three or more body systems in an individual are 
affected by chronic diseases. Compared to basic multimorbidity, complex 
multimorbidity, as the more discriminating definition, leads to selecting 
populations with discordant chronic conditions (Piette and Kerr, 2006). The 
benefit of using this measure lies in “zooming in” on groups with higher health 
care need and more targeted resource planning and care management (Fortin 
et al., 2012; Harrison et al., 2014; 2016). This thesis also proposed the measure of 
having ten or more functional limitations as this might reflect the increase in 
limitations arising from multiple body systems as part of the ageing process 
(Jindai et al., 2016; Calderón-Larrañaga et al., 2019).  
The comparison of the estimates of basic multimorbidity, complex 
multimorbidity and 10+ functional limitations in Chapter 3 is consistent with 
the literature that established the “zooming in” effect (Harrison et al., 2014; 
2016). The two latter measures as employed in the thesis have selective effects 
on the larger multimorbid population measured by the count of two or more 
diseases. Further stratification by age groups in Chapter 3 shows that all three 
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health outcomes are more prevalent in older than younger age groups. 
However, the difference in prevalence between the youngest and the oldest is 
higher for complex multimorbidity and functional limitation than for basic 
multimorbidity. This indicates a relationship between simultaneous damage in 
several body systems and age. Expressing this link through the measure of 
complex multimorbidity and multiple functional limitations is a novel 
observation as the authors are not aware of it having been published yet. 
 
6.4.2 Poorer people have complex multimorbidity 20 years earlier and 
functional limitations 30 years earlier then wealthier people. 
An additional advantage of using complex multimorbidity and the cut-off 10+ 
functional limitations is that both measures capture health inequalities better 
than the basic multimorbidity. This is demonstrated by higher prevalence 
estimates in Chapter 3 and higher odds ratios in Chapter 4. The health 
inequalities become more obvious when set against the age of onset. The 
youngest group aged 50-54 years in the poorest quintile has a prevalence of 
complex multimorbidity identical to people 20 years older in the most affluent 
category and a level of functional limitations comparable to those 30 years older 
in the top wealth group. This implies that the current literature might under-
report the actual scale of the inequalities when multimorbidity is defined as two 
or more diseases or when the cut-off for the number of limitations is too low. 
The earlier onset of multimorbidity was observed previously (Barnett et al., 
2012) but this thesis is the first study to point out that the way multimorbidity 
is measured impacts on the scale of identified inequality. 
The challenge of addressing the problem of health inequalities is a matter of life 
and death for some. The gap in healthy life expectancy (years lived in good 
health) between the most and least deprived areas of England was around 19 
years for both males and females from 2014 to 2016. The extra costs to the NHS 
of health inequalities were estimated at £4.8 billion a year, caused by the greater 




6.4.3 Differences in the risk of multimorbidity and functional limitation cannot 
be explained only by lifestyle choices or material circumstances. 
Studies pay insufficient attention to contextual factors of multimorbidity and 
functional limitation (Bayliss et al., 2014). Researchers use socio-demographic, 
socio-economic, psychological or behavioural characteristics in isolation from 
each other (Northwood et al., 2017, Pathirana and Jackson, 2018). As the current 
and predicted rise in the prevalence of multiple health problems cannot be 
explained by the forces of ageing only, understanding the societal influences 
becomes imperative. This thesis advances theory and methodology through its 
holistic approach to multimorbidity and functional limitation. It enriches 
existing literature by showing that material, psychosocial and behavioural 
determinants acting simultaneously can explain a share of the health 
inequalities across three different measures of multimorbidity.  
The approach this thesis took is still rare. A systematic review by Moor, Spallek 
& Richter (2017) found only eleven studies which jointly examined the 
contributions of material, psycho-social and behavioural determinants to health 
inequalities. These studies were cross-sectional and used self-reported health as 
the outcome. None examined multimorbidity or functional limitation (Moor, 
Spallek & Richter, 2017). Identifying three simultaneously acting groups of 
determinants challenges the dominant approach stressing ageing in 
combination with lifestyle factors as the major explanatory factors and seeking 
behavioural strategies in prevention (Bartley, 2017; Northwood et al., 2017). 
 
6.4.4 Multiple circumstances in childhood initiate diverging pathways in the 
risk  of adult multimorbidity and functional limitation. 
This thesis advances the methodology of multimorbidity studies through the 
application of complex Structural Equation Model with latent factors. Instead 
of a single measure of the situation in childhood, three domains are used in the 
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same holistic model. Three latent pathways that consist of the material, 
psychosocial and behavioural factors are hypothesized and tested.  
The thesis brings several novel contributions to multimorbidity in the life 
course perspective. Firstly, this study found that the effects of the individual 
differences in social class, adverse experiences and health reported for 
childhood are magnified through the effects of the material, psychosocial and 
behavioural pathways. Secondly, the pre-retirement period (age 50 to 64 years) 
appears to be an important period for adults in England as its impact on 
multimorbidity and functional limitation in old age is larger than the influence 
of childhood circumstances. Thirdly, this does not apply for the psychosocial 
pathway to complex multimorbidity. The effect of adverse childhood 
experiences is stronger than the effect of adult psychosocial circumstances. The 
role of early life seems to be more important for people with complex 
multimorbidity than for people with basic multimorbidity and multiple 
functional limitations. Finally, Chapter 5 took a holistic, multi-causal approach 
to the conceptual framework. Structural Equation Modelling with latent factors 
facilitated operationalizing key variables into multiple domains and treating 
them in the same model. The literature review found only one study of 
multimorbidity with comparable complexity but it lacked latent factors 
(Ferraro, Schafer & Wilkinson, 2016). This thesis also included a broader range 




6.5.1 Relationship between multimorbidity and functional limitation was not 
assessed. 
Studies found that multimorbidity predicts functional limitations (Sibbritt, 
Byles and Regan, 2007; Ryan et al., 2015; Jindai et al., 2016). A linear association 
was suggested where increasing number of morbidities lead to increasing 
number of functional limitations or higher score in a validated measure of 
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function, SF-36. The relationship might be more complex than the one 
described. The one-directional view has been challenged recently and instead 
of causality a “multimorbidity-functional impairment circle” has been proposed 
(Calderón-Larrañaga et al., 2019, p.3). The rationale behind this conception is 
that functional decline and physical limitations during ageing related to 
multimorbidity affect a person’s disease and treatment burden and their 
capacity to respond may further facilitate multimorbidity (Calderón-Larrañaga 
et al., 2019). In this framework, the life course psychosocial, lifestyle and 
biological factors act as determinants of the interaction between 
multimorbidity and physical functioning.  
The life course model in the final analytical chapter indicated  mixed evidence 
on the  potential relationship between multimorbidity and functional 
limitation. On the one hand, the same explanatory mechanisms lead to 
increased risk in both types of multimorbidity and multiple functional 
limitations. This might be interpreted as questioning the assumption of an 
underlying causal pathway leading from multimorbidity to functional 
limitation. On the other hand, Figure 5.3 in Chapter 5 shows an independent 
chain of risk from health in childhood through multimorbidity in pre-
retirement to multiple functional limitations after the age of 64 years. This 
suggests the presence of a causal effect. This thesis does not contribute to the 
current discussion on the relationship between multimorbidity and functional 
limitation. Such an understanding would help the society to identify ageing 
people with multimorbidity who are vulnerable to a range of adverse outcomes. 
 
6.5.2 Specific patterns of multimorbidity were not assessed 
Some combinations of multimorbid conditions have larger combined effects on 
specific health outcomes and use of health care than multimorbidity involving 
other conditions. For example, the common combination of diabetes with 
hypertension was found as causing less demand and the combinations of heart 
failure with COPD and heart failure with chronic kidney disease as causing 
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more demand on health care in England (Kadam et al., 2013). This implies that 
summing up the number of chronic diseases contains inherent limitations, 
especially if the research focus lies in the consequences of multimorbidity for 
health care and quality of life (Ng et al., 2018). This thesis uses the 
complementary measure of complex multimorbidity but this does not fully 
address the problem. The thesis does not consider specific patterns or clusters 
of multimorbidity and their relationship to the broad range of social 
determinants and life course pathways. A cluster of combined physical and 
psychiatric morbidities was found more common in deprived areas and among 
women (Barnett et al., 2012, McLean et al., 2014). More evidence of similar 
cluster-specific morbidities would be beneficial for a better targeting of public 
health interventions.  
 
6.6 Ideas for future development 
 
There are at least two research directions for future development of  the subject 
of this study.  
 
6.6.1 Elucidating the “multimorbidity-functional limitation circle” through 
modelling growth trajectories 
Evaluating the progress in life course epidemiology over the last 20 years, Ben-
Shlomo and Kuh (2016) emphasized the shift in research focus from outcomes 
fixed in time to temporal trajectories in the outcomes. Understanding the early 
development of multimorbidity and functional decline presents a chance for 
policy makers and health care professionals to delay the onset and decline of 
chronic outcomes. Taking the trajectory approach also enables the 
identification of high-risk population groups (Burton-Jeangros et al., 2015; Ben-
Shlomo and Kuh, 2016).  
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Modelling change in intra-personal outcome could be creatively employed to 
explore one of the limitations of this thesis – the unclear relationship between 
multimorbidity and functional limitation. The ‘multimorbidity-functional 
impairment circle’ (Calderón-Larrañaga et al., 2019, p.3) could be disentangled 
by modelling a growth curve model with the number of functional limitations 
as an outcome, with basic and complex multimorbidity as time-varying 
predictors. The framework could combine the structure of the parallel pathways 
from Chapter 5 acting as predictors of the rate of change between 
multimorbidity and functional limitation. The study could examine if the 
diverse social determinants affect the relationship between the outcomes and 
the rate of change differently.  
An alternative might be latent class analysis where individuals are classified into 
distinct groups based on individual response patterns so that those within a 
group are more similar than individuals between groups. Latent class growth 
analysis was used to summarize heterogeneity in the accumulation of 
multimorbidity over time in primary care in older adults.  Five distinct 
longitudinal trajectories of chronic multimorbidity were modelled (Strauss et 
al. 2014, Jackson et al. 2015). They suggest that describing an entire population 
using a single growth trajectory is oversimplifying the complex growth patterns 
that describe continuity and change between different population groups. 
Latent class growth modelling seems to be better at capturing information 
about interindividual differences in intraindividual change while taking into 
account the unobserved heterogeneity (different groups) in a larger population 
(Burton and Jeangros, 2017). 
 
6.6.2 Including biomarkers of allostatic load 
Accumulating knowledge in life course research shows that health trajectories 
are a result of interactions between social and biological processes (Krieger, 
2011; Burton-Jeangros et al., 2015). Incorporating socio-biological mesures into 
studies of multimorbidity opens up an exciting area for exploration. 
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The concept of allostatic load enables empirical measuring of the socio-
biological interaction. Allostatic load is often explained as the “wear and tear” 
of the body that results from repeated attempts to maintain its integrity in 
response to prolonged periods of stress (Beckie, 2012). Such exposures have 
physiological effects that compound over time and trigger chronic disease. 
Allostatic load can be measured through various biomarkers, such as the 
increased production of stress hormones which disrupt the neuroendocrine, 
immune and metabolic systems (Delpierre et al., 2016). A cross-sectional 
association between allostatic load and multimorbidity has been observed by 
Tomasdottir et al. (2015) and explained from a systems biology point of view by 
Juster et al. (2016). As the two concepts are related, they likely share the same 
pathways. Nine biomarker scores of allostatic load were associated with 
material (income, home ownership) and behavioural (smoking) pathways 
during a 20 years period in a Scottish cohort study (Robertson et al., 2015).  
The specific disease profile of the ELSA population, used in this thesis, suggests 
that the biomarkers of the allostatic load might be relevant for this sample. The 
most prevalent diseases that contributed to multimorbidity of the 64-78 age 
cohort in wave 8 were arthritis, respiratory diseases, diabetes, depression, 
coronary heart disease and cancer. Stress pathways with the related allostatic 
load have been found significantly associated with some of these chronic 
diseases (Beckie, 2012; Delpierre et al., 2016). A future study should explore if 
allostatic load represents an important biological mechanism underlying the 
three social pathways that were the focus of this thesis.  
 
6.7 Summary  
 
This thesis identified previously unmeasured polarization in the general 
population with multimorbidity and functional limitation aged 50 or more years 
in England. The polarization relates to an increase in two processes – in the 
complexity of multimorbidity and in social inequality. After establishing robust 
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inequalities in multimorbid population by differences in the amount of 
household wealth in Chapter 3, the focus of the thesis then narrowed down to 
explore if the polarization is related to factors other than the amount of 
household wealth. Chapter 4 introduced theory of social determinants of health 
and health inequalities in order to include a range of material, psychosocial and 
behavioural determinants into the analysis. These determinants were associated 
with the three outcomes. Whether people had minimum, medium or maximum 
of household wealth, sense of control over personal life, physical activity and 
loneliness was associated in a linear way with the risk of having basic 
multimorbidity, complex multimorbidity and functional limitation. The causal 
direction of these associations remained nevertheless unclear. Chapter 5 further 
developed the causal understanding of social determination of multimorbidity 
and functional limitation. A mediation model was postulated to test the relative 
contributions of childhood and adult life circumstances to late life 
multimorbidity and functional limitation. Multimorbidity and functional 
limitation of old people in England was explained by a life course model that 
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